data_6por_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6por _Structure_validation_residue.Date_analyzed 2019-11-29 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 121.384 0.435 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.49 -32.88 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 126.742 2.115 . . . . 0.0 112.875 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -138.88 117.62 12.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.821 1.648 . . . . 0.0 110.145 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.43 -166.7 33.31 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.381 2.419 . . . . 0.0 113.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -113.42 -17.92 12.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.34 114.71 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 121.082 1.764 . . . . 0.0 108.829 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 134.06 54.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.116 1.366 . . . . 0.0 110.884 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.97 -26.32 68.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.125 -1.609 . . . . 0.0 115.047 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -82.87 1.26 40.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.093 1.357 . . . . 0.0 114.513 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -52.78 -44.44 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.919 1.691 . . . . 0.0 114.837 -171.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -121.92 19.53 10.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.831 2.452 . . . . 0.0 111.585 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 154.9 80.81 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 127.604 2.362 . . . . 0.0 112.928 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.05 170.22 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.102 2.534 . . . . 0.0 108.686 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.7 mmt -71.85 63.45 0.46 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.102 0.961 . . . . 0.0 111.907 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.28 -26.72 32.87 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.518 1.927 . . . . 0.0 112.059 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.1 pt -57.59 145.12 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 128.552 2.741 . . . . 0.0 111.512 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -25.26 60.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 125.037 1.461 . . . . 0.0 113.534 171.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.8 -1.12 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.72 2.008 . . . . 0.0 115.496 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -61.23 -18.13 56.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 -168.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -108.85 0.64 20.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.78 85.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.982 1.713 . . . . 0.0 108.774 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 ttt -67.85 -14.28 62.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.864 -1.148 . . . . 0.0 114.058 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.27 -9.49 33.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.662 2.785 . . . . 0.0 113.686 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 t -138.9 174.55 10.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.262 1.425 . . . . 0.0 109.696 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.55 58.39 1.44 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.799 162.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.07 167.07 22.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.535 1.934 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.92 174.62 11.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.706 1.602 . . . . 0.0 113.713 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 174.069 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.6 112.3 4.05 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.668 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 57.84 81.15 0.15 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.862 2.065 . . . . 0.0 114.021 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.98 -148.47 5.29 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 116.339 1.295 . . . . 0.0 116.339 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.6 m -122.67 -36.3 2.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.232 1.813 . . . . 0.0 115.724 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -82.98 118.16 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.221 2.208 . . . . 0.0 107.567 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.86 122.69 6.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.978 1.371 . . . . 0.0 111.5 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -58.06 -33.0 68.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.108 -2.87 . . . . 0.0 113.822 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -97.71 11.52 36.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.018 2.127 . . . . 0.0 112.398 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -48.57 -41.41 30.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.949 2.5 . . . . 0.0 114.138 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -127.74 -2.14 6.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.432 1.093 . . . . 0.0 112.518 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -137.72 150.15 67.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.263 1.425 . . . . 0.0 112.415 -168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.2 143.37 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.446 2.097 . . . . 0.0 112.207 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.3 ptm -66.19 116.27 7.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -130.52 63.93 1.56 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.786 2.834 . . . . 0.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.59 157.36 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.054 1.341 . . . . 0.0 111.932 -171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.58 1.83 1.12 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -57.86 -13.27 4.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -105.77 -4.87 20.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.941 2.097 . . . . 0.0 113.293 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.29 107.43 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.638 1.175 . . . . 0.0 108.82 -167.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.45 58.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.918 2.087 . . . . 0.0 115.71 174.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 116.3 9.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.743 -1.223 . . . . 0.0 112.254 -165.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.63 17.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.163 -0.799 . . . . 0.0 114.085 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 155.92 32.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.024 1.912 . . . . 0.0 113.713 -167.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -141.31 -175.29 4.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.916 1.686 . . . . 0.0 112.612 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.395 1.95 . . . . 0.0 114.929 178.675 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 CA-C-O 117.742 -1.588 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.77 164.1 13.61 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 123.456 1.587 . . . . 0.0 113.914 158.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 58.0 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.765 2.826 . . . . 0.0 117.699 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.74 -172.86 30.4 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 120.651 -1.281 . . . . 0.0 115.416 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -75.8 -54.89 6.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.679 1.192 . . . . 0.0 112.406 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.48 105.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.454 2.302 . . . . 0.0 106.662 -165.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.68 104.08 0.4 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.639 1.576 . . . . 0.0 110.899 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -53.06 -31.07 39.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -164.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.18 -9.19 58.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.875 -1.536 . . . . 0.0 114.135 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.75 -20.72 61.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -136.12 -10.5 1.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -146.65 154.4 48.11 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 128.164 2.586 . . . . 0.0 110.383 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.81 143.66 80.83 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.083 2.522 . . . . 0.0 113.035 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.4 mmm -75.85 64.18 1.78 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.608 2.363 . . . . 0.0 108.068 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -67.47 1.78 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.59 1.956 . . . . 0.0 114.133 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.23 167.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.494 2.318 . . . . 0.0 111.601 -167.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -54.77 -19.64 6.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.822 2.449 . . . . 0.0 117.549 -166.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.92 -8.11 14.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -53.35 -22.08 6.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -110.23 2.18 19.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.757 2.526 . . . . 0.0 116.332 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.15 97.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 120.495 -1.378 . . . . 0.0 107.953 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttp -59.52 -29.23 67.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.313 1.845 . . . . 0.0 113.968 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.87 -1.07 12.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.088 2.555 . . . . 0.0 114.759 171.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -121.12 -176.31 3.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.074 2.55 . . . . 0.0 109.554 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.56 34.0 4.88 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 126.211 1.862 . . . . 0.0 113.562 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.17 160.39 40.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 117.646 0.723 . . . . 0.0 110.126 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -155.34 -173.18 4.45 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.038 2.535 . . . . 0.0 112.573 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.937 -2.465 . . . . 0.0 106.937 -177.817 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.79 -140.34 3.11 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 121.884 2.842 . . . . 0.0 113.229 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -66.99 137.31 56.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.316 2.247 . . . . 0.0 111.745 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.02 -164.38 31.8 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 126.328 1.918 . . . . 0.0 114.133 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 m -134.32 -31.65 1.09 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.6 138.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 107.417 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 128.3 33.59 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.495 -2.003 . . . . 0.0 114.586 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.61 -24.28 66.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.41 -1.757 . . . . 0.0 114.245 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -67.92 -21.39 65.12 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 121.252 1.842 . . . . 0.0 114.99 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -65.56 -36.12 82.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.96 98.91 5.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.497 1.919 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 66.33 156.79 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 129.551 3.14 . . . . 0.0 114.077 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.08 162.76 20.4 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.324 1.349 . . . . 0.0 113.087 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 51.7 mtt -126.75 114.07 17.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.777 163.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -80.9 67.52 6.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.821 -1.174 . . . . 0.0 109.62 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.3 151.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.578 1.951 . . . . 0.0 109.256 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -76.06 9.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -162.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -118.54 1.86 11.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.715 2.406 . . . . 0.0 114.407 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -53.56 -25.65 18.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -160.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.71 -29.13 27.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mp -75.41 116.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.466 0.706 . . . . 0.0 110.361 -158.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.4 mtt -57.92 -50.76 72.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.956 2.102 . . . . 0.0 113.878 -168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.25 6.52 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.259 1.024 . . . . 0.0 113.7 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 173.6 11.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.64 1.976 . . . . 0.0 108.959 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.2 20.33 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.135 -1.369 . . . . 0.0 113.001 162.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -83.87 171.9 12.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.296 2.048 . . . . 0.0 115.533 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.61 -179.06 7.08 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 131.814 4.045 . . . . 0.0 110.545 164.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.053 1.311 . . . . 0.0 111.982 -176.142 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.21 -72.99 0.23 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.115 0.958 . . . . 0.0 113.496 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -101.29 130.65 47.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -161.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.5 -136.05 8.57 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.875 1.226 . . . . 0.0 112.15 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -142.08 -18.33 0.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.44 1.496 . . . . 0.0 113.503 -170.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.9 mt -99.63 113.26 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.86 134.1 37.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 112.757 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.75 -9.85 3.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -93.65 15.43 16.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.263 3.025 . . . . 0.0 115.687 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -47.64 -49.34 27.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.729 2.011 . . . . 0.0 113.567 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -80.75 10.89 4.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.086 1.354 . . . . 0.0 113.726 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 98.78 148.93 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 133.244 4.618 . . . . 0.0 111.118 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -65.83 140.42 61.14 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 122.416 1.898 . . . . 0.0 111.612 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 83.3 mtp -66.1 18.38 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.448 2.299 . . . . 0.0 115.604 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 43.42 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.044 2.138 . . . . 0.0 112.355 -158.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.4 149.68 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.755 1.622 . . . . 0.0 110.478 -166.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -19.53 65.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -173.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.24 11.89 36.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -44.09 -48.8 9.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.51 1.924 . . . . 0.0 112.721 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -59.58 -13.64 10.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.03 121.86 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 121.191 1.814 . . . . 0.0 107.106 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.9 mtp -99.71 -39.68 8.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.001 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -16.45 63.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -149.49 177.98 9.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.858 2.863 . . . . 0.0 108.969 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.35 29.02 15.31 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 121.856 0.698 . . . . 0.0 113.851 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.0 168.05 11.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -126.79 173.66 9.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.432 3.093 . . . . 0.0 109.443 147.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 O-C-N 121.158 -0.964 . . . . 0.0 111.668 -172.564 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.62 77.01 1.64 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 113.569 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t70 57.51 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.204 3.001 . . . . 0.0 117.57 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.24 -156.64 27.25 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.093 1.33 . . . . 0.0 113.029 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -124.18 -38.56 2.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.16 2.184 . . . . 0.0 112.699 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -86.32 140.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.378 1.471 . . . . 0.0 108.449 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.17 130.36 41.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.263 -2.148 . . . . 0.0 111.871 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.42 -40.22 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.831 2.052 . . . . 0.0 112.794 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -82.35 1.88 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.18 3.392 . . . . 0.0 115.421 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -57.8 -56.63 19.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.281 0.946 . . . . 0.0 111.249 168.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -39.98 66.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -166.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -140.94 166.42 22.77 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.063 2.545 . . . . 0.0 110.601 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.41 161.74 6.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.503 2.136 . . . . 0.0 113.384 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.2 mmt -138.47 85.54 2.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.983 2.513 . . . . 0.0 108.808 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -74.88 64.47 1.29 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.312 3.045 . . . . 0.0 111.635 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.76 158.93 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.465 2.706 . . . . 0.0 113.987 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -63.31 -25.43 68.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.48 -15.75 40.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -58.99 -18.11 31.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.76 2.024 . . . . 0.0 115.572 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -86.86 -12.74 46.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.719 -1.238 . . . . 0.0 113.304 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.97 98.5 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.75 2.02 . . . . 0.0 110.358 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -61.22 -34.12 74.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.53 -5.83 55.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -132.99 105.87 7.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.26 61.37 0.02 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -133.43 160.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.804 1.642 . . . . 0.0 115.16 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -149.99 178.6 8.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.537 2.335 . . . . 0.0 111.434 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 O-C-N 121.188 -0.945 . . . . 0.0 115.268 178.392 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.23 98.58 1.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 126.952 2.215 . . . . 0.0 111.273 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 63.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.603 2.761 . . . . 0.0 117.771 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.79 179.88 27.82 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 127.866 2.65 . . . . 0.0 114.466 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -78.64 -17.39 56.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.89 146.72 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.776 1.23 . . . . 0.0 108.704 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.32 135.8 54.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.98 -1.7 . . . . 0.0 111.382 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.48 -29.87 59.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.228 -1.545 . . . . 0.0 114.499 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -106.8 17.3 23.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 130.602 3.561 . . . . 0.0 113.229 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -50.59 -41.33 54.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.68 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -118.02 5.64 12.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -147.64 160.79 37.66 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.95 -1.719 . . . . 0.0 114.108 -164.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.84 169.29 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.869 3.046 . . . . 0.0 113.607 156.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.8 mtm -93.41 -55.21 3.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 111.347 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m170 52.26 26.59 4.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.514 1.926 . . . . 0.0 115.432 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.4 156.34 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.053 2.141 . . . . 0.0 111.905 170.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -58.3 -26.08 62.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.406 2.283 . . . . 0.0 113.941 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -63.79 -7.54 8.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 118.924 -2.36 . . . . 0.0 114.778 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -60.02 -10.06 3.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.75 2.02 . . . . 0.0 114.901 -169.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.88 -8.76 14.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.776 1.631 . . . . 0.0 115.015 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.3 mt -71.6 94.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.41 2.284 . . . . 0.0 108.573 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.7 mtt -57.63 -26.42 61.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.417 1.487 . . . . 0.0 113.998 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.47 0.6 16.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 116.631 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 t -140.44 -172.96 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 118.977 -2.327 . . . . 0.0 111.443 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.58 5.3 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 121.375 -0.828 . . . . 0.0 111.966 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -135.35 156.82 48.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.489 -1.006 . . . . 0.0 111.351 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.07 170.29 19.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 123.911 1.815 . . . . 0.0 113.637 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.477 2.465 . . . . 0.0 113.724 167.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.651 0.621 . . . . 0.0 114.651 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 10.53 13.98 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.16 -1.2 . . . . 0.0 114.571 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -149.58 112.04 4.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.289 1.545 . . . . 0.0 113.603 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.84 -157.37 27.2 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.763 1.649 . . . . 0.0 110.346 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.1 m -125.97 -9.89 6.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.959 -1.318 . . . . 0.0 113.222 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -85.12 113.89 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 120.846 1.657 . . . . 0.0 108.932 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.45 113.12 1.46 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.694 1.712 . . . . 0.0 114.609 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -61.96 -4.44 1.6 Allowed 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.049 -2.907 . . . . 0.0 116.561 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -120.15 -0.92 10.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 129.581 3.153 . . . . 0.0 114.795 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -58.86 -43.3 90.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.746 2.066 . . . . 0.0 113.262 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.54 -68.77 0.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 119.916 -1.74 . . . . 0.0 108.522 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -142.66 140.7 18.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 127.161 2.185 . . . . 0.0 110.362 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -68.72 177.13 5.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.283 1.989 . . . . 0.0 110.883 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.1 mtp -71.64 -5.14 31.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 113.828 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.45 19.14 3.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.809 2.443 . . . . 0.0 116.079 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.7 -175.45 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 126.529 1.932 . . . . 0.0 110.571 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -59.05 6.15 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.591 3.157 . . . . 0.0 118.655 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -122.87 93.69 4.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.119 2.568 . . . . 0.0 112.589 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -150.82 -31.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.736 2.015 . . . . 0.0 114.885 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.05 -18.03 62.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.44 97.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.204 1.802 . . . . 0.0 110.221 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -64.03 -20.77 66.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.329 1.852 . . . . 0.0 114.008 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.7 -2.36 42.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 t -144.62 -173.04 3.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.32 1.448 . . . . 0.0 111.382 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.41 47.23 22.98 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.391 1.472 . . . . 0.0 112.499 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.2 154.08 50.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -138.39 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 166.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 126.766 2.127 . . . . 0.0 111.84 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 CA-C-O 118.074 -1.403 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.36 -31.22 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -133.46 125.73 29.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.22 1.51 . . . . 0.0 113.105 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.27 -164.86 30.68 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.37 1.462 . . . . 0.0 109.645 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -113.74 0.58 14.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.866 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -115.31 141.05 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.376 1.871 . . . . 0.0 110.842 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 126.85 31.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.185 1.394 . . . . 0.0 113.359 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.5 -36.05 82.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.075 0.95 . . . . 0.0 112.283 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -76.2 7.31 4.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -63.95 -49.35 72.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.599 1.545 . . . . 0.0 113.129 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -79.34 -22.56 44.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.22 157.68 25.06 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.999 1.72 . . . . 0.0 113.539 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.46 157.65 60.95 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.603 1.535 . . . . 0.0 108.378 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ptm -151.71 114.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.704 0.802 . . . . 0.0 111.813 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -82.81 71.81 9.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.961 1.305 . . . . 0.0 112.448 -164.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 pt -116.46 154.97 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.396 1.878 . . . . 0.0 113.198 -170.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -71.63 -22.14 61.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -1.43 23.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.591 2.356 . . . . 0.0 112.968 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -52.32 -19.34 2.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.605 1.962 . . . . 0.0 116.241 -169.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -109.39 -7.15 15.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.067 1.747 . . . . 0.0 114.429 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.25 82.01 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 120.437 -1.414 . . . . 0.0 109.362 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.0 ttp -57.3 -25.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.84 2.856 . . . . 0.0 113.774 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -92.44 9.65 33.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.185 1.794 . . . . 0.0 112.726 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 t -146.31 -165.42 2.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.747 -1.846 . . . . 0.0 112.721 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.27 77.17 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.147 2.308 . . . . 0.0 117.736 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -64.64 166.6 8.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.178 1.791 . . . . 0.0 114.899 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -178.87 6.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 114.122 160.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 130.389 3.852 . . . . 0.0 110.147 176.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 20.86 3.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.382 1.468 . . . . 0.0 115.833 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -143.77 110.41 5.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.217 1.509 . . . . 0.0 111.395 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.51 -143.9 15.43 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 126.0 1.762 . . . . 0.0 113.774 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.2 m -145.44 -23.33 0.48 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.47 138.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 118.456 -2.653 . . . . 0.0 110.45 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.44 107.95 0.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.85 1.66 . . . . 0.0 112.589 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.77 -6.27 3.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.98 11.32 19.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -55.12 -29.63 58.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.014 2.125 . . . . 0.0 113.817 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -134.19 58.9 1.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 123.188 1.471 . . . . 0.0 108.613 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -135.53 147.99 63.98 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 127.222 2.209 . . . . 0.0 112.38 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -66.97 167.56 19.48 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.734 2.956 . . . . 0.0 109.421 158.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.61 64.41 0.29 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.495 1.518 . . . . 0.0 113.169 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -149.0 29.19 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.062 1.345 . . . . 0.0 112.738 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 151.57 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.948 2.499 . . . . 0.0 109.693 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -84.14 -4.24 58.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.65 -13.45 61.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -24.52 4.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -131.0 8.01 4.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.065 2.146 . . . . 0.0 113.228 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mp -142.46 88.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.164 2.586 . . . . 0.0 108.803 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.6 mtp -58.94 -32.8 69.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.781 -1.199 . . . . 0.0 112.294 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.65 -28.6 69.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 t -78.09 40.01 0.32 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.344 1.858 . . . . 0.0 112.172 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.75 75.51 0.1 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.255 1.407 . . . . 0.0 114.543 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -111.95 130.22 55.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.16 0.981 . . . . 0.0 110.557 169.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -138.47 166.7 23.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 164.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 129.382 3.372 . . . . 0.0 107.403 174.237 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 116.386 -2.341 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.42 -94.96 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.37 1.585 . . . . 0.0 113.208 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -90.18 154.06 20.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.475 1.51 . . . . 0.0 113.558 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.02 -178.34 28.49 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 127.271 2.367 . . . . 0.0 114.821 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -110.88 -14.37 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.791 1.296 . . . . 0.0 114.377 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 mt -84.53 133.27 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.884 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.33 113.26 5.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.802 1.641 . . . . 0.0 112.758 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -72.84 -39.46 66.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -56.29 -21.22 22.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.357 2.663 . . . . 0.0 114.344 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.56 -36.13 75.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.797 -1.814 . . . . 0.0 114.69 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.944 1.697 . . . . 0.0 113.003 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 72.09 167.33 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.139 1.776 . . . . 0.0 112.141 -170.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 148.33 90.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.761 2.974 . . . . 0.0 115.597 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.5 mtp -85.93 99.31 11.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.879 -1.138 . . . . 0.0 108.605 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.79 22.99 0.17 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.07 1.748 . . . . 0.0 114.139 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.4 164.96 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.32 3.048 . . . . 0.0 111.213 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -16.56 63.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -159.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.31 -6.8 20.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.491 -1.381 . . . . 0.0 114.248 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -59.47 -5.8 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -164.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.66 -3.76 12.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 122.247 2.294 . . . . 0.0 113.947 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.07 104.43 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.831 1.652 . . . . 0.0 111.871 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -29.81 65.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.38 -9.1 58.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.637 1.975 . . . . 0.0 115.521 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -135.0 78.59 1.74 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.138 -1.602 . . . . 0.0 109.804 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.26 28.11 0.26 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.062 1.791 . . . . 0.0 114.121 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -137.63 167.69 21.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -157.44 -175.96 5.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.568 2.747 . . . . 0.0 111.33 173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 C-N-CA 126.554 2.026 . . . . 0.0 112.124 -176.616 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.52 163.45 19.48 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.769 2.128 . . . . 0.0 115.217 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.5 t70 57.59 119.77 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 132.005 4.122 . . . . 0.0 115.621 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 -169.13 24.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.888 2.661 . . . . 0.0 112.422 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -111.34 -14.91 13.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -78.01 111.98 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 120.082 -1.636 . . . . 0.0 106.783 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.99 111.05 2.0 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.187 1.795 . . . . 0.0 112.218 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -70.54 -42.54 71.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 119.843 -1.786 . . . . 0.0 114.515 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -64.92 -25.0 67.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.185 1.394 . . . . 0.0 113.747 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.44 -34.23 77.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.126 -1.609 . . . . 0.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -90.59 -22.11 21.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -137.5 153.48 74.44 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 121.365 1.893 . . . . 0.0 114.791 -167.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.02 168.3 23.59 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 126.161 4.574 . . . . 0.0 113.972 170.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.58 143.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.731 1.612 . . . . 0.0 110.903 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -176.09 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.055 2.942 . . . . 0.0 111.641 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.31 141.04 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.196 0.998 . . . . 0.0 113.415 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -71.3 -9.97 58.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.952 2.101 . . . . 0.0 114.944 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -75.03 85.93 2.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.013 2.125 . . . . 0.0 111.45 151.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -139.63 -6.82 1.31 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.669 1.987 . . . . 0.0 115.262 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -134.21 -24.29 1.64 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.525 1.93 . . . . 0.0 111.528 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.11 107.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.091 1.756 . . . . 0.0 108.363 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.7 mtp -56.76 -21.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -122.43 19.69 10.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.213 1.805 . . . . 0.0 113.725 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -124.74 94.64 4.25 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.979 1.712 . . . . 0.0 109.819 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.93 25.34 0.19 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-O 116.739 -2.145 . . . . 0.0 111.877 -167.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -138.94 158.11 44.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.936 2.368 . . . . 0.0 114.146 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -143.34 -177.65 5.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.21 161.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.734 2.588 . . . . 0.0 116.763 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 94.66 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 127.013 2.244 . . . . 0.0 111.812 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 58.56 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.854 2.462 . . . . 0.0 116.424 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.7 -162.47 32.51 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 126.359 1.933 . . . . 0.0 114.169 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.2 p -124.39 -34.35 2.91 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.115 2.166 . . . . 0.0 115.662 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.24 112.71 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.365 1.866 . . . . 0.0 110.17 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.96 107.64 0.22 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.814 2.046 . . . . 0.0 112.159 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.45 -57.55 12.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.445 1.098 . . . . 0.0 112.036 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.62 -26.93 68.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -65.6 -44.89 85.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.555 0.616 . . . . 0.0 109.984 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -72.03 -34.06 68.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.525 -1.984 . . . . 0.0 115.891 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -147.49 162.12 33.27 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.81 147.2 44.0 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.224 1.949 . . . . 0.0 110.852 163.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.3 132.84 17.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.501 1.12 . . . . 0.0 110.855 170.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -133.35 73.12 1.5 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.551 1.167 . . . . 0.0 110.544 -163.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.14 159.16 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.756 1.265 . . . . 0.0 114.194 -165.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -64.09 -24.73 67.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.89 14.59 2.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.375 1.87 . . . . 0.0 115.661 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -51.87 -43.09 63.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.325 -1.484 . . . . 0.0 114.345 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.19 8.9 7.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.62 114.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 119.952 1.251 . . . . 0.0 108.649 173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.7 mtm -82.01 -18.9 41.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.428 2.291 . . . . 0.0 111.966 173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.97 13.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.795 2.038 . . . . 0.0 114.587 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 t -151.53 -170.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.37 1.868 . . . . 0.0 112.846 -165.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.46 22.53 1.66 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.846 1.689 . . . . 0.0 115.016 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.33 137.2 32.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.802 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.72 -173.01 2.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.932 1.693 . . . . 0.0 112.527 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.336 -1.813 . . . . 0.0 116.376 -172.039 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.66 -15.48 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.09 128.59 12.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.382 2.091 . . . . 0.0 111.84 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.76 -139.37 7.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.287 1.422 . . . . 0.0 113.279 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -142.32 -34.27 0.46 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.8 133.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.74 -1.225 . . . . 0.0 110.069 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.55 129.4 38.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.632 -1.917 . . . . 0.0 109.947 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.74 -6.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 119.094 -2.253 . . . . 0.0 113.681 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -119.48 12.89 12.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.826 2.451 . . . . 0.0 113.495 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -62.72 -29.37 70.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.916 2.486 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -125.07 -0.41 7.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.345 1.858 . . . . 0.0 115.884 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -156.36 167.36 14.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.92 1.688 . . . . 0.0 111.87 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -64.75 170.39 10.08 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.87 2.38 . . . . 0.0 112.625 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.15 49.11 2.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.332 2.653 . . . . 0.0 110.043 165.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.36 47.11 0.36 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.947 3.699 . . . . 0.0 115.524 -169.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.83 -177.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 127.904 2.481 . . . . 0.0 112.09 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -80.15 1.52 27.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -115.39 78.91 1.22 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.238 1.815 . . . . 0.0 110.319 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.88 -0.83 1.14 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -138.04 52.23 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.579 2.352 . . . . 0.0 112.259 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.02 109.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.828 2.051 . . . . 0.0 109.362 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -54.33 -36.57 63.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.653 1.581 . . . . 0.0 113.89 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -86.28 -3.05 58.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 t -100.19 176.42 5.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.811 1.187 . . . . 0.0 112.441 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.47 -4.96 65.79 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 117.289 1.676 . . . . 0.0 117.289 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.06 1.93 . . . . 0.0 111.038 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -171.37 3.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.022 1.729 . . . . 0.0 112.025 167.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.549 2.976 . . . . 0.0 113.488 174.692 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 CA-C-O 121.029 0.238 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.91 -41.38 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 165.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -147.4 111.02 4.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.079 1.351 . . . . 0.0 111.791 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.04 -173.86 36.74 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 126.301 1.905 . . . . 0.0 114.156 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -119.12 -28.78 5.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.26 2.224 . . . . 0.0 113.1 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -73.45 135.39 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.303 1.041 . . . . 0.0 108.273 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.12 133.02 44.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.735 -1.228 . . . . 0.0 111.422 171.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.18 -52.88 52.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.799 0.839 . . . . 0.0 110.191 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -75.64 16.83 0.34 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.758 2.023 . . . . 0.0 113.378 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -48.53 -37.31 17.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.359 2.263 . . . . 0.0 112.698 -170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -99.23 -66.5 0.9 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.867 1.267 . . . . 0.0 111.621 167.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -139.32 153.44 70.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 126.63 1.972 . . . . 0.0 112.483 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.5 154.29 65.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.4 2.067 . . . . 0.0 110.513 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.74 22.53 5.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 119.99 -1.694 . . . . 0.0 113.951 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.0 p80 52.34 2.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 130.289 3.436 . . . . 0.0 118.165 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.95 168.46 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -59.37 -21.43 59.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.589 3.156 . . . . 0.0 115.686 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.64 -4.48 6.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -56.82 -23.6 44.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 167.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.18 11.64 25.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.776 2.43 . . . . 0.0 115.718 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.12 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 123.876 1.798 . . . . 0.0 108.48 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -52.66 -40.13 62.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 129.326 3.05 . . . . 0.0 112.331 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.96 -19.85 61.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.725 2.01 . . . . 0.0 114.478 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 t -131.75 -19.72 2.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -156.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 54.17 1.51 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 117.135 -1.925 . . . . 0.0 113.979 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -132.24 156.27 46.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.487 2.144 . . . . 0.0 114.016 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -143.24 -177.78 5.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.017 2.127 . . . . 0.0 111.493 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.979 1.752 . . . . 0.0 115.472 173.303 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.37 30.66 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.321 0.962 . . . . 0.0 111.752 163.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 49.3 80.75 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.079 2.151 . . . . 0.0 113.662 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.39 -169.13 32.33 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.387 1.47 . . . . 0.0 112.895 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -121.07 -22.16 6.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.932 0.893 . . . . 0.0 113.179 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.0 125.37 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.408 2.683 . . . . 0.0 108.842 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.21 126.23 30.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.862 0.756 . . . . 0.0 112.218 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.16 -55.31 35.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.059 -0.401 . . . . 0.0 110.789 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -64.56 -17.74 64.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -168.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -15.36 -73.0 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.951 3.301 . . . . 0.0 115.56 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -124.95 21.79 8.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.055 0.942 . . . . 0.0 113.274 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.67 158.83 66.08 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.586 1.554 . . . . 0.0 113.754 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.07 -178.27 4.39 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.363 2.042 . . . . 0.0 111.75 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.3 mtp 69.36 57.57 0.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.759 2.424 . . . . 0.0 110.916 -171.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -71.55 70.74 0.67 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.137 2.175 . . . . 0.0 113.358 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.17 -178.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 127.807 2.443 . . . . 0.0 111.384 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -62.31 -5.91 2.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -171.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -73.94 -5.82 43.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 119.203 -2.186 . . . . 0.0 116.838 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -177.12 0.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 163.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 56.74 10.2 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 165.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -66.03 151.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 119.47 -2.019 . . . . 0.0 107.901 165.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.0 ttm -121.63 -46.7 2.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.711 -1.243 . . . . 0.0 113.858 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.08 -7.38 1.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 163.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 t -162.9 -179.98 7.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.781 2.432 . . . . 0.0 111.122 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.51 12.18 33.75 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.508 -0.745 . . . . 0.0 114.88 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -123.5 169.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.525 1.663 . . . . 0.0 113.092 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -154.67 -176.97 6.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.478 2.711 . . . . 0.0 111.296 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 126.866 2.174 . . . . 0.0 111.774 171.083 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 117.574 -1.681 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.49 165.5 13.82 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 126.515 2.007 . . . . 0.0 109.429 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.5 t0 54.02 92.13 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.77 179.57 46.35 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 123.926 0.774 . . . . 0.0 112.682 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 t -94.77 -13.06 26.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.96 135.01 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.348 1.859 . . . . 0.0 110.41 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.37 120.18 12.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.539 1.063 . . . . 0.0 110.927 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.65 7.53 2.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -129.53 10.15 5.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.383 2.273 . . . . 0.0 111.657 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -41.61 -47.45 3.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.641 1.176 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.7 -43.65 0.27 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.251 1.821 . . . . 0.0 112.191 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -47.56 154.36 0.9 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 128.048 2.539 . . . . 0.0 115.289 168.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.51 171.01 12.5 Favored 'Trans proline' 0 N--CA 1.45 -1.069 1 C-N-CA 125.759 4.306 . . . . 0.0 114.792 -175.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.91 21.34 6.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.859 3.263 . . . . 0.0 112.22 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -51.25 -17.04 0.61 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.092 4.157 . . . . 0.0 116.073 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.73 151.24 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 123.264 1.507 . . . . 0.0 114.145 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -61.59 -16.35 47.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.687 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.33 -1.55 24.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.233 1.813 . . . . 0.0 114.141 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -50.9 -35.59 33.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -79.19 -16.26 56.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.968 -1.707 . . . . 0.0 114.262 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.87 105.05 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.708 1.14 . . . . 0.0 108.649 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.4 ptm -73.62 -22.1 60.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.163 0.985 . . . . 0.0 112.707 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.13 -12.27 54.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.9 m -131.33 65.57 1.56 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.655 1.182 . . . . 0.0 109.231 -169.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.58 18.53 5.71 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.303 2.383 . . . . 0.0 112.826 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -134.46 153.01 52.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 123.782 1.753 . . . . 0.0 113.801 -162.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -176.31 5.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 118.79 -2.444 . . . . 0.0 111.912 171.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 125.704 1.621 . . . . 0.0 112.763 -175.053 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.39 9.92 Favored Glycine 0 CA--C 1.522 0.487 0 O-C-N 121.133 -1.216 . . . . 0.0 114.299 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.6 t0 55.53 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.012 3.325 . . . . 0.0 118.646 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.65 -171.3 19.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 126.777 2.132 . . . . 0.0 111.097 -159.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.1 p -134.93 -4.66 2.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.4 123.16 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 120.596 1.544 . . . . 0.0 107.232 168.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 112.17 1.28 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.92 -28.82 70.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.05 1.74 . . . . 0.0 113.017 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -89.37 -6.63 56.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.94 119.61 11.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 121.76 2.073 . . . . 0.0 111.6 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t30 51.66 3.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 129.86 3.264 . . . . 0.0 117.308 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -129.67 146.63 62.0 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 130.482 3.513 . . . . 0.0 109.356 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.18 156.17 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.524 2.149 . . . . 0.0 111.931 -169.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' MET . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -119.07 56.44 0.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.213 2.605 . . . . 0.0 109.785 171.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -71.87 30.02 0.05 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 130.019 3.328 . . . . 0.0 113.526 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' MET . 1.1 pp -132.35 150.32 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 129.438 3.095 . . . . 0.0 113.168 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -57.09 -29.7 63.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -3.25 11.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 114.427 174.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -55.71 -20.05 13.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -103.72 -1.9 27.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.731 2.012 . . . . 0.0 113.08 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.98 98.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -171.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 mmt -54.22 -31.24 52.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.428 1.891 . . . . 0.0 111.811 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -65.44 -28.76 69.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -128.72 63.65 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.466 2.306 . . . . 0.0 110.09 -170.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.8 25.21 9.69 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 115.446 -2.863 . . . . 0.0 114.444 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.31 166.85 23.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.412 2.606 . . . . 0.0 112.824 -158.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -138.19 173.16 11.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.465 1.506 . . . . 0.0 110.99 156.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.594 -175.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.88 -75.74 1.3 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.113 1.34 . . . . 0.0 111.858 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.04 146.79 27.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 123.456 1.598 . . . . 0.0 112.76 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.43 -150.21 21.74 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 120.31 -1.493 . . . . 0.0 112.941 169.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -124.69 -49.92 1.75 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.974 1.31 . . . . 0.0 110.672 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.31 124.13 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 108.099 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.36 130.4 42.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 173.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -77.5 -17.06 58.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.793 -1.817 . . . . 0.0 113.277 -157.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.07 -3.79 18.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 169.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -46.22 -45.74 17.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -112.11 95.48 5.49 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 116.118 -1.896 . . . . 0.0 108.056 165.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 71.13 145.27 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 129.421 3.088 . . . . 0.0 112.938 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -63.27 149.89 90.07 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.146 1.897 . . . . 0.0 112.718 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -62.74 112.72 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.023 1.329 . . . . 0.0 110.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -80.99 -1.0 42.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.973 1.309 . . . . 0.0 114.475 -171.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.13 173.37 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.241 1.417 . . . . 0.0 111.235 162.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -68.4 -32.31 72.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 119.007 -2.308 . . . . 0.0 113.519 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -83.42 103.72 13.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.893 1.224 . . . . 0.0 111.043 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -142.13 -25.32 0.66 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.77 -11.68 60.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.3 mp -72.18 92.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.489 1.116 . . . . 0.0 108.373 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.8 mmm -57.83 -27.23 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.93 -16.24 62.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.354 1.862 . . . . 0.0 113.756 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 t -152.72 96.07 2.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.052 1.341 . . . . 0.0 110.288 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.24 0.39 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.327 1.441 . . . . 0.0 113.064 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -130.95 174.21 10.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.736 1.614 . . . . 0.0 113.936 -167.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.14 179.65 8.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.475 2.31 . . . . 0.0 112.581 170.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.825 3.107 . . . . 0.0 111.829 169.735 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.52 100.1 0.57 Allowed Glycine 0 CA--C 1.522 0.471 0 CA-C-N 120.527 2.163 . . . . 0.0 113.899 174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.2 160.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.516 2.326 . . . . 0.0 116.293 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.79 -143.48 16.94 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.044 -1.66 . . . . 0.0 109.184 -160.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -158.96 -8.56 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 172.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -71.79 124.34 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.48 110.59 0.58 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.811 1.644 . . . . 0.0 113.041 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.68 -6.64 32.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.234 1.413 . . . . 0.0 113.645 -175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.56 -7.16 19.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.136 2.174 . . . . 0.0 114.607 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -91.37 133.63 35.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.235 0.925 . . . . 0.0 113.276 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.41 18.46 2.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.156 2.182 . . . . 0.0 115.234 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -141.91 158.04 63.01 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 117.974 -1.013 . . . . 0.0 111.694 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.65 159.87 45.02 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.294 2.663 . . . . 0.0 110.203 163.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -121.74 -85.22 0.66 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.879 1.672 . . . . 0.0 110.63 -164.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.29 -6.47 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 130.941 3.696 . . . . 0.0 117.324 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 156.55 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 119.558 -1.964 . . . . 0.0 112.493 164.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.49 16.17 0.15 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -90.23 -3.27 57.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.794 1.638 . . . . 0.0 115.068 168.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.02 -7.87 4.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -119.01 -3.76 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.945 2.498 . . . . 0.0 114.182 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.05 101.9 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -160.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 71.6 mmm -60.14 -29.51 68.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -164.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.63 -50.76 69.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.671 1.588 . . . . 0.0 114.475 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 p -86.15 5.11 35.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -166.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.18 31.37 2.61 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 119.647 -1.908 . . . . 0.0 115.133 -171.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -127.62 165.4 20.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.501 1.65 . . . . 0.0 114.366 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -146.06 -173.08 4.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.65 1.98 . . . . 0.0 112.097 159.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.549 2.5 . . . . 0.0 110.843 175.405 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 121.384 0.435 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.49 -32.88 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 126.742 2.115 . . . . 0.0 112.875 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -138.88 117.62 12.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.821 1.648 . . . . 0.0 110.145 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.43 -166.7 33.31 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.381 2.419 . . . . 0.0 113.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -113.42 -17.92 12.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.34 114.71 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 121.082 1.764 . . . . 0.0 108.829 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 134.06 54.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.116 1.366 . . . . 0.0 110.884 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.97 -26.32 68.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.125 -1.609 . . . . 0.0 115.047 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -82.87 1.26 40.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.093 1.357 . . . . 0.0 114.513 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -52.78 -44.44 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.919 1.691 . . . . 0.0 114.837 -171.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -121.92 19.53 10.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.831 2.452 . . . . 0.0 111.585 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 154.9 80.81 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 127.604 2.362 . . . . 0.0 112.928 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.05 170.22 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.102 2.534 . . . . 0.0 108.686 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.7 mmt -71.85 63.45 0.46 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.102 0.961 . . . . 0.0 111.907 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.28 -26.72 32.87 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.518 1.927 . . . . 0.0 112.059 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.1 pt -57.59 145.12 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 128.552 2.741 . . . . 0.0 111.512 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -25.26 60.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 125.037 1.461 . . . . 0.0 113.534 171.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.8 -1.12 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.72 2.008 . . . . 0.0 115.496 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -61.23 -18.13 56.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 -168.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -108.85 0.64 20.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.78 85.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.982 1.713 . . . . 0.0 108.774 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 ttt -67.85 -14.28 62.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.864 -1.148 . . . . 0.0 114.058 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.27 -9.49 33.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.662 2.785 . . . . 0.0 113.686 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 t -138.9 174.55 10.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.262 1.425 . . . . 0.0 109.696 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.55 58.39 1.44 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.799 162.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.07 167.07 22.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.535 1.934 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.92 174.62 11.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.706 1.602 . . . . 0.0 113.713 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 174.069 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.6 112.3 4.05 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.668 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 57.84 81.15 0.15 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.862 2.065 . . . . 0.0 114.021 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.98 -148.47 5.29 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 116.339 1.295 . . . . 0.0 116.339 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.6 m -122.67 -36.3 2.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.232 1.813 . . . . 0.0 115.724 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -82.98 118.16 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.221 2.208 . . . . 0.0 107.567 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.86 122.69 6.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.978 1.371 . . . . 0.0 111.5 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -58.06 -33.0 68.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.108 -2.87 . . . . 0.0 113.822 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -97.71 11.52 36.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.018 2.127 . . . . 0.0 112.398 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -48.57 -41.41 30.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.949 2.5 . . . . 0.0 114.138 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -127.74 -2.14 6.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.432 1.093 . . . . 0.0 112.518 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -137.72 150.15 67.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.263 1.425 . . . . 0.0 112.415 -168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.2 143.37 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.446 2.097 . . . . 0.0 112.207 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.3 ptm -66.19 116.27 7.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -130.52 63.93 1.56 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.786 2.834 . . . . 0.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.59 157.36 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.054 1.341 . . . . 0.0 111.932 -171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.58 1.83 1.12 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -57.86 -13.27 4.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -105.77 -4.87 20.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.941 2.097 . . . . 0.0 113.293 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.29 107.43 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.638 1.175 . . . . 0.0 108.82 -167.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.45 58.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.918 2.087 . . . . 0.0 115.71 174.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 116.3 9.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.743 -1.223 . . . . 0.0 112.254 -165.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.63 17.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.163 -0.799 . . . . 0.0 114.085 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 155.92 32.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.024 1.912 . . . . 0.0 113.713 -167.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -141.31 -175.29 4.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.916 1.686 . . . . 0.0 112.612 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.395 1.95 . . . . 0.0 114.929 178.675 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 CA-C-O 117.742 -1.588 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.77 164.1 13.61 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 123.456 1.587 . . . . 0.0 113.914 158.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 58.0 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.765 2.826 . . . . 0.0 117.699 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.74 -172.86 30.4 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 120.651 -1.281 . . . . 0.0 115.416 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -75.8 -54.89 6.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.679 1.192 . . . . 0.0 112.406 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.48 105.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.454 2.302 . . . . 0.0 106.662 -165.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.68 104.08 0.4 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.639 1.576 . . . . 0.0 110.899 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -53.06 -31.07 39.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -164.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.18 -9.19 58.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.875 -1.536 . . . . 0.0 114.135 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.75 -20.72 61.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -136.12 -10.5 1.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -146.65 154.4 48.11 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 128.164 2.586 . . . . 0.0 110.383 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.81 143.66 80.83 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.083 2.522 . . . . 0.0 113.035 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.4 mmm -75.85 64.18 1.78 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.608 2.363 . . . . 0.0 108.068 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -67.47 1.78 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.59 1.956 . . . . 0.0 114.133 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.23 167.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.494 2.318 . . . . 0.0 111.601 -167.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -54.77 -19.64 6.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.822 2.449 . . . . 0.0 117.549 -166.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.92 -8.11 14.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -53.35 -22.08 6.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -110.23 2.18 19.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.757 2.526 . . . . 0.0 116.332 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.15 97.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 120.495 -1.378 . . . . 0.0 107.953 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttp -59.52 -29.23 67.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.313 1.845 . . . . 0.0 113.968 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.87 -1.07 12.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.088 2.555 . . . . 0.0 114.759 171.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -121.12 -176.31 3.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.074 2.55 . . . . 0.0 109.554 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.56 34.0 4.88 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 126.211 1.862 . . . . 0.0 113.562 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.17 160.39 40.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 117.646 0.723 . . . . 0.0 110.126 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -155.34 -173.18 4.45 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.038 2.535 . . . . 0.0 112.573 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.937 -2.465 . . . . 0.0 106.937 -177.817 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.79 -140.34 3.11 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 121.884 2.842 . . . . 0.0 113.229 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -66.99 137.31 56.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.316 2.247 . . . . 0.0 111.745 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.02 -164.38 31.8 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 126.328 1.918 . . . . 0.0 114.133 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 m -134.32 -31.65 1.09 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.6 138.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 107.417 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 128.3 33.59 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.495 -2.003 . . . . 0.0 114.586 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.61 -24.28 66.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.41 -1.757 . . . . 0.0 114.245 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -67.92 -21.39 65.12 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 121.252 1.842 . . . . 0.0 114.99 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -65.56 -36.12 82.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.96 98.91 5.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.497 1.919 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 66.33 156.79 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 129.551 3.14 . . . . 0.0 114.077 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.08 162.76 20.4 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.324 1.349 . . . . 0.0 113.087 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 51.7 mtt -126.75 114.07 17.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.777 163.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -80.9 67.52 6.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.821 -1.174 . . . . 0.0 109.62 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.3 151.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.578 1.951 . . . . 0.0 109.256 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -76.06 9.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -162.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -118.54 1.86 11.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.715 2.406 . . . . 0.0 114.407 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -53.56 -25.65 18.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -160.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.71 -29.13 27.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mp -75.41 116.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.466 0.706 . . . . 0.0 110.361 -158.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.4 mtt -57.92 -50.76 72.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.956 2.102 . . . . 0.0 113.878 -168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.25 6.52 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.259 1.024 . . . . 0.0 113.7 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 173.6 11.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.64 1.976 . . . . 0.0 108.959 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.2 20.33 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.135 -1.369 . . . . 0.0 113.001 162.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -83.87 171.9 12.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.296 2.048 . . . . 0.0 115.533 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.61 -179.06 7.08 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 131.814 4.045 . . . . 0.0 110.545 164.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.053 1.311 . . . . 0.0 111.982 -176.142 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.21 -72.99 0.23 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.115 0.958 . . . . 0.0 113.496 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -101.29 130.65 47.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -161.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.5 -136.05 8.57 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.875 1.226 . . . . 0.0 112.15 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -142.08 -18.33 0.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.44 1.496 . . . . 0.0 113.503 -170.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.9 mt -99.63 113.26 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.86 134.1 37.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 112.757 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.75 -9.85 3.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -93.65 15.43 16.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.263 3.025 . . . . 0.0 115.687 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -47.64 -49.34 27.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.729 2.011 . . . . 0.0 113.567 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -80.75 10.89 4.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.086 1.354 . . . . 0.0 113.726 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 98.78 148.93 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 133.244 4.618 . . . . 0.0 111.118 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -65.83 140.42 61.14 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 122.416 1.898 . . . . 0.0 111.612 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 83.3 mtp -66.1 18.38 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.448 2.299 . . . . 0.0 115.604 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 43.42 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.044 2.138 . . . . 0.0 112.355 -158.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.4 149.68 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.755 1.622 . . . . 0.0 110.478 -166.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -19.53 65.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -173.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.24 11.89 36.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -44.09 -48.8 9.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.51 1.924 . . . . 0.0 112.721 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -59.58 -13.64 10.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.03 121.86 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 121.191 1.814 . . . . 0.0 107.106 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.9 mtp -99.71 -39.68 8.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.001 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -16.45 63.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -149.49 177.98 9.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.858 2.863 . . . . 0.0 108.969 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.35 29.02 15.31 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 121.856 0.698 . . . . 0.0 113.851 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.0 168.05 11.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -126.79 173.66 9.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.432 3.093 . . . . 0.0 109.443 147.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 O-C-N 121.158 -0.964 . . . . 0.0 111.668 -172.564 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.62 77.01 1.64 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 113.569 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t70 57.51 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.204 3.001 . . . . 0.0 117.57 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.24 -156.64 27.25 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.093 1.33 . . . . 0.0 113.029 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -124.18 -38.56 2.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.16 2.184 . . . . 0.0 112.699 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -86.32 140.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.378 1.471 . . . . 0.0 108.449 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.17 130.36 41.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.263 -2.148 . . . . 0.0 111.871 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.42 -40.22 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.831 2.052 . . . . 0.0 112.794 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -82.35 1.88 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.18 3.392 . . . . 0.0 115.421 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -57.8 -56.63 19.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.281 0.946 . . . . 0.0 111.249 168.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -39.98 66.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -166.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -140.94 166.42 22.77 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.063 2.545 . . . . 0.0 110.601 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.41 161.74 6.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.503 2.136 . . . . 0.0 113.384 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.2 mmt -138.47 85.54 2.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.983 2.513 . . . . 0.0 108.808 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -74.88 64.47 1.29 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.312 3.045 . . . . 0.0 111.635 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.76 158.93 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.465 2.706 . . . . 0.0 113.987 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -63.31 -25.43 68.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.48 -15.75 40.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -58.99 -18.11 31.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.76 2.024 . . . . 0.0 115.572 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -86.86 -12.74 46.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.719 -1.238 . . . . 0.0 113.304 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.97 98.5 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.75 2.02 . . . . 0.0 110.358 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -61.22 -34.12 74.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.53 -5.83 55.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -132.99 105.87 7.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.26 61.37 0.02 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -133.43 160.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.804 1.642 . . . . 0.0 115.16 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -149.99 178.6 8.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.537 2.335 . . . . 0.0 111.434 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 O-C-N 121.188 -0.945 . . . . 0.0 115.268 178.392 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.23 98.58 1.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 126.952 2.215 . . . . 0.0 111.273 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 63.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.603 2.761 . . . . 0.0 117.771 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.79 179.88 27.82 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 127.866 2.65 . . . . 0.0 114.466 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -78.64 -17.39 56.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.89 146.72 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.776 1.23 . . . . 0.0 108.704 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.32 135.8 54.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.98 -1.7 . . . . 0.0 111.382 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.48 -29.87 59.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.228 -1.545 . . . . 0.0 114.499 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -106.8 17.3 23.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 130.602 3.561 . . . . 0.0 113.229 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -50.59 -41.33 54.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.68 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -118.02 5.64 12.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -147.64 160.79 37.66 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.95 -1.719 . . . . 0.0 114.108 -164.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.84 169.29 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.869 3.046 . . . . 0.0 113.607 156.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.8 mtm -93.41 -55.21 3.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 111.347 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m170 52.26 26.59 4.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.514 1.926 . . . . 0.0 115.432 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.4 156.34 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.053 2.141 . . . . 0.0 111.905 170.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -58.3 -26.08 62.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.406 2.283 . . . . 0.0 113.941 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -63.79 -7.54 8.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 118.924 -2.36 . . . . 0.0 114.778 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -60.02 -10.06 3.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.75 2.02 . . . . 0.0 114.901 -169.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.88 -8.76 14.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.776 1.631 . . . . 0.0 115.015 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.3 mt -71.6 94.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.41 2.284 . . . . 0.0 108.573 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.7 mtt -57.63 -26.42 61.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.417 1.487 . . . . 0.0 113.998 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.47 0.6 16.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 116.631 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 t -140.44 -172.96 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 118.977 -2.327 . . . . 0.0 111.443 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.58 5.3 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 121.375 -0.828 . . . . 0.0 111.966 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -135.35 156.82 48.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.489 -1.006 . . . . 0.0 111.351 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.07 170.29 19.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 123.911 1.815 . . . . 0.0 113.637 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.477 2.465 . . . . 0.0 113.724 167.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.651 0.621 . . . . 0.0 114.651 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 10.53 13.98 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.16 -1.2 . . . . 0.0 114.571 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -149.58 112.04 4.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.289 1.545 . . . . 0.0 113.603 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.84 -157.37 27.2 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.763 1.649 . . . . 0.0 110.346 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.1 m -125.97 -9.89 6.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.959 -1.318 . . . . 0.0 113.222 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -85.12 113.89 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 120.846 1.657 . . . . 0.0 108.932 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.45 113.12 1.46 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.694 1.712 . . . . 0.0 114.609 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -61.96 -4.44 1.6 Allowed 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.049 -2.907 . . . . 0.0 116.561 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -120.15 -0.92 10.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 129.581 3.153 . . . . 0.0 114.795 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -58.86 -43.3 90.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.746 2.066 . . . . 0.0 113.262 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.54 -68.77 0.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 119.916 -1.74 . . . . 0.0 108.522 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -142.66 140.7 18.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 127.161 2.185 . . . . 0.0 110.362 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -68.72 177.13 5.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.283 1.989 . . . . 0.0 110.883 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.1 mtp -71.64 -5.14 31.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 113.828 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.45 19.14 3.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.809 2.443 . . . . 0.0 116.079 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.7 -175.45 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 126.529 1.932 . . . . 0.0 110.571 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -59.05 6.15 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.591 3.157 . . . . 0.0 118.655 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -122.87 93.69 4.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.119 2.568 . . . . 0.0 112.589 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.5 p-90 -150.82 -31.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.736 2.015 . . . . 0.0 114.885 167.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -71.05 -18.03 62.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.44 97.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.204 1.802 . . . . 0.0 110.221 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -64.03 -20.77 66.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.329 1.852 . . . . 0.0 114.008 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.7 -2.36 42.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 t -144.62 -173.04 3.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.32 1.448 . . . . 0.0 111.382 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.41 47.23 22.98 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.391 1.472 . . . . 0.0 112.499 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.2 154.08 50.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -138.39 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 166.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 126.766 2.127 . . . . 0.0 111.84 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 CA-C-O 118.074 -1.403 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.36 -31.22 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -133.46 125.73 29.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.22 1.51 . . . . 0.0 113.105 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.27 -164.86 30.68 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.37 1.462 . . . . 0.0 109.645 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -113.74 0.58 14.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.866 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -115.31 141.05 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.376 1.871 . . . . 0.0 110.842 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 126.85 31.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.185 1.394 . . . . 0.0 113.359 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.5 -36.05 82.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.075 0.95 . . . . 0.0 112.283 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -76.2 7.31 4.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -63.95 -49.35 72.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.599 1.545 . . . . 0.0 113.129 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -79.34 -22.56 44.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.22 157.68 25.06 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.999 1.72 . . . . 0.0 113.539 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.46 157.65 60.95 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.603 1.535 . . . . 0.0 108.378 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ptm -151.71 114.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.704 0.802 . . . . 0.0 111.813 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -82.81 71.81 9.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.961 1.305 . . . . 0.0 112.448 -164.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 pt -116.46 154.97 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.396 1.878 . . . . 0.0 113.198 -170.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -71.63 -22.14 61.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -1.43 23.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.591 2.356 . . . . 0.0 112.968 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -52.32 -19.34 2.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.605 1.962 . . . . 0.0 116.241 -169.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -109.39 -7.15 15.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.067 1.747 . . . . 0.0 114.429 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.25 82.01 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 120.437 -1.414 . . . . 0.0 109.362 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.0 ttp -57.3 -25.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.84 2.856 . . . . 0.0 113.774 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -92.44 9.65 33.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.185 1.794 . . . . 0.0 112.726 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 t -146.31 -165.42 2.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.747 -1.846 . . . . 0.0 112.721 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.27 77.17 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.147 2.308 . . . . 0.0 117.736 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -64.64 166.6 8.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.178 1.791 . . . . 0.0 114.899 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -178.87 6.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 114.122 160.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 130.389 3.852 . . . . 0.0 110.147 176.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 20.86 3.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.382 1.468 . . . . 0.0 115.833 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -143.77 110.41 5.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.217 1.509 . . . . 0.0 111.395 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.51 -143.9 15.43 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 126.0 1.762 . . . . 0.0 113.774 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.2 m -145.44 -23.33 0.48 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.47 138.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 118.456 -2.653 . . . . 0.0 110.45 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.44 107.95 0.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.85 1.66 . . . . 0.0 112.589 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.77 -6.27 3.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.98 11.32 19.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -55.12 -29.63 58.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.014 2.125 . . . . 0.0 113.817 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -134.19 58.9 1.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 123.188 1.471 . . . . 0.0 108.613 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -135.53 147.99 63.98 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 127.222 2.209 . . . . 0.0 112.38 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -66.97 167.56 19.48 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.734 2.956 . . . . 0.0 109.421 158.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.61 64.41 0.29 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.495 1.518 . . . . 0.0 113.169 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -149.0 29.19 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.062 1.345 . . . . 0.0 112.738 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 151.57 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.948 2.499 . . . . 0.0 109.693 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -84.14 -4.24 58.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.65 -13.45 61.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -24.52 4.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -131.0 8.01 4.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.065 2.146 . . . . 0.0 113.228 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mp -142.46 88.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.164 2.586 . . . . 0.0 108.803 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.6 mtp -58.94 -32.8 69.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.781 -1.199 . . . . 0.0 112.294 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.65 -28.6 69.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 t -78.09 40.01 0.32 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.344 1.858 . . . . 0.0 112.172 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.75 75.51 0.1 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.255 1.407 . . . . 0.0 114.543 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -111.95 130.22 55.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.16 0.981 . . . . 0.0 110.557 169.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -138.47 166.7 23.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 164.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 129.382 3.372 . . . . 0.0 107.403 174.237 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 116.386 -2.341 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.42 -94.96 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.37 1.585 . . . . 0.0 113.208 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -90.18 154.06 20.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.475 1.51 . . . . 0.0 113.558 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.02 -178.34 28.49 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 127.271 2.367 . . . . 0.0 114.821 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -110.88 -14.37 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.791 1.296 . . . . 0.0 114.377 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 mt -84.53 133.27 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.884 168.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.33 113.26 5.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.802 1.641 . . . . 0.0 112.758 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -72.84 -39.46 66.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -56.29 -21.22 22.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.357 2.663 . . . . 0.0 114.344 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.56 -36.13 75.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.797 -1.814 . . . . 0.0 114.69 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.944 1.697 . . . . 0.0 113.003 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 72.09 167.33 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.139 1.776 . . . . 0.0 112.141 -170.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 148.33 90.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.761 2.974 . . . . 0.0 115.597 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.5 mtp -85.93 99.31 11.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.879 -1.138 . . . . 0.0 108.605 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.79 22.99 0.17 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.07 1.748 . . . . 0.0 114.139 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.4 164.96 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.32 3.048 . . . . 0.0 111.213 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -16.56 63.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -159.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.31 -6.8 20.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.491 -1.381 . . . . 0.0 114.248 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -59.47 -5.8 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -164.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.66 -3.76 12.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 122.247 2.294 . . . . 0.0 113.947 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.07 104.43 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.831 1.652 . . . . 0.0 111.871 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -29.81 65.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.38 -9.1 58.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.637 1.975 . . . . 0.0 115.521 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -135.0 78.59 1.74 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.138 -1.602 . . . . 0.0 109.804 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.26 28.11 0.26 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.062 1.791 . . . . 0.0 114.121 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -137.63 167.69 21.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -157.44 -175.96 5.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.568 2.747 . . . . 0.0 111.33 173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 C-N-CA 126.554 2.026 . . . . 0.0 112.124 -176.616 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.52 163.45 19.48 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.769 2.128 . . . . 0.0 115.217 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.5 t70 57.59 119.77 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 132.005 4.122 . . . . 0.0 115.621 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 -169.13 24.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.888 2.661 . . . . 0.0 112.422 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -111.34 -14.91 13.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -78.01 111.98 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 120.082 -1.636 . . . . 0.0 106.783 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.99 111.05 2.0 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.187 1.795 . . . . 0.0 112.218 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -70.54 -42.54 71.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 119.843 -1.786 . . . . 0.0 114.515 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -64.92 -25.0 67.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.185 1.394 . . . . 0.0 113.747 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.44 -34.23 77.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.126 -1.609 . . . . 0.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -90.59 -22.11 21.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -137.5 153.48 74.44 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 121.365 1.893 . . . . 0.0 114.791 -167.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.02 168.3 23.59 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 126.161 4.574 . . . . 0.0 113.972 170.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.58 143.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.731 1.612 . . . . 0.0 110.903 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -176.09 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.055 2.942 . . . . 0.0 111.641 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.31 141.04 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.196 0.998 . . . . 0.0 113.415 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -71.3 -9.97 58.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.952 2.101 . . . . 0.0 114.944 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -75.03 85.93 2.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.013 2.125 . . . . 0.0 111.45 151.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -139.63 -6.82 1.31 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.669 1.987 . . . . 0.0 115.262 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -134.21 -24.29 1.64 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.525 1.93 . . . . 0.0 111.528 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.11 107.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.091 1.756 . . . . 0.0 108.363 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.7 mtp -56.76 -21.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -122.43 19.69 10.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.213 1.805 . . . . 0.0 113.725 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -124.74 94.64 4.25 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.979 1.712 . . . . 0.0 109.819 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.93 25.34 0.19 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-O 116.739 -2.145 . . . . 0.0 111.877 -167.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -138.94 158.11 44.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.936 2.368 . . . . 0.0 114.146 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -143.34 -177.65 5.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.21 161.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.734 2.588 . . . . 0.0 116.763 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 94.66 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 127.013 2.244 . . . . 0.0 111.812 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 58.56 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.854 2.462 . . . . 0.0 116.424 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.7 -162.47 32.51 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 126.359 1.933 . . . . 0.0 114.169 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.2 p -124.39 -34.35 2.91 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.115 2.166 . . . . 0.0 115.662 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.24 112.71 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.365 1.866 . . . . 0.0 110.17 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.96 107.64 0.22 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.814 2.046 . . . . 0.0 112.159 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.45 -57.55 12.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.445 1.098 . . . . 0.0 112.036 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.62 -26.93 68.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -65.6 -44.89 85.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.555 0.616 . . . . 0.0 109.984 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -72.03 -34.06 68.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.525 -1.984 . . . . 0.0 115.891 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -147.49 162.12 33.27 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.81 147.2 44.0 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.224 1.949 . . . . 0.0 110.852 163.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.3 132.84 17.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.501 1.12 . . . . 0.0 110.855 170.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -133.35 73.12 1.5 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.551 1.167 . . . . 0.0 110.544 -163.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.14 159.16 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.756 1.265 . . . . 0.0 114.194 -165.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -64.09 -24.73 67.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.89 14.59 2.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.375 1.87 . . . . 0.0 115.661 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -51.87 -43.09 63.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.325 -1.484 . . . . 0.0 114.345 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.19 8.9 7.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.62 114.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 119.952 1.251 . . . . 0.0 108.649 173.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.7 mtm -82.01 -18.9 41.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.428 2.291 . . . . 0.0 111.966 173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.97 13.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.795 2.038 . . . . 0.0 114.587 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 t -151.53 -170.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.37 1.868 . . . . 0.0 112.846 -165.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.46 22.53 1.66 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.846 1.689 . . . . 0.0 115.016 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.33 137.2 32.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.802 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.72 -173.01 2.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.932 1.693 . . . . 0.0 112.527 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.336 -1.813 . . . . 0.0 116.376 -172.039 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.66 -15.48 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.09 128.59 12.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.382 2.091 . . . . 0.0 111.84 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.76 -139.37 7.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.287 1.422 . . . . 0.0 113.279 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -142.32 -34.27 0.46 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.8 133.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.74 -1.225 . . . . 0.0 110.069 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.55 129.4 38.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.632 -1.917 . . . . 0.0 109.947 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.74 -6.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 119.094 -2.253 . . . . 0.0 113.681 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -119.48 12.89 12.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.826 2.451 . . . . 0.0 113.495 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -62.72 -29.37 70.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.916 2.486 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -125.07 -0.41 7.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.345 1.858 . . . . 0.0 115.884 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -156.36 167.36 14.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.92 1.688 . . . . 0.0 111.87 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -64.75 170.39 10.08 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.87 2.38 . . . . 0.0 112.625 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.15 49.11 2.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.332 2.653 . . . . 0.0 110.043 165.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.36 47.11 0.36 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.947 3.699 . . . . 0.0 115.524 -169.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.83 -177.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 127.904 2.481 . . . . 0.0 112.09 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -80.15 1.52 27.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -115.39 78.91 1.22 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.238 1.815 . . . . 0.0 110.319 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.88 -0.83 1.14 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -138.04 52.23 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.579 2.352 . . . . 0.0 112.259 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.02 109.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.828 2.051 . . . . 0.0 109.362 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -54.33 -36.57 63.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.653 1.581 . . . . 0.0 113.89 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -86.28 -3.05 58.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 t -100.19 176.42 5.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.811 1.187 . . . . 0.0 112.441 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.47 -4.96 65.79 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 117.289 1.676 . . . . 0.0 117.289 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.06 1.93 . . . . 0.0 111.038 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -171.37 3.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.022 1.729 . . . . 0.0 112.025 167.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.549 2.976 . . . . 0.0 113.488 174.692 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 CA-C-O 121.029 0.238 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.91 -41.38 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 165.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -147.4 111.02 4.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.079 1.351 . . . . 0.0 111.791 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.04 -173.86 36.74 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 126.301 1.905 . . . . 0.0 114.156 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -119.12 -28.78 5.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.26 2.224 . . . . 0.0 113.1 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -73.45 135.39 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.303 1.041 . . . . 0.0 108.273 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.12 133.02 44.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.735 -1.228 . . . . 0.0 111.422 171.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.18 -52.88 52.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.799 0.839 . . . . 0.0 110.191 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -75.64 16.83 0.34 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.758 2.023 . . . . 0.0 113.378 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -48.53 -37.31 17.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.359 2.263 . . . . 0.0 112.698 -170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -99.23 -66.5 0.9 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.867 1.267 . . . . 0.0 111.621 167.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -139.32 153.44 70.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 126.63 1.972 . . . . 0.0 112.483 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.5 154.29 65.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.4 2.067 . . . . 0.0 110.513 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.74 22.53 5.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 119.99 -1.694 . . . . 0.0 113.951 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.0 p80 52.34 2.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 130.289 3.436 . . . . 0.0 118.165 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.95 168.46 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -59.37 -21.43 59.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.589 3.156 . . . . 0.0 115.686 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.64 -4.48 6.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -56.82 -23.6 44.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 167.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.18 11.64 25.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.776 2.43 . . . . 0.0 115.718 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.12 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 123.876 1.798 . . . . 0.0 108.48 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -52.66 -40.13 62.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 129.326 3.05 . . . . 0.0 112.331 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.96 -19.85 61.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.725 2.01 . . . . 0.0 114.478 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 t -131.75 -19.72 2.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -156.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 54.17 1.51 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 117.135 -1.925 . . . . 0.0 113.979 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -132.24 156.27 46.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.487 2.144 . . . . 0.0 114.016 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -143.24 -177.78 5.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.017 2.127 . . . . 0.0 111.493 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.979 1.752 . . . . 0.0 115.472 173.303 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.37 30.66 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.321 0.962 . . . . 0.0 111.752 163.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 49.3 80.75 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.079 2.151 . . . . 0.0 113.662 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.39 -169.13 32.33 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.387 1.47 . . . . 0.0 112.895 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -121.07 -22.16 6.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.932 0.893 . . . . 0.0 113.179 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.0 125.37 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.408 2.683 . . . . 0.0 108.842 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.21 126.23 30.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.862 0.756 . . . . 0.0 112.218 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.16 -55.31 35.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.059 -0.401 . . . . 0.0 110.789 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -64.56 -17.74 64.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -168.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -15.36 -73.0 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.951 3.301 . . . . 0.0 115.56 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -124.95 21.79 8.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.055 0.942 . . . . 0.0 113.274 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.67 158.83 66.08 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.586 1.554 . . . . 0.0 113.754 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.07 -178.27 4.39 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.363 2.042 . . . . 0.0 111.75 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.3 mtp 69.36 57.57 0.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.759 2.424 . . . . 0.0 110.916 -171.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -71.55 70.74 0.67 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.137 2.175 . . . . 0.0 113.358 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.17 -178.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 127.807 2.443 . . . . 0.0 111.384 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -62.31 -5.91 2.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -171.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -73.94 -5.82 43.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 119.203 -2.186 . . . . 0.0 116.838 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -177.12 0.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 163.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 56.74 10.2 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 165.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -66.03 151.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 119.47 -2.019 . . . . 0.0 107.901 165.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.0 ttm -121.63 -46.7 2.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.711 -1.243 . . . . 0.0 113.858 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.08 -7.38 1.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 163.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 t -162.9 -179.98 7.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.781 2.432 . . . . 0.0 111.122 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.51 12.18 33.75 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.508 -0.745 . . . . 0.0 114.88 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -123.5 169.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.525 1.663 . . . . 0.0 113.092 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -154.67 -176.97 6.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.478 2.711 . . . . 0.0 111.296 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 126.866 2.174 . . . . 0.0 111.774 171.083 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 117.574 -1.681 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.49 165.5 13.82 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 126.515 2.007 . . . . 0.0 109.429 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.5 t0 54.02 92.13 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.77 179.57 46.35 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 123.926 0.774 . . . . 0.0 112.682 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 t -94.77 -13.06 26.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.96 135.01 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.348 1.859 . . . . 0.0 110.41 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.37 120.18 12.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.539 1.063 . . . . 0.0 110.927 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.65 7.53 2.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -129.53 10.15 5.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.383 2.273 . . . . 0.0 111.657 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -41.61 -47.45 3.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.641 1.176 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.7 -43.65 0.27 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.251 1.821 . . . . 0.0 112.191 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -47.56 154.36 0.9 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 128.048 2.539 . . . . 0.0 115.289 168.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.51 171.01 12.5 Favored 'Trans proline' 0 N--CA 1.45 -1.069 1 C-N-CA 125.759 4.306 . . . . 0.0 114.792 -175.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.91 21.34 6.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.859 3.263 . . . . 0.0 112.22 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -51.25 -17.04 0.61 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.092 4.157 . . . . 0.0 116.073 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.73 151.24 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 123.264 1.507 . . . . 0.0 114.145 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -61.59 -16.35 47.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.687 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.33 -1.55 24.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.233 1.813 . . . . 0.0 114.141 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -50.9 -35.59 33.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -79.19 -16.26 56.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.968 -1.707 . . . . 0.0 114.262 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.87 105.05 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.708 1.14 . . . . 0.0 108.649 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.4 ptm -73.62 -22.1 60.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.163 0.985 . . . . 0.0 112.707 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.13 -12.27 54.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.9 m -131.33 65.57 1.56 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.655 1.182 . . . . 0.0 109.231 -169.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.58 18.53 5.71 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.303 2.383 . . . . 0.0 112.826 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -134.46 153.01 52.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 123.782 1.753 . . . . 0.0 113.801 -162.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -176.31 5.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 118.79 -2.444 . . . . 0.0 111.912 171.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 125.704 1.621 . . . . 0.0 112.763 -175.053 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.39 9.92 Favored Glycine 0 CA--C 1.522 0.487 0 O-C-N 121.133 -1.216 . . . . 0.0 114.299 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.6 t0 55.53 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.012 3.325 . . . . 0.0 118.646 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.65 -171.3 19.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 126.777 2.132 . . . . 0.0 111.097 -159.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.1 p -134.93 -4.66 2.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.4 123.16 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 120.596 1.544 . . . . 0.0 107.232 168.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 112.17 1.28 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.92 -28.82 70.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.05 1.74 . . . . 0.0 113.017 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -89.37 -6.63 56.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.94 119.61 11.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 121.76 2.073 . . . . 0.0 111.6 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t30 51.66 3.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 129.86 3.264 . . . . 0.0 117.308 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -129.67 146.63 62.0 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 130.482 3.513 . . . . 0.0 109.356 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.18 156.17 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.524 2.149 . . . . 0.0 111.931 -169.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -119.07 56.44 0.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.213 2.605 . . . . 0.0 109.785 171.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -71.87 30.02 0.05 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 130.019 3.328 . . . . 0.0 113.526 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' MET . 1.1 pp -132.35 150.32 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 129.438 3.095 . . . . 0.0 113.168 -172.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -57.09 -29.7 63.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.7 -3.25 11.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 114.427 174.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -55.71 -20.05 13.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -103.72 -1.9 27.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.731 2.012 . . . . 0.0 113.08 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.98 98.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -171.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 mmt -54.22 -31.24 52.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.428 1.891 . . . . 0.0 111.811 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -65.44 -28.76 69.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -128.72 63.65 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.466 2.306 . . . . 0.0 110.09 -170.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.8 25.21 9.69 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 115.446 -2.863 . . . . 0.0 114.444 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.31 166.85 23.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.412 2.606 . . . . 0.0 112.824 -158.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -138.19 173.16 11.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.465 1.506 . . . . 0.0 110.99 156.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.594 -175.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.88 -75.74 1.3 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.113 1.34 . . . . 0.0 111.858 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.04 146.79 27.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 123.456 1.598 . . . . 0.0 112.76 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.43 -150.21 21.74 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 120.31 -1.493 . . . . 0.0 112.941 169.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -124.69 -49.92 1.75 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.974 1.31 . . . . 0.0 110.672 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.31 124.13 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 108.099 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.36 130.4 42.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 173.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -77.5 -17.06 58.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.793 -1.817 . . . . 0.0 113.277 -157.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.07 -3.79 18.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 169.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -46.22 -45.74 17.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -112.11 95.48 5.49 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 116.118 -1.896 . . . . 0.0 108.056 165.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 71.13 145.27 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 129.421 3.088 . . . . 0.0 112.938 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -63.27 149.89 90.07 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.146 1.897 . . . . 0.0 112.718 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -62.74 112.72 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.023 1.329 . . . . 0.0 110.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -80.99 -1.0 42.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.973 1.309 . . . . 0.0 114.475 -171.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.13 173.37 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.241 1.417 . . . . 0.0 111.235 162.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -68.4 -32.31 72.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 119.007 -2.308 . . . . 0.0 113.519 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -83.42 103.72 13.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.893 1.224 . . . . 0.0 111.043 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -142.13 -25.32 0.66 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.77 -11.68 60.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.3 mp -72.18 92.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.489 1.116 . . . . 0.0 108.373 177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.8 mmm -57.83 -27.23 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.93 -16.24 62.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.354 1.862 . . . . 0.0 113.756 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 t -152.72 96.07 2.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.052 1.341 . . . . 0.0 110.288 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.24 0.39 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.327 1.441 . . . . 0.0 113.064 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -130.95 174.21 10.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.736 1.614 . . . . 0.0 113.936 -167.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.14 179.65 8.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.475 2.31 . . . . 0.0 112.581 170.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.825 3.107 . . . . 0.0 111.829 169.735 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.52 100.1 0.57 Allowed Glycine 0 CA--C 1.522 0.471 0 CA-C-N 120.527 2.163 . . . . 0.0 113.899 174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.2 160.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.516 2.326 . . . . 0.0 116.293 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.79 -143.48 16.94 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.044 -1.66 . . . . 0.0 109.184 -160.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -158.96 -8.56 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 172.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -71.79 124.34 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.48 110.59 0.58 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.811 1.644 . . . . 0.0 113.041 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.68 -6.64 32.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.234 1.413 . . . . 0.0 113.645 -175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.56 -7.16 19.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.136 2.174 . . . . 0.0 114.607 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -91.37 133.63 35.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.235 0.925 . . . . 0.0 113.276 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.41 18.46 2.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.156 2.182 . . . . 0.0 115.234 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -141.91 158.04 63.01 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 117.974 -1.013 . . . . 0.0 111.694 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.65 159.87 45.02 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.294 2.663 . . . . 0.0 110.203 163.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -121.74 -85.22 0.66 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.879 1.672 . . . . 0.0 110.63 -164.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.29 -6.47 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 130.941 3.696 . . . . 0.0 117.324 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 156.55 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 119.558 -1.964 . . . . 0.0 112.493 164.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.49 16.17 0.15 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -90.23 -3.27 57.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.794 1.638 . . . . 0.0 115.068 168.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.02 -7.87 4.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -119.01 -3.76 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.945 2.498 . . . . 0.0 114.182 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.05 101.9 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -160.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 71.6 mmm -60.14 -29.51 68.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -164.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.63 -50.76 69.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.671 1.588 . . . . 0.0 114.475 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 p -86.15 5.11 35.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -166.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.18 31.37 2.61 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 119.647 -1.908 . . . . 0.0 115.133 -171.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -127.62 165.4 20.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.501 1.65 . . . . 0.0 114.366 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -146.06 -173.08 4.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.65 1.98 . . . . 0.0 112.097 159.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.549 2.5 . . . . 0.0 110.843 175.405 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 121.384 0.435 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.49 -32.88 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 126.742 2.115 . . . . 0.0 112.875 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -138.88 117.62 12.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.821 1.648 . . . . 0.0 110.145 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.43 -166.7 33.31 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.381 2.419 . . . . 0.0 113.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -113.42 -17.92 12.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.34 114.71 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 121.082 1.764 . . . . 0.0 108.829 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 134.06 54.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.116 1.366 . . . . 0.0 110.884 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.97 -26.32 68.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.125 -1.609 . . . . 0.0 115.047 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -82.87 1.26 40.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.093 1.357 . . . . 0.0 114.513 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -52.78 -44.44 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.919 1.691 . . . . 0.0 114.837 -171.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -121.92 19.53 10.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.831 2.452 . . . . 0.0 111.585 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 154.9 80.81 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 127.604 2.362 . . . . 0.0 112.928 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.05 170.22 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.102 2.534 . . . . 0.0 108.686 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.7 mmt -71.85 63.45 0.46 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.102 0.961 . . . . 0.0 111.907 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.28 -26.72 32.87 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.518 1.927 . . . . 0.0 112.059 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.1 pt -57.59 145.12 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 128.552 2.741 . . . . 0.0 111.512 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -25.26 60.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 125.037 1.461 . . . . 0.0 113.534 171.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.8 -1.12 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.72 2.008 . . . . 0.0 115.496 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -61.23 -18.13 56.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 -168.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -108.85 0.64 20.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.78 85.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.982 1.713 . . . . 0.0 108.774 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 ttt -67.85 -14.28 62.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.864 -1.148 . . . . 0.0 114.058 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.27 -9.49 33.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.662 2.785 . . . . 0.0 113.686 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 t -138.9 174.55 10.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.262 1.425 . . . . 0.0 109.696 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.55 58.39 1.44 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.799 162.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.07 167.07 22.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.535 1.934 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.92 174.62 11.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.706 1.602 . . . . 0.0 113.713 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 174.069 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.6 112.3 4.05 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.668 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 57.84 81.15 0.15 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.862 2.065 . . . . 0.0 114.021 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.98 -148.47 5.29 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 116.339 1.295 . . . . 0.0 116.339 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.6 m -122.67 -36.3 2.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.232 1.813 . . . . 0.0 115.724 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -82.98 118.16 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.221 2.208 . . . . 0.0 107.567 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.86 122.69 6.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.978 1.371 . . . . 0.0 111.5 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -58.06 -33.0 68.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.108 -2.87 . . . . 0.0 113.822 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -97.71 11.52 36.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.018 2.127 . . . . 0.0 112.398 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -48.57 -41.41 30.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.949 2.5 . . . . 0.0 114.138 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -127.74 -2.14 6.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.432 1.093 . . . . 0.0 112.518 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -137.72 150.15 67.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.263 1.425 . . . . 0.0 112.415 -168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.2 143.37 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.446 2.097 . . . . 0.0 112.207 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.3 ptm -66.19 116.27 7.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -130.52 63.93 1.56 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.786 2.834 . . . . 0.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.59 157.36 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.054 1.341 . . . . 0.0 111.932 -171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.58 1.83 1.12 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -57.86 -13.27 4.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -105.77 -4.87 20.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.941 2.097 . . . . 0.0 113.293 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.29 107.43 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.638 1.175 . . . . 0.0 108.82 -167.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.45 58.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.918 2.087 . . . . 0.0 115.71 174.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 116.3 9.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.743 -1.223 . . . . 0.0 112.254 -165.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.63 17.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.163 -0.799 . . . . 0.0 114.085 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 155.92 32.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.024 1.912 . . . . 0.0 113.713 -167.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -141.31 -175.29 4.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.916 1.686 . . . . 0.0 112.612 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.395 1.95 . . . . 0.0 114.929 178.675 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 CA-C-O 117.742 -1.588 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.77 164.1 13.61 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 123.456 1.587 . . . . 0.0 113.914 158.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 58.0 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.765 2.826 . . . . 0.0 117.699 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.74 -172.86 30.4 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 120.651 -1.281 . . . . 0.0 115.416 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -75.8 -54.89 6.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.679 1.192 . . . . 0.0 112.406 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.48 105.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.454 2.302 . . . . 0.0 106.662 -165.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.68 104.08 0.4 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.639 1.576 . . . . 0.0 110.899 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -53.06 -31.07 39.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -164.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.18 -9.19 58.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.875 -1.536 . . . . 0.0 114.135 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.75 -20.72 61.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -136.12 -10.5 1.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -146.65 154.4 48.11 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 128.164 2.586 . . . . 0.0 110.383 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.81 143.66 80.83 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.083 2.522 . . . . 0.0 113.035 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.4 mmm -75.85 64.18 1.78 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.608 2.363 . . . . 0.0 108.068 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -67.47 1.78 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.59 1.956 . . . . 0.0 114.133 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.23 167.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.494 2.318 . . . . 0.0 111.601 -167.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -54.77 -19.64 6.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.822 2.449 . . . . 0.0 117.549 -166.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.92 -8.11 14.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -53.35 -22.08 6.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -110.23 2.18 19.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.757 2.526 . . . . 0.0 116.332 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.15 97.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 120.495 -1.378 . . . . 0.0 107.953 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttp -59.52 -29.23 67.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.313 1.845 . . . . 0.0 113.968 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.87 -1.07 12.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.088 2.555 . . . . 0.0 114.759 171.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -121.12 -176.31 3.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.074 2.55 . . . . 0.0 109.554 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.56 34.0 4.88 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 126.211 1.862 . . . . 0.0 113.562 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.17 160.39 40.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 117.646 0.723 . . . . 0.0 110.126 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -155.34 -173.18 4.45 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.038 2.535 . . . . 0.0 112.573 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.937 -2.465 . . . . 0.0 106.937 -177.817 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.79 -140.34 3.11 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 121.884 2.842 . . . . 0.0 113.229 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -66.99 137.31 56.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.316 2.247 . . . . 0.0 111.745 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.02 -164.38 31.8 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 126.328 1.918 . . . . 0.0 114.133 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 m -134.32 -31.65 1.09 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.6 138.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 107.417 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 128.3 33.59 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.495 -2.003 . . . . 0.0 114.586 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.61 -24.28 66.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.41 -1.757 . . . . 0.0 114.245 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -67.92 -21.39 65.12 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 121.252 1.842 . . . . 0.0 114.99 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -65.56 -36.12 82.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.96 98.91 5.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.497 1.919 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 66.33 156.79 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 129.551 3.14 . . . . 0.0 114.077 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.08 162.76 20.4 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.324 1.349 . . . . 0.0 113.087 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 51.7 mtt -126.75 114.07 17.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.777 163.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -80.9 67.52 6.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.821 -1.174 . . . . 0.0 109.62 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.3 151.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.578 1.951 . . . . 0.0 109.256 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -76.06 9.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -162.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -118.54 1.86 11.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.715 2.406 . . . . 0.0 114.407 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -53.56 -25.65 18.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -160.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.71 -29.13 27.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mp -75.41 116.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.466 0.706 . . . . 0.0 110.361 -158.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.4 mtt -57.92 -50.76 72.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.956 2.102 . . . . 0.0 113.878 -168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.25 6.52 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.259 1.024 . . . . 0.0 113.7 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 173.6 11.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.64 1.976 . . . . 0.0 108.959 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.2 20.33 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.135 -1.369 . . . . 0.0 113.001 162.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -83.87 171.9 12.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.296 2.048 . . . . 0.0 115.533 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.61 -179.06 7.08 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 131.814 4.045 . . . . 0.0 110.545 164.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.053 1.311 . . . . 0.0 111.982 -176.142 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.21 -72.99 0.23 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.115 0.958 . . . . 0.0 113.496 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -101.29 130.65 47.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -161.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.5 -136.05 8.57 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.875 1.226 . . . . 0.0 112.15 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -142.08 -18.33 0.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.44 1.496 . . . . 0.0 113.503 -170.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.9 mt -99.63 113.26 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.86 134.1 37.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 112.757 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.75 -9.85 3.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -93.65 15.43 16.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.263 3.025 . . . . 0.0 115.687 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -47.64 -49.34 27.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.729 2.011 . . . . 0.0 113.567 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -80.75 10.89 4.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.086 1.354 . . . . 0.0 113.726 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 98.78 148.93 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 133.244 4.618 . . . . 0.0 111.118 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -65.83 140.42 61.14 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 122.416 1.898 . . . . 0.0 111.612 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 83.3 mtp -66.1 18.38 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.448 2.299 . . . . 0.0 115.604 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 43.42 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.044 2.138 . . . . 0.0 112.355 -158.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.4 149.68 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.755 1.622 . . . . 0.0 110.478 -166.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -19.53 65.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -173.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.24 11.89 36.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -44.09 -48.8 9.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.51 1.924 . . . . 0.0 112.721 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -59.58 -13.64 10.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.03 121.86 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 121.191 1.814 . . . . 0.0 107.106 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.9 mtp -99.71 -39.68 8.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.001 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -16.45 63.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -149.49 177.98 9.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.858 2.863 . . . . 0.0 108.969 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.35 29.02 15.31 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 121.856 0.698 . . . . 0.0 113.851 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.0 168.05 11.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -126.79 173.66 9.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.432 3.093 . . . . 0.0 109.443 147.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 O-C-N 121.158 -0.964 . . . . 0.0 111.668 -172.564 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.62 77.01 1.64 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 113.569 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t70 57.51 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.204 3.001 . . . . 0.0 117.57 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.24 -156.64 27.25 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.093 1.33 . . . . 0.0 113.029 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -124.18 -38.56 2.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.16 2.184 . . . . 0.0 112.699 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -86.32 140.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.378 1.471 . . . . 0.0 108.449 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.17 130.36 41.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.263 -2.148 . . . . 0.0 111.871 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.42 -40.22 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.831 2.052 . . . . 0.0 112.794 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -82.35 1.88 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.18 3.392 . . . . 0.0 115.421 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -57.8 -56.63 19.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.281 0.946 . . . . 0.0 111.249 168.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -39.98 66.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -166.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -140.94 166.42 22.77 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.063 2.545 . . . . 0.0 110.601 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.41 161.74 6.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.503 2.136 . . . . 0.0 113.384 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.2 mmt -138.47 85.54 2.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.983 2.513 . . . . 0.0 108.808 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -74.88 64.47 1.29 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.312 3.045 . . . . 0.0 111.635 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.76 158.93 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.465 2.706 . . . . 0.0 113.987 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -63.31 -25.43 68.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.48 -15.75 40.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -58.99 -18.11 31.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.76 2.024 . . . . 0.0 115.572 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -86.86 -12.74 46.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.719 -1.238 . . . . 0.0 113.304 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.97 98.5 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.75 2.02 . . . . 0.0 110.358 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -61.22 -34.12 74.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.53 -5.83 55.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -132.99 105.87 7.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.26 61.37 0.02 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -133.43 160.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.804 1.642 . . . . 0.0 115.16 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -149.99 178.6 8.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.537 2.335 . . . . 0.0 111.434 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 O-C-N 121.188 -0.945 . . . . 0.0 115.268 178.392 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.23 98.58 1.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 126.952 2.215 . . . . 0.0 111.273 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 63.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.603 2.761 . . . . 0.0 117.771 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.79 179.88 27.82 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 127.866 2.65 . . . . 0.0 114.466 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -78.64 -17.39 56.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.89 146.72 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.776 1.23 . . . . 0.0 108.704 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.32 135.8 54.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.98 -1.7 . . . . 0.0 111.382 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.48 -29.87 59.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.228 -1.545 . . . . 0.0 114.499 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -106.8 17.3 23.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 130.602 3.561 . . . . 0.0 113.229 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -50.59 -41.33 54.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.68 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -118.02 5.64 12.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -147.64 160.79 37.66 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.95 -1.719 . . . . 0.0 114.108 -164.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.84 169.29 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.869 3.046 . . . . 0.0 113.607 156.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.8 mtm -93.41 -55.21 3.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 111.347 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m170 52.26 26.59 4.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.514 1.926 . . . . 0.0 115.432 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.4 156.34 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.053 2.141 . . . . 0.0 111.905 170.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -58.3 -26.08 62.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.406 2.283 . . . . 0.0 113.941 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -63.79 -7.54 8.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 118.924 -2.36 . . . . 0.0 114.778 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -60.02 -10.06 3.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.75 2.02 . . . . 0.0 114.901 -169.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.88 -8.76 14.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.776 1.631 . . . . 0.0 115.015 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.3 mt -71.6 94.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.41 2.284 . . . . 0.0 108.573 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.7 mtt -57.63 -26.42 61.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.417 1.487 . . . . 0.0 113.998 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.47 0.6 16.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 116.631 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 t -140.44 -172.96 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 118.977 -2.327 . . . . 0.0 111.443 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.58 5.3 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 121.375 -0.828 . . . . 0.0 111.966 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -135.35 156.82 48.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.489 -1.006 . . . . 0.0 111.351 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.07 170.29 19.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 123.911 1.815 . . . . 0.0 113.637 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.477 2.465 . . . . 0.0 113.724 167.911 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.651 0.621 . . . . 0.0 114.651 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 10.53 13.98 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.16 -1.2 . . . . 0.0 114.571 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -149.58 112.04 4.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.289 1.545 . . . . 0.0 113.603 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.84 -157.37 27.2 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.763 1.649 . . . . 0.0 110.346 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.1 m -125.97 -9.89 6.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.959 -1.318 . . . . 0.0 113.222 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -85.12 113.89 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 120.846 1.657 . . . . 0.0 108.932 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.45 113.12 1.46 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.694 1.712 . . . . 0.0 114.609 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -61.96 -4.44 1.6 Allowed 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.049 -2.907 . . . . 0.0 116.561 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -120.15 -0.92 10.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 129.581 3.153 . . . . 0.0 114.795 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -58.86 -43.3 90.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.746 2.066 . . . . 0.0 113.262 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.54 -68.77 0.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 119.916 -1.74 . . . . 0.0 108.522 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -142.66 140.7 18.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 127.161 2.185 . . . . 0.0 110.362 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -68.72 177.13 5.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.283 1.989 . . . . 0.0 110.883 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.1 mtp -71.64 -5.14 31.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 113.828 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.45 19.14 3.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.809 2.443 . . . . 0.0 116.079 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.7 -175.45 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 126.529 1.932 . . . . 0.0 110.571 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -59.05 6.15 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.591 3.157 . . . . 0.0 118.655 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -122.87 93.69 4.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.119 2.568 . . . . 0.0 112.589 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.412 ' CE2' ' HG3' ' A' ' 20' ' ' GLN . 17.5 p-90 -150.82 -31.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.736 2.015 . . . . 0.0 114.885 167.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 19' ' ' TRP . 22.9 mt-30 -71.05 -18.03 62.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.44 97.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.204 1.802 . . . . 0.0 110.221 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -64.03 -20.77 66.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.329 1.852 . . . . 0.0 114.008 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.7 -2.36 42.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 t -144.62 -173.04 3.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.32 1.448 . . . . 0.0 111.382 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.41 47.23 22.98 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.391 1.472 . . . . 0.0 112.499 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.2 154.08 50.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -138.39 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 166.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 126.766 2.127 . . . . 0.0 111.84 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 CA-C-O 118.074 -1.403 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.36 -31.22 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -133.46 125.73 29.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.22 1.51 . . . . 0.0 113.105 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.27 -164.86 30.68 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.37 1.462 . . . . 0.0 109.645 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -113.74 0.58 14.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.866 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -115.31 141.05 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.376 1.871 . . . . 0.0 110.842 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 126.85 31.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.185 1.394 . . . . 0.0 113.359 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.5 -36.05 82.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.075 0.95 . . . . 0.0 112.283 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -76.2 7.31 4.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -63.95 -49.35 72.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.599 1.545 . . . . 0.0 113.129 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -79.34 -22.56 44.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.22 157.68 25.06 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.999 1.72 . . . . 0.0 113.539 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.46 157.65 60.95 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.603 1.535 . . . . 0.0 108.378 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ptm -151.71 114.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.704 0.802 . . . . 0.0 111.813 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -82.81 71.81 9.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.961 1.305 . . . . 0.0 112.448 -164.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 pt -116.46 154.97 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.396 1.878 . . . . 0.0 113.198 -170.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -71.63 -22.14 61.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -1.43 23.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.591 2.356 . . . . 0.0 112.968 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -52.32 -19.34 2.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.605 1.962 . . . . 0.0 116.241 -169.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -109.39 -7.15 15.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.067 1.747 . . . . 0.0 114.429 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.25 82.01 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 120.437 -1.414 . . . . 0.0 109.362 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.0 ttp -57.3 -25.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.84 2.856 . . . . 0.0 113.774 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -92.44 9.65 33.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.185 1.794 . . . . 0.0 112.726 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 t -146.31 -165.42 2.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.747 -1.846 . . . . 0.0 112.721 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.27 77.17 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.147 2.308 . . . . 0.0 117.736 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -64.64 166.6 8.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.178 1.791 . . . . 0.0 114.899 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -178.87 6.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 114.122 160.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 130.389 3.852 . . . . 0.0 110.147 176.813 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 20.86 3.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.382 1.468 . . . . 0.0 115.833 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -143.77 110.41 5.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.217 1.509 . . . . 0.0 111.395 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.51 -143.9 15.43 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 126.0 1.762 . . . . 0.0 113.774 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.2 m -145.44 -23.33 0.48 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.47 138.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 118.456 -2.653 . . . . 0.0 110.45 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.44 107.95 0.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.85 1.66 . . . . 0.0 112.589 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.77 -6.27 3.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.98 11.32 19.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -55.12 -29.63 58.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.014 2.125 . . . . 0.0 113.817 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -134.19 58.9 1.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 123.188 1.471 . . . . 0.0 108.613 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -135.53 147.99 63.98 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 127.222 2.209 . . . . 0.0 112.38 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -66.97 167.56 19.48 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.734 2.956 . . . . 0.0 109.421 158.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.61 64.41 0.29 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.495 1.518 . . . . 0.0 113.169 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -149.0 29.19 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.062 1.345 . . . . 0.0 112.738 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 151.57 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.948 2.499 . . . . 0.0 109.693 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -84.14 -4.24 58.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.65 -13.45 61.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -24.52 4.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -131.0 8.01 4.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.065 2.146 . . . . 0.0 113.228 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mp -142.46 88.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.164 2.586 . . . . 0.0 108.803 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.6 mtp -58.94 -32.8 69.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.781 -1.199 . . . . 0.0 112.294 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.65 -28.6 69.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 t -78.09 40.01 0.32 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.344 1.858 . . . . 0.0 112.172 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.75 75.51 0.1 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.255 1.407 . . . . 0.0 114.543 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -111.95 130.22 55.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.16 0.981 . . . . 0.0 110.557 169.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -138.47 166.7 23.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 164.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 129.382 3.372 . . . . 0.0 107.403 174.237 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 116.386 -2.341 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.42 -94.96 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.37 1.585 . . . . 0.0 113.208 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -90.18 154.06 20.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.475 1.51 . . . . 0.0 113.558 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.02 -178.34 28.49 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 127.271 2.367 . . . . 0.0 114.821 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -110.88 -14.37 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.791 1.296 . . . . 0.0 114.377 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 6' ' ' ILE . 17.7 mt -84.53 133.27 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.884 168.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.33 113.26 5.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.802 1.641 . . . . 0.0 112.758 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -72.84 -39.46 66.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -56.29 -21.22 22.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.357 2.663 . . . . 0.0 114.344 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.56 -36.13 75.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.797 -1.814 . . . . 0.0 114.69 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.944 1.697 . . . . 0.0 113.003 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 72.09 167.33 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.139 1.776 . . . . 0.0 112.141 -170.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 148.33 90.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.761 2.974 . . . . 0.0 115.597 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.5 mtp -85.93 99.31 11.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.879 -1.138 . . . . 0.0 108.605 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.79 22.99 0.17 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.07 1.748 . . . . 0.0 114.139 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.4 164.96 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.32 3.048 . . . . 0.0 111.213 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -16.56 63.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -159.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.31 -6.8 20.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.491 -1.381 . . . . 0.0 114.248 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -59.47 -5.8 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -164.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.66 -3.76 12.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 122.247 2.294 . . . . 0.0 113.947 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.07 104.43 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.831 1.652 . . . . 0.0 111.871 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -29.81 65.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.38 -9.1 58.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.637 1.975 . . . . 0.0 115.521 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -135.0 78.59 1.74 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.138 -1.602 . . . . 0.0 109.804 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.26 28.11 0.26 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.062 1.791 . . . . 0.0 114.121 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -137.63 167.69 21.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -157.44 -175.96 5.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.568 2.747 . . . . 0.0 111.33 173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 C-N-CA 126.554 2.026 . . . . 0.0 112.124 -176.616 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.52 163.45 19.48 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.769 2.128 . . . . 0.0 115.217 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.5 t70 57.59 119.77 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 132.005 4.122 . . . . 0.0 115.621 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 -169.13 24.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.888 2.661 . . . . 0.0 112.422 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -111.34 -14.91 13.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -78.01 111.98 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 120.082 -1.636 . . . . 0.0 106.783 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.99 111.05 2.0 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.187 1.795 . . . . 0.0 112.218 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -70.54 -42.54 71.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 119.843 -1.786 . . . . 0.0 114.515 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -64.92 -25.0 67.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.185 1.394 . . . . 0.0 113.747 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.44 -34.23 77.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.126 -1.609 . . . . 0.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -90.59 -22.11 21.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -137.5 153.48 74.44 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 121.365 1.893 . . . . 0.0 114.791 -167.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.02 168.3 23.59 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 126.161 4.574 . . . . 0.0 113.972 170.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.58 143.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.731 1.612 . . . . 0.0 110.903 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -176.09 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.055 2.942 . . . . 0.0 111.641 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -55.31 141.04 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.196 0.998 . . . . 0.0 113.415 174.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -71.3 -9.97 58.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.952 2.101 . . . . 0.0 114.944 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -75.03 85.93 2.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.013 2.125 . . . . 0.0 111.45 151.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -139.63 -6.82 1.31 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.669 1.987 . . . . 0.0 115.262 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -134.21 -24.29 1.64 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.525 1.93 . . . . 0.0 111.528 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.11 107.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.091 1.756 . . . . 0.0 108.363 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.7 mtp -56.76 -21.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -122.43 19.69 10.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.213 1.805 . . . . 0.0 113.725 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -124.74 94.64 4.25 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.979 1.712 . . . . 0.0 109.819 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.93 25.34 0.19 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-O 116.739 -2.145 . . . . 0.0 111.877 -167.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -138.94 158.11 44.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.936 2.368 . . . . 0.0 114.146 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -143.34 -177.65 5.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.21 161.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.734 2.588 . . . . 0.0 116.763 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 94.66 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 127.013 2.244 . . . . 0.0 111.812 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 58.56 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.854 2.462 . . . . 0.0 116.424 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.7 -162.47 32.51 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 126.359 1.933 . . . . 0.0 114.169 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.2 p -124.39 -34.35 2.91 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.115 2.166 . . . . 0.0 115.662 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.24 112.71 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.365 1.866 . . . . 0.0 110.17 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.96 107.64 0.22 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.814 2.046 . . . . 0.0 112.159 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.45 -57.55 12.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.445 1.098 . . . . 0.0 112.036 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.62 -26.93 68.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -65.6 -44.89 85.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.555 0.616 . . . . 0.0 109.984 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -72.03 -34.06 68.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.525 -1.984 . . . . 0.0 115.891 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -147.49 162.12 33.27 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.81 147.2 44.0 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.224 1.949 . . . . 0.0 110.852 163.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.3 132.84 17.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.501 1.12 . . . . 0.0 110.855 170.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -133.35 73.12 1.5 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.551 1.167 . . . . 0.0 110.544 -163.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.14 159.16 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.756 1.265 . . . . 0.0 114.194 -165.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -64.09 -24.73 67.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.89 14.59 2.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.375 1.87 . . . . 0.0 115.661 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -51.87 -43.09 63.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.325 -1.484 . . . . 0.0 114.345 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.19 8.9 7.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.62 114.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 119.952 1.251 . . . . 0.0 108.649 173.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.7 mtm -82.01 -18.9 41.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.428 2.291 . . . . 0.0 111.966 173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.97 13.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.795 2.038 . . . . 0.0 114.587 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 t -151.53 -170.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.37 1.868 . . . . 0.0 112.846 -165.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.46 22.53 1.66 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.846 1.689 . . . . 0.0 115.016 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.33 137.2 32.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.802 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.72 -173.01 2.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.932 1.693 . . . . 0.0 112.527 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.336 -1.813 . . . . 0.0 116.376 -172.039 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.66 -15.48 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.09 128.59 12.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.382 2.091 . . . . 0.0 111.84 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.76 -139.37 7.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.287 1.422 . . . . 0.0 113.279 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -142.32 -34.27 0.46 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.8 133.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.74 -1.225 . . . . 0.0 110.069 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.55 129.4 38.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.632 -1.917 . . . . 0.0 109.947 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.74 -6.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 119.094 -2.253 . . . . 0.0 113.681 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -119.48 12.89 12.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.826 2.451 . . . . 0.0 113.495 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -62.72 -29.37 70.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.916 2.486 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -125.07 -0.41 7.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.345 1.858 . . . . 0.0 115.884 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -156.36 167.36 14.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.92 1.688 . . . . 0.0 111.87 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -64.75 170.39 10.08 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.87 2.38 . . . . 0.0 112.625 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.15 49.11 2.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.332 2.653 . . . . 0.0 110.043 165.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.36 47.11 0.36 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.947 3.699 . . . . 0.0 115.524 -169.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.83 -177.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 127.904 2.481 . . . . 0.0 112.09 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -80.15 1.52 27.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -115.39 78.91 1.22 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.238 1.815 . . . . 0.0 110.319 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.88 -0.83 1.14 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -138.04 52.23 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.579 2.352 . . . . 0.0 112.259 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.02 109.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.828 2.051 . . . . 0.0 109.362 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -54.33 -36.57 63.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.653 1.581 . . . . 0.0 113.89 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -86.28 -3.05 58.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 t -100.19 176.42 5.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.811 1.187 . . . . 0.0 112.441 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.47 -4.96 65.79 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 117.289 1.676 . . . . 0.0 117.289 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.06 1.93 . . . . 0.0 111.038 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -171.37 3.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.022 1.729 . . . . 0.0 112.025 167.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.549 2.976 . . . . 0.0 113.488 174.692 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 CA-C-O 121.029 0.238 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.91 -41.38 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 165.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -147.4 111.02 4.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.079 1.351 . . . . 0.0 111.791 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.04 -173.86 36.74 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 126.301 1.905 . . . . 0.0 114.156 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -119.12 -28.78 5.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.26 2.224 . . . . 0.0 113.1 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -73.45 135.39 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.303 1.041 . . . . 0.0 108.273 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.12 133.02 44.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.735 -1.228 . . . . 0.0 111.422 171.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.18 -52.88 52.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.799 0.839 . . . . 0.0 110.191 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -75.64 16.83 0.34 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.758 2.023 . . . . 0.0 113.378 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -48.53 -37.31 17.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.359 2.263 . . . . 0.0 112.698 -170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -99.23 -66.5 0.9 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.867 1.267 . . . . 0.0 111.621 167.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -139.32 153.44 70.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 126.63 1.972 . . . . 0.0 112.483 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.5 154.29 65.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.4 2.067 . . . . 0.0 110.513 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.74 22.53 5.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 119.99 -1.694 . . . . 0.0 113.951 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.0 p80 52.34 2.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 130.289 3.436 . . . . 0.0 118.165 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.95 168.46 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -59.37 -21.43 59.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.589 3.156 . . . . 0.0 115.686 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.64 -4.48 6.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -56.82 -23.6 44.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 167.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.18 11.64 25.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.776 2.43 . . . . 0.0 115.718 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.12 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 123.876 1.798 . . . . 0.0 108.48 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -52.66 -40.13 62.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 129.326 3.05 . . . . 0.0 112.331 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.96 -19.85 61.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.725 2.01 . . . . 0.0 114.478 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 t -131.75 -19.72 2.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -156.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 54.17 1.51 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 117.135 -1.925 . . . . 0.0 113.979 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -132.24 156.27 46.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.487 2.144 . . . . 0.0 114.016 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -143.24 -177.78 5.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.017 2.127 . . . . 0.0 111.493 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.979 1.752 . . . . 0.0 115.472 173.303 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.37 30.66 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.321 0.962 . . . . 0.0 111.752 163.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 49.3 80.75 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.079 2.151 . . . . 0.0 113.662 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.39 -169.13 32.33 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.387 1.47 . . . . 0.0 112.895 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -121.07 -22.16 6.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.932 0.893 . . . . 0.0 113.179 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.0 125.37 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.408 2.683 . . . . 0.0 108.842 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.21 126.23 30.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.862 0.756 . . . . 0.0 112.218 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.16 -55.31 35.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.059 -0.401 . . . . 0.0 110.789 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -64.56 -17.74 64.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -168.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -15.36 -73.0 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.951 3.301 . . . . 0.0 115.56 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -124.95 21.79 8.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.055 0.942 . . . . 0.0 113.274 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.67 158.83 66.08 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.586 1.554 . . . . 0.0 113.754 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.07 -178.27 4.39 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.363 2.042 . . . . 0.0 111.75 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.3 mtp 69.36 57.57 0.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.759 2.424 . . . . 0.0 110.916 -171.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -71.55 70.74 0.67 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.137 2.175 . . . . 0.0 113.358 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.17 -178.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 127.807 2.443 . . . . 0.0 111.384 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -62.31 -5.91 2.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -171.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -73.94 -5.82 43.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 119.203 -2.186 . . . . 0.0 116.838 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -177.12 0.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 163.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 56.74 10.2 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 165.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -66.03 151.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 119.47 -2.019 . . . . 0.0 107.901 165.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.0 ttm -121.63 -46.7 2.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.711 -1.243 . . . . 0.0 113.858 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.08 -7.38 1.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 163.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 t -162.9 -179.98 7.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.781 2.432 . . . . 0.0 111.122 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.51 12.18 33.75 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.508 -0.745 . . . . 0.0 114.88 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -123.5 169.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.525 1.663 . . . . 0.0 113.092 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -154.67 -176.97 6.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.478 2.711 . . . . 0.0 111.296 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 126.866 2.174 . . . . 0.0 111.774 171.083 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 117.574 -1.681 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.49 165.5 13.82 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 126.515 2.007 . . . . 0.0 109.429 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.5 t0 54.02 92.13 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.77 179.57 46.35 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 123.926 0.774 . . . . 0.0 112.682 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 t -94.77 -13.06 26.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.96 135.01 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.348 1.859 . . . . 0.0 110.41 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.37 120.18 12.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.539 1.063 . . . . 0.0 110.927 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.65 7.53 2.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -129.53 10.15 5.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.383 2.273 . . . . 0.0 111.657 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -41.61 -47.45 3.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.641 1.176 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.7 -43.65 0.27 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.251 1.821 . . . . 0.0 112.191 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -47.56 154.36 0.9 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 128.048 2.539 . . . . 0.0 115.289 168.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.51 171.01 12.5 Favored 'Trans proline' 0 N--CA 1.45 -1.069 1 C-N-CA 125.759 4.306 . . . . 0.0 114.792 -175.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.91 21.34 6.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.859 3.263 . . . . 0.0 112.22 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -51.25 -17.04 0.61 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.092 4.157 . . . . 0.0 116.073 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.73 151.24 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 123.264 1.507 . . . . 0.0 114.145 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -61.59 -16.35 47.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.687 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.33 -1.55 24.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.233 1.813 . . . . 0.0 114.141 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -50.9 -35.59 33.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -79.19 -16.26 56.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.968 -1.707 . . . . 0.0 114.262 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.87 105.05 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.708 1.14 . . . . 0.0 108.649 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.4 ptm -73.62 -22.1 60.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.163 0.985 . . . . 0.0 112.707 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.13 -12.27 54.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.9 m -131.33 65.57 1.56 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.655 1.182 . . . . 0.0 109.231 -169.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.58 18.53 5.71 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.303 2.383 . . . . 0.0 112.826 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -134.46 153.01 52.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 123.782 1.753 . . . . 0.0 113.801 -162.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -176.31 5.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 118.79 -2.444 . . . . 0.0 111.912 171.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 125.704 1.621 . . . . 0.0 112.763 -175.053 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.39 9.92 Favored Glycine 0 CA--C 1.522 0.487 0 O-C-N 121.133 -1.216 . . . . 0.0 114.299 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.6 t0 55.53 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.012 3.325 . . . . 0.0 118.646 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.65 -171.3 19.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 126.777 2.132 . . . . 0.0 111.097 -159.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.1 p -134.93 -4.66 2.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -77.4 123.16 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 120.596 1.544 . . . . 0.0 107.232 168.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 112.17 1.28 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.92 -28.82 70.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.05 1.74 . . . . 0.0 113.017 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -89.37 -6.63 56.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.94 119.61 11.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 121.76 2.073 . . . . 0.0 111.6 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t30 51.66 3.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 129.86 3.264 . . . . 0.0 117.308 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -129.67 146.63 62.0 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 130.482 3.513 . . . . 0.0 109.356 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.18 156.17 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.524 2.149 . . . . 0.0 111.931 -169.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.07 56.44 0.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.213 2.605 . . . . 0.0 109.785 171.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -71.87 30.02 0.05 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 130.019 3.328 . . . . 0.0 113.526 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.35 150.32 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 129.438 3.095 . . . . 0.0 113.168 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -57.09 -29.7 63.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HA ' HD13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.7 -3.25 11.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 114.427 174.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -55.71 -20.05 13.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -103.72 -1.9 27.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.731 2.012 . . . . 0.0 113.08 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 18' ' ' ASP . 1.4 mp -99.98 98.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -171.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 mmt -54.22 -31.24 52.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.428 1.891 . . . . 0.0 111.811 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -65.44 -28.76 69.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -128.72 63.65 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.466 2.306 . . . . 0.0 110.09 -170.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.8 25.21 9.69 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 115.446 -2.863 . . . . 0.0 114.444 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.31 166.85 23.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.412 2.606 . . . . 0.0 112.824 -158.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -138.19 173.16 11.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.465 1.506 . . . . 0.0 110.99 156.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.594 -175.575 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.88 -75.74 1.3 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.113 1.34 . . . . 0.0 111.858 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.04 146.79 27.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 123.456 1.598 . . . . 0.0 112.76 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.43 -150.21 21.74 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 120.31 -1.493 . . . . 0.0 112.941 169.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -124.69 -49.92 1.75 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.974 1.31 . . . . 0.0 110.672 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.31 124.13 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 108.099 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.36 130.4 42.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 173.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -77.5 -17.06 58.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.793 -1.817 . . . . 0.0 113.277 -157.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.07 -3.79 18.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 169.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -46.22 -45.74 17.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -112.11 95.48 5.49 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 116.118 -1.896 . . . . 0.0 108.056 165.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 71.13 145.27 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 129.421 3.088 . . . . 0.0 112.938 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -63.27 149.89 90.07 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.146 1.897 . . . . 0.0 112.718 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -62.74 112.72 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.023 1.329 . . . . 0.0 110.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -80.99 -1.0 42.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.973 1.309 . . . . 0.0 114.475 -171.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.13 173.37 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.241 1.417 . . . . 0.0 111.235 162.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -68.4 -32.31 72.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 119.007 -2.308 . . . . 0.0 113.519 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -83.42 103.72 13.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.893 1.224 . . . . 0.0 111.043 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -142.13 -25.32 0.66 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.77 -11.68 60.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.3 mp -72.18 92.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.489 1.116 . . . . 0.0 108.373 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.8 mmm -57.83 -27.23 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.93 -16.24 62.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.354 1.862 . . . . 0.0 113.756 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 t -152.72 96.07 2.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.052 1.341 . . . . 0.0 110.288 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.24 0.39 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.327 1.441 . . . . 0.0 113.064 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -130.95 174.21 10.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.736 1.614 . . . . 0.0 113.936 -167.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.14 179.65 8.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.475 2.31 . . . . 0.0 112.581 170.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.825 3.107 . . . . 0.0 111.829 169.735 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.52 100.1 0.57 Allowed Glycine 0 CA--C 1.522 0.471 0 CA-C-N 120.527 2.163 . . . . 0.0 113.899 174.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.2 160.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.516 2.326 . . . . 0.0 116.293 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.79 -143.48 16.94 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.044 -1.66 . . . . 0.0 109.184 -160.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -158.96 -8.56 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 172.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -71.79 124.34 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.48 110.59 0.58 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.811 1.644 . . . . 0.0 113.041 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.68 -6.64 32.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.234 1.413 . . . . 0.0 113.645 -175.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.56 -7.16 19.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.136 2.174 . . . . 0.0 114.607 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -91.37 133.63 35.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.235 0.925 . . . . 0.0 113.276 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.41 18.46 2.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.156 2.182 . . . . 0.0 115.234 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -141.91 158.04 63.01 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 117.974 -1.013 . . . . 0.0 111.694 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.65 159.87 45.02 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.294 2.663 . . . . 0.0 110.203 163.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -121.74 -85.22 0.66 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.879 1.672 . . . . 0.0 110.63 -164.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.29 -6.47 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 130.941 3.696 . . . . 0.0 117.324 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 156.55 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 119.558 -1.964 . . . . 0.0 112.493 164.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.49 16.17 0.15 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -90.23 -3.27 57.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.794 1.638 . . . . 0.0 115.068 168.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.02 -7.87 4.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -119.01 -3.76 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.945 2.498 . . . . 0.0 114.182 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.05 101.9 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -160.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 71.6 mmm -60.14 -29.51 68.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -164.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.63 -50.76 69.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.671 1.588 . . . . 0.0 114.475 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 p -86.15 5.11 35.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -166.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.18 31.37 2.61 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 119.647 -1.908 . . . . 0.0 115.133 -171.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -127.62 165.4 20.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.501 1.65 . . . . 0.0 114.366 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -146.06 -173.08 4.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.65 1.98 . . . . 0.0 112.097 159.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.549 2.5 . . . . 0.0 110.843 175.405 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 121.384 0.435 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.49 -32.88 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 126.742 2.115 . . . . 0.0 112.875 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -138.88 117.62 12.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.821 1.648 . . . . 0.0 110.145 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.43 -166.7 33.31 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.381 2.419 . . . . 0.0 113.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -113.42 -17.92 12.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.34 114.71 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 121.082 1.764 . . . . 0.0 108.829 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 134.06 54.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.116 1.366 . . . . 0.0 110.884 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.97 -26.32 68.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.125 -1.609 . . . . 0.0 115.047 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -82.87 1.26 40.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.093 1.357 . . . . 0.0 114.513 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -52.78 -44.44 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.919 1.691 . . . . 0.0 114.837 -171.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -121.92 19.53 10.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.831 2.452 . . . . 0.0 111.585 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 154.9 80.81 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 127.604 2.362 . . . . 0.0 112.928 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.05 170.22 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.102 2.534 . . . . 0.0 108.686 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.7 mmt -71.85 63.45 0.46 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.102 0.961 . . . . 0.0 111.907 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.28 -26.72 32.87 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.518 1.927 . . . . 0.0 112.059 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.1 pt -57.59 145.12 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 128.552 2.741 . . . . 0.0 111.512 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -25.26 60.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 125.037 1.461 . . . . 0.0 113.534 171.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.8 -1.12 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.72 2.008 . . . . 0.0 115.496 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -61.23 -18.13 56.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 -168.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -108.85 0.64 20.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.78 85.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.982 1.713 . . . . 0.0 108.774 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 ttt -67.85 -14.28 62.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.864 -1.148 . . . . 0.0 114.058 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.27 -9.49 33.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.662 2.785 . . . . 0.0 113.686 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 t -138.9 174.55 10.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.262 1.425 . . . . 0.0 109.696 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.55 58.39 1.44 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.799 162.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.07 167.07 22.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.535 1.934 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.92 174.62 11.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.706 1.602 . . . . 0.0 113.713 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 174.069 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.6 112.3 4.05 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.668 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 57.84 81.15 0.15 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.862 2.065 . . . . 0.0 114.021 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.98 -148.47 5.29 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 116.339 1.295 . . . . 0.0 116.339 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.6 m -122.67 -36.3 2.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.232 1.813 . . . . 0.0 115.724 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -82.98 118.16 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.221 2.208 . . . . 0.0 107.567 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.86 122.69 6.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.978 1.371 . . . . 0.0 111.5 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -58.06 -33.0 68.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.108 -2.87 . . . . 0.0 113.822 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -97.71 11.52 36.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.018 2.127 . . . . 0.0 112.398 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -48.57 -41.41 30.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.949 2.5 . . . . 0.0 114.138 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -127.74 -2.14 6.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.432 1.093 . . . . 0.0 112.518 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -137.72 150.15 67.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.263 1.425 . . . . 0.0 112.415 -168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.2 143.37 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.446 2.097 . . . . 0.0 112.207 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.3 ptm -66.19 116.27 7.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -130.52 63.93 1.56 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.786 2.834 . . . . 0.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.59 157.36 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.054 1.341 . . . . 0.0 111.932 -171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.58 1.83 1.12 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -57.86 -13.27 4.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -105.77 -4.87 20.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.941 2.097 . . . . 0.0 113.293 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.29 107.43 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.638 1.175 . . . . 0.0 108.82 -167.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.45 58.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.918 2.087 . . . . 0.0 115.71 174.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 116.3 9.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.743 -1.223 . . . . 0.0 112.254 -165.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.63 17.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.163 -0.799 . . . . 0.0 114.085 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 155.92 32.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.024 1.912 . . . . 0.0 113.713 -167.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -141.31 -175.29 4.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.916 1.686 . . . . 0.0 112.612 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.395 1.95 . . . . 0.0 114.929 178.675 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 CA-C-O 117.742 -1.588 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.77 164.1 13.61 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 123.456 1.587 . . . . 0.0 113.914 158.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 58.0 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.765 2.826 . . . . 0.0 117.699 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.74 -172.86 30.4 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 120.651 -1.281 . . . . 0.0 115.416 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -75.8 -54.89 6.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.679 1.192 . . . . 0.0 112.406 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.48 105.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.454 2.302 . . . . 0.0 106.662 -165.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.68 104.08 0.4 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.639 1.576 . . . . 0.0 110.899 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -53.06 -31.07 39.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -164.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.18 -9.19 58.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.875 -1.536 . . . . 0.0 114.135 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.75 -20.72 61.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -136.12 -10.5 1.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -146.65 154.4 48.11 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 128.164 2.586 . . . . 0.0 110.383 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.81 143.66 80.83 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.083 2.522 . . . . 0.0 113.035 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.4 mmm -75.85 64.18 1.78 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.608 2.363 . . . . 0.0 108.068 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -67.47 1.78 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.59 1.956 . . . . 0.0 114.133 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.23 167.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.494 2.318 . . . . 0.0 111.601 -167.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -54.77 -19.64 6.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.822 2.449 . . . . 0.0 117.549 -166.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.92 -8.11 14.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -53.35 -22.08 6.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -110.23 2.18 19.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.757 2.526 . . . . 0.0 116.332 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.15 97.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 120.495 -1.378 . . . . 0.0 107.953 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttp -59.52 -29.23 67.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.313 1.845 . . . . 0.0 113.968 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.87 -1.07 12.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.088 2.555 . . . . 0.0 114.759 171.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -121.12 -176.31 3.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.074 2.55 . . . . 0.0 109.554 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.56 34.0 4.88 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 126.211 1.862 . . . . 0.0 113.562 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.17 160.39 40.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 117.646 0.723 . . . . 0.0 110.126 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -155.34 -173.18 4.45 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.038 2.535 . . . . 0.0 112.573 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.937 -2.465 . . . . 0.0 106.937 -177.817 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.79 -140.34 3.11 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 121.884 2.842 . . . . 0.0 113.229 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -66.99 137.31 56.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.316 2.247 . . . . 0.0 111.745 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.02 -164.38 31.8 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 126.328 1.918 . . . . 0.0 114.133 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 m -134.32 -31.65 1.09 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.6 138.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 107.417 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 128.3 33.59 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.495 -2.003 . . . . 0.0 114.586 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.61 -24.28 66.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.41 -1.757 . . . . 0.0 114.245 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -67.92 -21.39 65.12 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 121.252 1.842 . . . . 0.0 114.99 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -65.56 -36.12 82.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.96 98.91 5.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.497 1.919 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 66.33 156.79 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 129.551 3.14 . . . . 0.0 114.077 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.08 162.76 20.4 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.324 1.349 . . . . 0.0 113.087 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 51.7 mtt -126.75 114.07 17.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.777 163.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -80.9 67.52 6.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.821 -1.174 . . . . 0.0 109.62 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.3 151.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.578 1.951 . . . . 0.0 109.256 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -76.06 9.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -162.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -118.54 1.86 11.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.715 2.406 . . . . 0.0 114.407 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -53.56 -25.65 18.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -160.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.71 -29.13 27.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mp -75.41 116.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.466 0.706 . . . . 0.0 110.361 -158.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.4 mtt -57.92 -50.76 72.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.956 2.102 . . . . 0.0 113.878 -168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.25 6.52 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.259 1.024 . . . . 0.0 113.7 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 173.6 11.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.64 1.976 . . . . 0.0 108.959 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.2 20.33 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.135 -1.369 . . . . 0.0 113.001 162.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -83.87 171.9 12.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.296 2.048 . . . . 0.0 115.533 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.61 -179.06 7.08 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 131.814 4.045 . . . . 0.0 110.545 164.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.053 1.311 . . . . 0.0 111.982 -176.142 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.21 -72.99 0.23 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.115 0.958 . . . . 0.0 113.496 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -101.29 130.65 47.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -161.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.5 -136.05 8.57 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.875 1.226 . . . . 0.0 112.15 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -142.08 -18.33 0.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.44 1.496 . . . . 0.0 113.503 -170.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.9 mt -99.63 113.26 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.86 134.1 37.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 112.757 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.75 -9.85 3.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -93.65 15.43 16.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.263 3.025 . . . . 0.0 115.687 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -47.64 -49.34 27.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.729 2.011 . . . . 0.0 113.567 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -80.75 10.89 4.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.086 1.354 . . . . 0.0 113.726 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 98.78 148.93 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 133.244 4.618 . . . . 0.0 111.118 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -65.83 140.42 61.14 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 122.416 1.898 . . . . 0.0 111.612 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 83.3 mtp -66.1 18.38 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.448 2.299 . . . . 0.0 115.604 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 43.42 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.044 2.138 . . . . 0.0 112.355 -158.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.4 149.68 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.755 1.622 . . . . 0.0 110.478 -166.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -19.53 65.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -173.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.24 11.89 36.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -44.09 -48.8 9.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.51 1.924 . . . . 0.0 112.721 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -59.58 -13.64 10.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.03 121.86 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 121.191 1.814 . . . . 0.0 107.106 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.9 mtp -99.71 -39.68 8.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.001 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -16.45 63.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -149.49 177.98 9.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.858 2.863 . . . . 0.0 108.969 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.35 29.02 15.31 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 121.856 0.698 . . . . 0.0 113.851 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.0 168.05 11.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -126.79 173.66 9.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.432 3.093 . . . . 0.0 109.443 147.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 O-C-N 121.158 -0.964 . . . . 0.0 111.668 -172.564 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.62 77.01 1.64 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 113.569 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t70 57.51 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.204 3.001 . . . . 0.0 117.57 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.24 -156.64 27.25 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.093 1.33 . . . . 0.0 113.029 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -124.18 -38.56 2.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.16 2.184 . . . . 0.0 112.699 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -86.32 140.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.378 1.471 . . . . 0.0 108.449 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.17 130.36 41.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.263 -2.148 . . . . 0.0 111.871 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.42 -40.22 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.831 2.052 . . . . 0.0 112.794 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -82.35 1.88 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.18 3.392 . . . . 0.0 115.421 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -57.8 -56.63 19.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.281 0.946 . . . . 0.0 111.249 168.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -39.98 66.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -166.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -140.94 166.42 22.77 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.063 2.545 . . . . 0.0 110.601 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.41 161.74 6.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.503 2.136 . . . . 0.0 113.384 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.2 mmt -138.47 85.54 2.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.983 2.513 . . . . 0.0 108.808 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -74.88 64.47 1.29 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.312 3.045 . . . . 0.0 111.635 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.76 158.93 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.465 2.706 . . . . 0.0 113.987 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -63.31 -25.43 68.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.48 -15.75 40.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -58.99 -18.11 31.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.76 2.024 . . . . 0.0 115.572 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -86.86 -12.74 46.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.719 -1.238 . . . . 0.0 113.304 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.97 98.5 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.75 2.02 . . . . 0.0 110.358 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -61.22 -34.12 74.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.53 -5.83 55.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -132.99 105.87 7.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.26 61.37 0.02 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -133.43 160.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.804 1.642 . . . . 0.0 115.16 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -149.99 178.6 8.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.537 2.335 . . . . 0.0 111.434 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 O-C-N 121.188 -0.945 . . . . 0.0 115.268 178.392 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.23 98.58 1.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 126.952 2.215 . . . . 0.0 111.273 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 63.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.603 2.761 . . . . 0.0 117.771 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.79 179.88 27.82 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 127.866 2.65 . . . . 0.0 114.466 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -78.64 -17.39 56.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.89 146.72 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.776 1.23 . . . . 0.0 108.704 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.32 135.8 54.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.98 -1.7 . . . . 0.0 111.382 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.48 -29.87 59.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.228 -1.545 . . . . 0.0 114.499 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -106.8 17.3 23.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 130.602 3.561 . . . . 0.0 113.229 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -50.59 -41.33 54.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.68 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -118.02 5.64 12.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -147.64 160.79 37.66 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.95 -1.719 . . . . 0.0 114.108 -164.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.84 169.29 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.869 3.046 . . . . 0.0 113.607 156.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.8 mtm -93.41 -55.21 3.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 111.347 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m170 52.26 26.59 4.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.514 1.926 . . . . 0.0 115.432 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.4 156.34 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.053 2.141 . . . . 0.0 111.905 170.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -58.3 -26.08 62.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.406 2.283 . . . . 0.0 113.941 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -63.79 -7.54 8.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 118.924 -2.36 . . . . 0.0 114.778 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -60.02 -10.06 3.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.75 2.02 . . . . 0.0 114.901 -169.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.88 -8.76 14.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.776 1.631 . . . . 0.0 115.015 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.3 mt -71.6 94.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.41 2.284 . . . . 0.0 108.573 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.7 mtt -57.63 -26.42 61.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.417 1.487 . . . . 0.0 113.998 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.47 0.6 16.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 116.631 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 t -140.44 -172.96 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 118.977 -2.327 . . . . 0.0 111.443 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.58 5.3 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 121.375 -0.828 . . . . 0.0 111.966 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -135.35 156.82 48.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.489 -1.006 . . . . 0.0 111.351 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.07 170.29 19.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 123.911 1.815 . . . . 0.0 113.637 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.477 2.465 . . . . 0.0 113.724 167.911 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.651 0.621 . . . . 0.0 114.651 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 10.53 13.98 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.16 -1.2 . . . . 0.0 114.571 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -149.58 112.04 4.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.289 1.545 . . . . 0.0 113.603 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.84 -157.37 27.2 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.763 1.649 . . . . 0.0 110.346 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.1 m -125.97 -9.89 6.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.959 -1.318 . . . . 0.0 113.222 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -85.12 113.89 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 120.846 1.657 . . . . 0.0 108.932 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.45 113.12 1.46 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.694 1.712 . . . . 0.0 114.609 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -61.96 -4.44 1.6 Allowed 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.049 -2.907 . . . . 0.0 116.561 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -120.15 -0.92 10.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 129.581 3.153 . . . . 0.0 114.795 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -58.86 -43.3 90.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.746 2.066 . . . . 0.0 113.262 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.54 -68.77 0.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 119.916 -1.74 . . . . 0.0 108.522 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -142.66 140.7 18.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 127.161 2.185 . . . . 0.0 110.362 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -68.72 177.13 5.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.283 1.989 . . . . 0.0 110.883 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.1 mtp -71.64 -5.14 31.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 113.828 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.45 19.14 3.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.809 2.443 . . . . 0.0 116.079 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.7 -175.45 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 126.529 1.932 . . . . 0.0 110.571 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -59.05 6.15 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.591 3.157 . . . . 0.0 118.655 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -122.87 93.69 4.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.119 2.568 . . . . 0.0 112.589 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.412 ' CE2' ' HG3' ' A' ' 20' ' ' GLN . 17.5 p-90 -150.82 -31.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.736 2.015 . . . . 0.0 114.885 167.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 19' ' ' TRP . 22.9 mt-30 -71.05 -18.03 62.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.44 97.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.204 1.802 . . . . 0.0 110.221 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -64.03 -20.77 66.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.329 1.852 . . . . 0.0 114.008 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.7 -2.36 42.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 t -144.62 -173.04 3.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.32 1.448 . . . . 0.0 111.382 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.41 47.23 22.98 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.391 1.472 . . . . 0.0 112.499 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.2 154.08 50.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -138.39 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 166.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 126.766 2.127 . . . . 0.0 111.84 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 CA-C-O 118.074 -1.403 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.36 -31.22 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -133.46 125.73 29.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.22 1.51 . . . . 0.0 113.105 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.27 -164.86 30.68 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.37 1.462 . . . . 0.0 109.645 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -113.74 0.58 14.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.866 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -115.31 141.05 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.376 1.871 . . . . 0.0 110.842 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 126.85 31.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.185 1.394 . . . . 0.0 113.359 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.5 -36.05 82.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.075 0.95 . . . . 0.0 112.283 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -76.2 7.31 4.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -63.95 -49.35 72.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.599 1.545 . . . . 0.0 113.129 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -79.34 -22.56 44.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.22 157.68 25.06 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.999 1.72 . . . . 0.0 113.539 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.46 157.65 60.95 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.603 1.535 . . . . 0.0 108.378 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ptm -151.71 114.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.704 0.802 . . . . 0.0 111.813 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -82.81 71.81 9.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.961 1.305 . . . . 0.0 112.448 -164.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 pt -116.46 154.97 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.396 1.878 . . . . 0.0 113.198 -170.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -71.63 -22.14 61.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -1.43 23.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.591 2.356 . . . . 0.0 112.968 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -52.32 -19.34 2.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.605 1.962 . . . . 0.0 116.241 -169.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -109.39 -7.15 15.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.067 1.747 . . . . 0.0 114.429 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.25 82.01 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 120.437 -1.414 . . . . 0.0 109.362 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.0 ttp -57.3 -25.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.84 2.856 . . . . 0.0 113.774 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -92.44 9.65 33.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.185 1.794 . . . . 0.0 112.726 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 t -146.31 -165.42 2.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.747 -1.846 . . . . 0.0 112.721 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.27 77.17 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.147 2.308 . . . . 0.0 117.736 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -64.64 166.6 8.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.178 1.791 . . . . 0.0 114.899 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -178.87 6.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 114.122 160.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 130.389 3.852 . . . . 0.0 110.147 176.813 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 20.86 3.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.382 1.468 . . . . 0.0 115.833 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -143.77 110.41 5.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.217 1.509 . . . . 0.0 111.395 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.51 -143.9 15.43 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 126.0 1.762 . . . . 0.0 113.774 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.2 m -145.44 -23.33 0.48 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.47 138.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 118.456 -2.653 . . . . 0.0 110.45 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.44 107.95 0.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.85 1.66 . . . . 0.0 112.589 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.77 -6.27 3.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.98 11.32 19.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -55.12 -29.63 58.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.014 2.125 . . . . 0.0 113.817 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -134.19 58.9 1.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 123.188 1.471 . . . . 0.0 108.613 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -135.53 147.99 63.98 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 127.222 2.209 . . . . 0.0 112.38 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -66.97 167.56 19.48 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.734 2.956 . . . . 0.0 109.421 158.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.61 64.41 0.29 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.495 1.518 . . . . 0.0 113.169 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -149.0 29.19 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.062 1.345 . . . . 0.0 112.738 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 151.57 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.948 2.499 . . . . 0.0 109.693 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -84.14 -4.24 58.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.65 -13.45 61.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -24.52 4.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -131.0 8.01 4.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.065 2.146 . . . . 0.0 113.228 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mp -142.46 88.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.164 2.586 . . . . 0.0 108.803 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.6 mtp -58.94 -32.8 69.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.781 -1.199 . . . . 0.0 112.294 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.65 -28.6 69.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 t -78.09 40.01 0.32 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.344 1.858 . . . . 0.0 112.172 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.75 75.51 0.1 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.255 1.407 . . . . 0.0 114.543 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -111.95 130.22 55.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.16 0.981 . . . . 0.0 110.557 169.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -138.47 166.7 23.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 164.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 129.382 3.372 . . . . 0.0 107.403 174.237 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 116.386 -2.341 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.42 -94.96 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.37 1.585 . . . . 0.0 113.208 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -90.18 154.06 20.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.475 1.51 . . . . 0.0 113.558 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.02 -178.34 28.49 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 127.271 2.367 . . . . 0.0 114.821 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -110.88 -14.37 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.791 1.296 . . . . 0.0 114.377 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 6' ' ' ILE . 17.7 mt -84.53 133.27 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.884 168.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.33 113.26 5.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.802 1.641 . . . . 0.0 112.758 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -72.84 -39.46 66.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -56.29 -21.22 22.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.357 2.663 . . . . 0.0 114.344 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.56 -36.13 75.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.797 -1.814 . . . . 0.0 114.69 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.944 1.697 . . . . 0.0 113.003 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 72.09 167.33 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.139 1.776 . . . . 0.0 112.141 -170.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 148.33 90.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.761 2.974 . . . . 0.0 115.597 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.5 mtp -85.93 99.31 11.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.879 -1.138 . . . . 0.0 108.605 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.79 22.99 0.17 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.07 1.748 . . . . 0.0 114.139 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.4 164.96 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.32 3.048 . . . . 0.0 111.213 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -16.56 63.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -159.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.31 -6.8 20.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.491 -1.381 . . . . 0.0 114.248 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -59.47 -5.8 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -164.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.66 -3.76 12.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 122.247 2.294 . . . . 0.0 113.947 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.07 104.43 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.831 1.652 . . . . 0.0 111.871 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -29.81 65.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.38 -9.1 58.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.637 1.975 . . . . 0.0 115.521 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -135.0 78.59 1.74 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.138 -1.602 . . . . 0.0 109.804 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.26 28.11 0.26 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.062 1.791 . . . . 0.0 114.121 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -137.63 167.69 21.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -157.44 -175.96 5.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.568 2.747 . . . . 0.0 111.33 173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 C-N-CA 126.554 2.026 . . . . 0.0 112.124 -176.616 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.52 163.45 19.48 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.769 2.128 . . . . 0.0 115.217 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.5 t70 57.59 119.77 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 132.005 4.122 . . . . 0.0 115.621 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 -169.13 24.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.888 2.661 . . . . 0.0 112.422 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -111.34 -14.91 13.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -78.01 111.98 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 120.082 -1.636 . . . . 0.0 106.783 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.99 111.05 2.0 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.187 1.795 . . . . 0.0 112.218 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -70.54 -42.54 71.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 119.843 -1.786 . . . . 0.0 114.515 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -64.92 -25.0 67.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.185 1.394 . . . . 0.0 113.747 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.44 -34.23 77.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.126 -1.609 . . . . 0.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -90.59 -22.11 21.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -137.5 153.48 74.44 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 121.365 1.893 . . . . 0.0 114.791 -167.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.02 168.3 23.59 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 126.161 4.574 . . . . 0.0 113.972 170.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.58 143.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.731 1.612 . . . . 0.0 110.903 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -176.09 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.055 2.942 . . . . 0.0 111.641 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -55.31 141.04 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.196 0.998 . . . . 0.0 113.415 174.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -71.3 -9.97 58.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.952 2.101 . . . . 0.0 114.944 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -75.03 85.93 2.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.013 2.125 . . . . 0.0 111.45 151.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -139.63 -6.82 1.31 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.669 1.987 . . . . 0.0 115.262 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -134.21 -24.29 1.64 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.525 1.93 . . . . 0.0 111.528 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.11 107.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.091 1.756 . . . . 0.0 108.363 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.7 mtp -56.76 -21.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -122.43 19.69 10.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.213 1.805 . . . . 0.0 113.725 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -124.74 94.64 4.25 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.979 1.712 . . . . 0.0 109.819 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.93 25.34 0.19 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-O 116.739 -2.145 . . . . 0.0 111.877 -167.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -138.94 158.11 44.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.936 2.368 . . . . 0.0 114.146 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -143.34 -177.65 5.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.21 161.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.734 2.588 . . . . 0.0 116.763 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 94.66 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 127.013 2.244 . . . . 0.0 111.812 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 58.56 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.854 2.462 . . . . 0.0 116.424 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.7 -162.47 32.51 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 126.359 1.933 . . . . 0.0 114.169 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.2 p -124.39 -34.35 2.91 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.115 2.166 . . . . 0.0 115.662 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.24 112.71 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.365 1.866 . . . . 0.0 110.17 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.96 107.64 0.22 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.814 2.046 . . . . 0.0 112.159 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.45 -57.55 12.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.445 1.098 . . . . 0.0 112.036 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.62 -26.93 68.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -65.6 -44.89 85.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.555 0.616 . . . . 0.0 109.984 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -72.03 -34.06 68.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.525 -1.984 . . . . 0.0 115.891 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -147.49 162.12 33.27 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.81 147.2 44.0 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.224 1.949 . . . . 0.0 110.852 163.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.3 132.84 17.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.501 1.12 . . . . 0.0 110.855 170.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -133.35 73.12 1.5 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.551 1.167 . . . . 0.0 110.544 -163.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.14 159.16 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.756 1.265 . . . . 0.0 114.194 -165.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -64.09 -24.73 67.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.89 14.59 2.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.375 1.87 . . . . 0.0 115.661 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -51.87 -43.09 63.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.325 -1.484 . . . . 0.0 114.345 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.19 8.9 7.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.62 114.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 119.952 1.251 . . . . 0.0 108.649 173.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.7 mtm -82.01 -18.9 41.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.428 2.291 . . . . 0.0 111.966 173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.97 13.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.795 2.038 . . . . 0.0 114.587 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 t -151.53 -170.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.37 1.868 . . . . 0.0 112.846 -165.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.46 22.53 1.66 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.846 1.689 . . . . 0.0 115.016 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.33 137.2 32.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.802 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.72 -173.01 2.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.932 1.693 . . . . 0.0 112.527 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.336 -1.813 . . . . 0.0 116.376 -172.039 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.66 -15.48 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.09 128.59 12.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.382 2.091 . . . . 0.0 111.84 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.76 -139.37 7.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.287 1.422 . . . . 0.0 113.279 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -142.32 -34.27 0.46 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.8 133.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.74 -1.225 . . . . 0.0 110.069 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.55 129.4 38.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.632 -1.917 . . . . 0.0 109.947 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.74 -6.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 119.094 -2.253 . . . . 0.0 113.681 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -119.48 12.89 12.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.826 2.451 . . . . 0.0 113.495 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -62.72 -29.37 70.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.916 2.486 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -125.07 -0.41 7.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.345 1.858 . . . . 0.0 115.884 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -156.36 167.36 14.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.92 1.688 . . . . 0.0 111.87 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -64.75 170.39 10.08 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.87 2.38 . . . . 0.0 112.625 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.15 49.11 2.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.332 2.653 . . . . 0.0 110.043 165.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.36 47.11 0.36 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.947 3.699 . . . . 0.0 115.524 -169.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.83 -177.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 127.904 2.481 . . . . 0.0 112.09 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -80.15 1.52 27.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -115.39 78.91 1.22 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.238 1.815 . . . . 0.0 110.319 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.88 -0.83 1.14 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -138.04 52.23 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.579 2.352 . . . . 0.0 112.259 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.02 109.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.828 2.051 . . . . 0.0 109.362 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -54.33 -36.57 63.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.653 1.581 . . . . 0.0 113.89 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -86.28 -3.05 58.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 t -100.19 176.42 5.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.811 1.187 . . . . 0.0 112.441 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.47 -4.96 65.79 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 117.289 1.676 . . . . 0.0 117.289 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.06 1.93 . . . . 0.0 111.038 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -171.37 3.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.022 1.729 . . . . 0.0 112.025 167.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.549 2.976 . . . . 0.0 113.488 174.692 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 CA-C-O 121.029 0.238 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.91 -41.38 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 165.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -147.4 111.02 4.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.079 1.351 . . . . 0.0 111.791 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.04 -173.86 36.74 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 126.301 1.905 . . . . 0.0 114.156 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -119.12 -28.78 5.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.26 2.224 . . . . 0.0 113.1 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -73.45 135.39 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.303 1.041 . . . . 0.0 108.273 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.12 133.02 44.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.735 -1.228 . . . . 0.0 111.422 171.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.18 -52.88 52.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.799 0.839 . . . . 0.0 110.191 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -75.64 16.83 0.34 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.758 2.023 . . . . 0.0 113.378 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -48.53 -37.31 17.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.359 2.263 . . . . 0.0 112.698 -170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -99.23 -66.5 0.9 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.867 1.267 . . . . 0.0 111.621 167.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -139.32 153.44 70.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 126.63 1.972 . . . . 0.0 112.483 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.5 154.29 65.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.4 2.067 . . . . 0.0 110.513 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.74 22.53 5.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 119.99 -1.694 . . . . 0.0 113.951 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.0 p80 52.34 2.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 130.289 3.436 . . . . 0.0 118.165 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.95 168.46 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -59.37 -21.43 59.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.589 3.156 . . . . 0.0 115.686 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.64 -4.48 6.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -56.82 -23.6 44.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 167.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.18 11.64 25.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.776 2.43 . . . . 0.0 115.718 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.12 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 123.876 1.798 . . . . 0.0 108.48 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -52.66 -40.13 62.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 129.326 3.05 . . . . 0.0 112.331 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.96 -19.85 61.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.725 2.01 . . . . 0.0 114.478 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 t -131.75 -19.72 2.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -156.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 54.17 1.51 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 117.135 -1.925 . . . . 0.0 113.979 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -132.24 156.27 46.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.487 2.144 . . . . 0.0 114.016 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -143.24 -177.78 5.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.017 2.127 . . . . 0.0 111.493 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.979 1.752 . . . . 0.0 115.472 173.303 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.37 30.66 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.321 0.962 . . . . 0.0 111.752 163.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 49.3 80.75 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.079 2.151 . . . . 0.0 113.662 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.39 -169.13 32.33 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.387 1.47 . . . . 0.0 112.895 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -121.07 -22.16 6.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.932 0.893 . . . . 0.0 113.179 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.0 125.37 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.408 2.683 . . . . 0.0 108.842 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.21 126.23 30.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.862 0.756 . . . . 0.0 112.218 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.16 -55.31 35.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.059 -0.401 . . . . 0.0 110.789 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -64.56 -17.74 64.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -168.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -15.36 -73.0 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.951 3.301 . . . . 0.0 115.56 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -124.95 21.79 8.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.055 0.942 . . . . 0.0 113.274 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.67 158.83 66.08 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.586 1.554 . . . . 0.0 113.754 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.07 -178.27 4.39 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.363 2.042 . . . . 0.0 111.75 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.3 mtp 69.36 57.57 0.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.759 2.424 . . . . 0.0 110.916 -171.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -71.55 70.74 0.67 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.137 2.175 . . . . 0.0 113.358 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.17 -178.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 127.807 2.443 . . . . 0.0 111.384 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -62.31 -5.91 2.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -171.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -73.94 -5.82 43.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 119.203 -2.186 . . . . 0.0 116.838 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -177.12 0.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 163.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 56.74 10.2 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 165.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -66.03 151.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 119.47 -2.019 . . . . 0.0 107.901 165.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.0 ttm -121.63 -46.7 2.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.711 -1.243 . . . . 0.0 113.858 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.08 -7.38 1.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 163.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 t -162.9 -179.98 7.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.781 2.432 . . . . 0.0 111.122 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.51 12.18 33.75 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.508 -0.745 . . . . 0.0 114.88 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -123.5 169.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.525 1.663 . . . . 0.0 113.092 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -154.67 -176.97 6.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.478 2.711 . . . . 0.0 111.296 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 126.866 2.174 . . . . 0.0 111.774 171.083 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 117.574 -1.681 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.49 165.5 13.82 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 126.515 2.007 . . . . 0.0 109.429 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.5 t0 54.02 92.13 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.77 179.57 46.35 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 123.926 0.774 . . . . 0.0 112.682 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 t -94.77 -13.06 26.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.96 135.01 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.348 1.859 . . . . 0.0 110.41 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.37 120.18 12.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.539 1.063 . . . . 0.0 110.927 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.65 7.53 2.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -129.53 10.15 5.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.383 2.273 . . . . 0.0 111.657 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -41.61 -47.45 3.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.641 1.176 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.7 -43.65 0.27 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.251 1.821 . . . . 0.0 112.191 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -47.56 154.36 0.9 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 128.048 2.539 . . . . 0.0 115.289 168.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.51 171.01 12.5 Favored 'Trans proline' 0 N--CA 1.45 -1.069 1 C-N-CA 125.759 4.306 . . . . 0.0 114.792 -175.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.91 21.34 6.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.859 3.263 . . . . 0.0 112.22 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -51.25 -17.04 0.61 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.092 4.157 . . . . 0.0 116.073 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.73 151.24 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 123.264 1.507 . . . . 0.0 114.145 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -61.59 -16.35 47.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.687 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.33 -1.55 24.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.233 1.813 . . . . 0.0 114.141 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -50.9 -35.59 33.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -79.19 -16.26 56.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.968 -1.707 . . . . 0.0 114.262 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.87 105.05 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.708 1.14 . . . . 0.0 108.649 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.4 ptm -73.62 -22.1 60.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.163 0.985 . . . . 0.0 112.707 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.13 -12.27 54.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.9 m -131.33 65.57 1.56 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.655 1.182 . . . . 0.0 109.231 -169.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.58 18.53 5.71 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.303 2.383 . . . . 0.0 112.826 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -134.46 153.01 52.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 123.782 1.753 . . . . 0.0 113.801 -162.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -176.31 5.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 118.79 -2.444 . . . . 0.0 111.912 171.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 125.704 1.621 . . . . 0.0 112.763 -175.053 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.39 9.92 Favored Glycine 0 CA--C 1.522 0.487 0 O-C-N 121.133 -1.216 . . . . 0.0 114.299 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.6 t0 55.53 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.012 3.325 . . . . 0.0 118.646 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.65 -171.3 19.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 126.777 2.132 . . . . 0.0 111.097 -159.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.1 p -134.93 -4.66 2.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -77.4 123.16 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 120.596 1.544 . . . . 0.0 107.232 168.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 112.17 1.28 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.92 -28.82 70.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.05 1.74 . . . . 0.0 113.017 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -89.37 -6.63 56.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.94 119.61 11.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 121.76 2.073 . . . . 0.0 111.6 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t30 51.66 3.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 129.86 3.264 . . . . 0.0 117.308 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -129.67 146.63 62.0 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 130.482 3.513 . . . . 0.0 109.356 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.18 156.17 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.524 2.149 . . . . 0.0 111.931 -169.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.07 56.44 0.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.213 2.605 . . . . 0.0 109.785 171.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -71.87 30.02 0.05 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 130.019 3.328 . . . . 0.0 113.526 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.35 150.32 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 129.438 3.095 . . . . 0.0 113.168 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -57.09 -29.7 63.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HA ' HD13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.7 -3.25 11.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 114.427 174.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -55.71 -20.05 13.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -103.72 -1.9 27.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.731 2.012 . . . . 0.0 113.08 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 18' ' ' ASP . 1.4 mp -99.98 98.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -171.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 mmt -54.22 -31.24 52.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.428 1.891 . . . . 0.0 111.811 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -65.44 -28.76 69.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -128.72 63.65 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.466 2.306 . . . . 0.0 110.09 -170.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.8 25.21 9.69 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 115.446 -2.863 . . . . 0.0 114.444 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.31 166.85 23.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.412 2.606 . . . . 0.0 112.824 -158.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -138.19 173.16 11.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.465 1.506 . . . . 0.0 110.99 156.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.594 -175.575 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.88 -75.74 1.3 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.113 1.34 . . . . 0.0 111.858 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.04 146.79 27.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 123.456 1.598 . . . . 0.0 112.76 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.43 -150.21 21.74 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 120.31 -1.493 . . . . 0.0 112.941 169.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -124.69 -49.92 1.75 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.974 1.31 . . . . 0.0 110.672 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.31 124.13 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 108.099 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.36 130.4 42.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 173.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -77.5 -17.06 58.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.793 -1.817 . . . . 0.0 113.277 -157.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.07 -3.79 18.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 169.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -46.22 -45.74 17.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -112.11 95.48 5.49 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 116.118 -1.896 . . . . 0.0 108.056 165.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 71.13 145.27 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 129.421 3.088 . . . . 0.0 112.938 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -63.27 149.89 90.07 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.146 1.897 . . . . 0.0 112.718 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -62.74 112.72 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.023 1.329 . . . . 0.0 110.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -80.99 -1.0 42.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.973 1.309 . . . . 0.0 114.475 -171.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.13 173.37 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.241 1.417 . . . . 0.0 111.235 162.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -68.4 -32.31 72.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 119.007 -2.308 . . . . 0.0 113.519 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -83.42 103.72 13.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.893 1.224 . . . . 0.0 111.043 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -142.13 -25.32 0.66 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.77 -11.68 60.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.3 mp -72.18 92.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.489 1.116 . . . . 0.0 108.373 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.8 mmm -57.83 -27.23 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.93 -16.24 62.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.354 1.862 . . . . 0.0 113.756 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 t -152.72 96.07 2.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.052 1.341 . . . . 0.0 110.288 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.24 0.39 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.327 1.441 . . . . 0.0 113.064 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -130.95 174.21 10.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.736 1.614 . . . . 0.0 113.936 -167.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.14 179.65 8.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.475 2.31 . . . . 0.0 112.581 170.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.825 3.107 . . . . 0.0 111.829 169.735 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.52 100.1 0.57 Allowed Glycine 0 CA--C 1.522 0.471 0 CA-C-N 120.527 2.163 . . . . 0.0 113.899 174.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.2 160.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.516 2.326 . . . . 0.0 116.293 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.79 -143.48 16.94 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.044 -1.66 . . . . 0.0 109.184 -160.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -158.96 -8.56 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 172.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -71.79 124.34 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.48 110.59 0.58 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.811 1.644 . . . . 0.0 113.041 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.68 -6.64 32.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.234 1.413 . . . . 0.0 113.645 -175.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.56 -7.16 19.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.136 2.174 . . . . 0.0 114.607 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -91.37 133.63 35.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.235 0.925 . . . . 0.0 113.276 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.41 18.46 2.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.156 2.182 . . . . 0.0 115.234 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -141.91 158.04 63.01 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 117.974 -1.013 . . . . 0.0 111.694 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.65 159.87 45.02 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.294 2.663 . . . . 0.0 110.203 163.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -121.74 -85.22 0.66 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.879 1.672 . . . . 0.0 110.63 -164.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.29 -6.47 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 130.941 3.696 . . . . 0.0 117.324 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 156.55 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 119.558 -1.964 . . . . 0.0 112.493 164.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.49 16.17 0.15 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -90.23 -3.27 57.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.794 1.638 . . . . 0.0 115.068 168.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.02 -7.87 4.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -119.01 -3.76 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.945 2.498 . . . . 0.0 114.182 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.05 101.9 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -160.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 71.6 mmm -60.14 -29.51 68.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -164.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.63 -50.76 69.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.671 1.588 . . . . 0.0 114.475 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 p -86.15 5.11 35.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -166.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.18 31.37 2.61 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 119.647 -1.908 . . . . 0.0 115.133 -171.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -127.62 165.4 20.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.501 1.65 . . . . 0.0 114.366 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -146.06 -173.08 4.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.65 1.98 . . . . 0.0 112.097 159.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.549 2.5 . . . . 0.0 110.843 175.405 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 121.384 0.435 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.49 -32.88 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 126.742 2.115 . . . . 0.0 112.875 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -138.88 117.62 12.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.821 1.648 . . . . 0.0 110.145 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.43 -166.7 33.31 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.381 2.419 . . . . 0.0 113.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -113.42 -17.92 12.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.34 114.71 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 121.082 1.764 . . . . 0.0 108.829 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 134.06 54.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.116 1.366 . . . . 0.0 110.884 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.97 -26.32 68.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.125 -1.609 . . . . 0.0 115.047 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -82.87 1.26 40.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.093 1.357 . . . . 0.0 114.513 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -52.78 -44.44 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.919 1.691 . . . . 0.0 114.837 -171.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -121.92 19.53 10.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.831 2.452 . . . . 0.0 111.585 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 154.9 80.81 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 127.604 2.362 . . . . 0.0 112.928 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.05 170.22 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.102 2.534 . . . . 0.0 108.686 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.7 mmt -71.85 63.45 0.46 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.102 0.961 . . . . 0.0 111.907 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.28 -26.72 32.87 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.518 1.927 . . . . 0.0 112.059 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.1 pt -57.59 145.12 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 128.552 2.741 . . . . 0.0 111.512 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -25.26 60.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 125.037 1.461 . . . . 0.0 113.534 171.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.8 -1.12 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.72 2.008 . . . . 0.0 115.496 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -61.23 -18.13 56.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 -168.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -108.85 0.64 20.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.78 85.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.982 1.713 . . . . 0.0 108.774 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 ttt -67.85 -14.28 62.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.864 -1.148 . . . . 0.0 114.058 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.27 -9.49 33.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.662 2.785 . . . . 0.0 113.686 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 t -138.9 174.55 10.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.262 1.425 . . . . 0.0 109.696 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.55 58.39 1.44 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.799 162.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.07 167.07 22.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.535 1.934 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.92 174.62 11.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.706 1.602 . . . . 0.0 113.713 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 174.069 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.6 112.3 4.05 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.668 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 57.84 81.15 0.15 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.862 2.065 . . . . 0.0 114.021 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.98 -148.47 5.29 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 116.339 1.295 . . . . 0.0 116.339 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.6 m -122.67 -36.3 2.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.232 1.813 . . . . 0.0 115.724 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -82.98 118.16 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.221 2.208 . . . . 0.0 107.567 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.86 122.69 6.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.978 1.371 . . . . 0.0 111.5 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -58.06 -33.0 68.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.108 -2.87 . . . . 0.0 113.822 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -97.71 11.52 36.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.018 2.127 . . . . 0.0 112.398 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -48.57 -41.41 30.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.949 2.5 . . . . 0.0 114.138 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -127.74 -2.14 6.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.432 1.093 . . . . 0.0 112.518 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -137.72 150.15 67.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.263 1.425 . . . . 0.0 112.415 -168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.2 143.37 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.446 2.097 . . . . 0.0 112.207 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.3 ptm -66.19 116.27 7.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -130.52 63.93 1.56 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.786 2.834 . . . . 0.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.59 157.36 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.054 1.341 . . . . 0.0 111.932 -171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.58 1.83 1.12 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -57.86 -13.27 4.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -105.77 -4.87 20.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.941 2.097 . . . . 0.0 113.293 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.29 107.43 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.638 1.175 . . . . 0.0 108.82 -167.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.45 58.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.918 2.087 . . . . 0.0 115.71 174.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 116.3 9.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.743 -1.223 . . . . 0.0 112.254 -165.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.63 17.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.163 -0.799 . . . . 0.0 114.085 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 155.92 32.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.024 1.912 . . . . 0.0 113.713 -167.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -141.31 -175.29 4.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.916 1.686 . . . . 0.0 112.612 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.395 1.95 . . . . 0.0 114.929 178.675 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 CA-C-O 117.742 -1.588 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.77 164.1 13.61 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 123.456 1.587 . . . . 0.0 113.914 158.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 58.0 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.765 2.826 . . . . 0.0 117.699 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.74 -172.86 30.4 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 120.651 -1.281 . . . . 0.0 115.416 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -75.8 -54.89 6.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.679 1.192 . . . . 0.0 112.406 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.48 105.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.454 2.302 . . . . 0.0 106.662 -165.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.68 104.08 0.4 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.639 1.576 . . . . 0.0 110.899 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -53.06 -31.07 39.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -164.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.18 -9.19 58.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.875 -1.536 . . . . 0.0 114.135 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.75 -20.72 61.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -136.12 -10.5 1.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -146.65 154.4 48.11 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 128.164 2.586 . . . . 0.0 110.383 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.81 143.66 80.83 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.083 2.522 . . . . 0.0 113.035 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.4 mmm -75.85 64.18 1.78 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.608 2.363 . . . . 0.0 108.068 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -67.47 1.78 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.59 1.956 . . . . 0.0 114.133 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.23 167.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.494 2.318 . . . . 0.0 111.601 -167.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -54.77 -19.64 6.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.822 2.449 . . . . 0.0 117.549 -166.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.92 -8.11 14.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -53.35 -22.08 6.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -110.23 2.18 19.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.757 2.526 . . . . 0.0 116.332 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.15 97.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 120.495 -1.378 . . . . 0.0 107.953 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttp -59.52 -29.23 67.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.313 1.845 . . . . 0.0 113.968 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.87 -1.07 12.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.088 2.555 . . . . 0.0 114.759 171.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -121.12 -176.31 3.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.074 2.55 . . . . 0.0 109.554 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.56 34.0 4.88 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 126.211 1.862 . . . . 0.0 113.562 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.17 160.39 40.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 117.646 0.723 . . . . 0.0 110.126 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -155.34 -173.18 4.45 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.038 2.535 . . . . 0.0 112.573 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.937 -2.465 . . . . 0.0 106.937 -177.817 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.79 -140.34 3.11 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 121.884 2.842 . . . . 0.0 113.229 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -66.99 137.31 56.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.316 2.247 . . . . 0.0 111.745 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.02 -164.38 31.8 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 126.328 1.918 . . . . 0.0 114.133 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 m -134.32 -31.65 1.09 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.6 138.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 107.417 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 128.3 33.59 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.495 -2.003 . . . . 0.0 114.586 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.61 -24.28 66.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.41 -1.757 . . . . 0.0 114.245 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -67.92 -21.39 65.12 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 121.252 1.842 . . . . 0.0 114.99 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -65.56 -36.12 82.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.96 98.91 5.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.497 1.919 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 66.33 156.79 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 129.551 3.14 . . . . 0.0 114.077 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.08 162.76 20.4 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.324 1.349 . . . . 0.0 113.087 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 51.7 mtt -126.75 114.07 17.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.777 163.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -80.9 67.52 6.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.821 -1.174 . . . . 0.0 109.62 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.3 151.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.578 1.951 . . . . 0.0 109.256 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -76.06 9.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -162.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -118.54 1.86 11.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.715 2.406 . . . . 0.0 114.407 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -53.56 -25.65 18.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -160.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.71 -29.13 27.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mp -75.41 116.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.466 0.706 . . . . 0.0 110.361 -158.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.4 mtt -57.92 -50.76 72.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.956 2.102 . . . . 0.0 113.878 -168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.25 6.52 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.259 1.024 . . . . 0.0 113.7 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 173.6 11.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.64 1.976 . . . . 0.0 108.959 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.2 20.33 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.135 -1.369 . . . . 0.0 113.001 162.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -83.87 171.9 12.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.296 2.048 . . . . 0.0 115.533 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.61 -179.06 7.08 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 131.814 4.045 . . . . 0.0 110.545 164.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.053 1.311 . . . . 0.0 111.982 -176.142 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.21 -72.99 0.23 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.115 0.958 . . . . 0.0 113.496 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -101.29 130.65 47.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -161.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.5 -136.05 8.57 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.875 1.226 . . . . 0.0 112.15 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -142.08 -18.33 0.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.44 1.496 . . . . 0.0 113.503 -170.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.9 mt -99.63 113.26 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.86 134.1 37.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 112.757 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.75 -9.85 3.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -93.65 15.43 16.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.263 3.025 . . . . 0.0 115.687 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -47.64 -49.34 27.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.729 2.011 . . . . 0.0 113.567 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -80.75 10.89 4.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.086 1.354 . . . . 0.0 113.726 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 98.78 148.93 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 133.244 4.618 . . . . 0.0 111.118 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -65.83 140.42 61.14 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 122.416 1.898 . . . . 0.0 111.612 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 83.3 mtp -66.1 18.38 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.448 2.299 . . . . 0.0 115.604 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 43.42 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.044 2.138 . . . . 0.0 112.355 -158.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.4 149.68 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.755 1.622 . . . . 0.0 110.478 -166.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -19.53 65.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -173.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.24 11.89 36.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -44.09 -48.8 9.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.51 1.924 . . . . 0.0 112.721 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -59.58 -13.64 10.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.03 121.86 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 121.191 1.814 . . . . 0.0 107.106 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.9 mtp -99.71 -39.68 8.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.001 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -16.45 63.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -149.49 177.98 9.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.858 2.863 . . . . 0.0 108.969 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.35 29.02 15.31 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 121.856 0.698 . . . . 0.0 113.851 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.0 168.05 11.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -126.79 173.66 9.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.432 3.093 . . . . 0.0 109.443 147.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 O-C-N 121.158 -0.964 . . . . 0.0 111.668 -172.564 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.62 77.01 1.64 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 113.569 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t70 57.51 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.204 3.001 . . . . 0.0 117.57 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.24 -156.64 27.25 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.093 1.33 . . . . 0.0 113.029 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -124.18 -38.56 2.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.16 2.184 . . . . 0.0 112.699 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -86.32 140.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.378 1.471 . . . . 0.0 108.449 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.17 130.36 41.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.263 -2.148 . . . . 0.0 111.871 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.42 -40.22 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.831 2.052 . . . . 0.0 112.794 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -82.35 1.88 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.18 3.392 . . . . 0.0 115.421 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -57.8 -56.63 19.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.281 0.946 . . . . 0.0 111.249 168.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -39.98 66.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -166.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -140.94 166.42 22.77 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.063 2.545 . . . . 0.0 110.601 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.41 161.74 6.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.503 2.136 . . . . 0.0 113.384 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.2 mmt -138.47 85.54 2.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.983 2.513 . . . . 0.0 108.808 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -74.88 64.47 1.29 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.312 3.045 . . . . 0.0 111.635 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.76 158.93 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.465 2.706 . . . . 0.0 113.987 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -63.31 -25.43 68.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.48 -15.75 40.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -58.99 -18.11 31.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.76 2.024 . . . . 0.0 115.572 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -86.86 -12.74 46.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.719 -1.238 . . . . 0.0 113.304 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.97 98.5 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.75 2.02 . . . . 0.0 110.358 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -61.22 -34.12 74.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.53 -5.83 55.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -132.99 105.87 7.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.26 61.37 0.02 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -133.43 160.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.804 1.642 . . . . 0.0 115.16 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -149.99 178.6 8.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.537 2.335 . . . . 0.0 111.434 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 O-C-N 121.188 -0.945 . . . . 0.0 115.268 178.392 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.23 98.58 1.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 126.952 2.215 . . . . 0.0 111.273 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 63.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.603 2.761 . . . . 0.0 117.771 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.79 179.88 27.82 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 127.866 2.65 . . . . 0.0 114.466 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -78.64 -17.39 56.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.89 146.72 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.776 1.23 . . . . 0.0 108.704 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.32 135.8 54.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.98 -1.7 . . . . 0.0 111.382 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.48 -29.87 59.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.228 -1.545 . . . . 0.0 114.499 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -106.8 17.3 23.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 130.602 3.561 . . . . 0.0 113.229 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -50.59 -41.33 54.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.68 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -118.02 5.64 12.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -147.64 160.79 37.66 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.95 -1.719 . . . . 0.0 114.108 -164.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.84 169.29 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.869 3.046 . . . . 0.0 113.607 156.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.8 mtm -93.41 -55.21 3.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 111.347 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m170 52.26 26.59 4.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.514 1.926 . . . . 0.0 115.432 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.4 156.34 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.053 2.141 . . . . 0.0 111.905 170.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -58.3 -26.08 62.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.406 2.283 . . . . 0.0 113.941 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -63.79 -7.54 8.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 118.924 -2.36 . . . . 0.0 114.778 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -60.02 -10.06 3.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.75 2.02 . . . . 0.0 114.901 -169.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.88 -8.76 14.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.776 1.631 . . . . 0.0 115.015 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.3 mt -71.6 94.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.41 2.284 . . . . 0.0 108.573 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.7 mtt -57.63 -26.42 61.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.417 1.487 . . . . 0.0 113.998 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.47 0.6 16.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 116.631 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 t -140.44 -172.96 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 118.977 -2.327 . . . . 0.0 111.443 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.58 5.3 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 121.375 -0.828 . . . . 0.0 111.966 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -135.35 156.82 48.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.489 -1.006 . . . . 0.0 111.351 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.07 170.29 19.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 123.911 1.815 . . . . 0.0 113.637 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.477 2.465 . . . . 0.0 113.724 167.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.651 0.621 . . . . 0.0 114.651 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 10.53 13.98 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.16 -1.2 . . . . 0.0 114.571 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -149.58 112.04 4.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.289 1.545 . . . . 0.0 113.603 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.84 -157.37 27.2 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.763 1.649 . . . . 0.0 110.346 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.1 m -125.97 -9.89 6.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.959 -1.318 . . . . 0.0 113.222 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -85.12 113.89 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 120.846 1.657 . . . . 0.0 108.932 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.45 113.12 1.46 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.694 1.712 . . . . 0.0 114.609 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -61.96 -4.44 1.6 Allowed 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.049 -2.907 . . . . 0.0 116.561 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -120.15 -0.92 10.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 129.581 3.153 . . . . 0.0 114.795 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -58.86 -43.3 90.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.746 2.066 . . . . 0.0 113.262 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.54 -68.77 0.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 119.916 -1.74 . . . . 0.0 108.522 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -142.66 140.7 18.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 127.161 2.185 . . . . 0.0 110.362 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -68.72 177.13 5.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.283 1.989 . . . . 0.0 110.883 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.1 mtp -71.64 -5.14 31.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 113.828 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.45 19.14 3.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.809 2.443 . . . . 0.0 116.079 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.7 -175.45 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 126.529 1.932 . . . . 0.0 110.571 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -59.05 6.15 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.591 3.157 . . . . 0.0 118.655 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -122.87 93.69 4.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.119 2.568 . . . . 0.0 112.589 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.412 ' CE2' ' HG3' ' A' ' 20' ' ' GLN . 17.5 p-90 -150.82 -31.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.736 2.015 . . . . 0.0 114.885 167.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 19' ' ' TRP . 22.9 mt-30 -71.05 -18.03 62.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.44 97.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.204 1.802 . . . . 0.0 110.221 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -64.03 -20.77 66.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.329 1.852 . . . . 0.0 114.008 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.7 -2.36 42.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 t -144.62 -173.04 3.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.32 1.448 . . . . 0.0 111.382 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.41 47.23 22.98 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.391 1.472 . . . . 0.0 112.499 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.2 154.08 50.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -138.39 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 166.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 126.766 2.127 . . . . 0.0 111.84 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 CA-C-O 118.074 -1.403 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.36 -31.22 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -133.46 125.73 29.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.22 1.51 . . . . 0.0 113.105 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.27 -164.86 30.68 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.37 1.462 . . . . 0.0 109.645 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -113.74 0.58 14.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.866 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -115.31 141.05 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.376 1.871 . . . . 0.0 110.842 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 126.85 31.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.185 1.394 . . . . 0.0 113.359 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.5 -36.05 82.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.075 0.95 . . . . 0.0 112.283 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -76.2 7.31 4.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -63.95 -49.35 72.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.599 1.545 . . . . 0.0 113.129 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -79.34 -22.56 44.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.22 157.68 25.06 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.999 1.72 . . . . 0.0 113.539 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.46 157.65 60.95 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.603 1.535 . . . . 0.0 108.378 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ptm -151.71 114.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.704 0.802 . . . . 0.0 111.813 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -82.81 71.81 9.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.961 1.305 . . . . 0.0 112.448 -164.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 pt -116.46 154.97 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.396 1.878 . . . . 0.0 113.198 -170.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -71.63 -22.14 61.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -1.43 23.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.591 2.356 . . . . 0.0 112.968 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -52.32 -19.34 2.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.605 1.962 . . . . 0.0 116.241 -169.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -109.39 -7.15 15.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.067 1.747 . . . . 0.0 114.429 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.25 82.01 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 120.437 -1.414 . . . . 0.0 109.362 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.0 ttp -57.3 -25.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.84 2.856 . . . . 0.0 113.774 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -92.44 9.65 33.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.185 1.794 . . . . 0.0 112.726 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 t -146.31 -165.42 2.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.747 -1.846 . . . . 0.0 112.721 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.27 77.17 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.147 2.308 . . . . 0.0 117.736 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -64.64 166.6 8.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.178 1.791 . . . . 0.0 114.899 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -178.87 6.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 114.122 160.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 130.389 3.852 . . . . 0.0 110.147 176.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 20.86 3.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.382 1.468 . . . . 0.0 115.833 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -143.77 110.41 5.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.217 1.509 . . . . 0.0 111.395 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.51 -143.9 15.43 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 126.0 1.762 . . . . 0.0 113.774 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.2 m -145.44 -23.33 0.48 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.47 138.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 118.456 -2.653 . . . . 0.0 110.45 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.44 107.95 0.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.85 1.66 . . . . 0.0 112.589 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.77 -6.27 3.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.98 11.32 19.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -55.12 -29.63 58.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.014 2.125 . . . . 0.0 113.817 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -134.19 58.9 1.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 123.188 1.471 . . . . 0.0 108.613 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -135.53 147.99 63.98 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 127.222 2.209 . . . . 0.0 112.38 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -66.97 167.56 19.48 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.734 2.956 . . . . 0.0 109.421 158.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.61 64.41 0.29 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.495 1.518 . . . . 0.0 113.169 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -149.0 29.19 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.062 1.345 . . . . 0.0 112.738 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 151.57 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.948 2.499 . . . . 0.0 109.693 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -84.14 -4.24 58.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.65 -13.45 61.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -24.52 4.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -131.0 8.01 4.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.065 2.146 . . . . 0.0 113.228 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mp -142.46 88.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.164 2.586 . . . . 0.0 108.803 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.6 mtp -58.94 -32.8 69.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.781 -1.199 . . . . 0.0 112.294 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.65 -28.6 69.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 t -78.09 40.01 0.32 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.344 1.858 . . . . 0.0 112.172 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.75 75.51 0.1 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.255 1.407 . . . . 0.0 114.543 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -111.95 130.22 55.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.16 0.981 . . . . 0.0 110.557 169.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -138.47 166.7 23.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 164.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 129.382 3.372 . . . . 0.0 107.403 174.237 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 116.386 -2.341 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.42 -94.96 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.37 1.585 . . . . 0.0 113.208 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -90.18 154.06 20.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.475 1.51 . . . . 0.0 113.558 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.02 -178.34 28.49 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 127.271 2.367 . . . . 0.0 114.821 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -110.88 -14.37 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.791 1.296 . . . . 0.0 114.377 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 6' ' ' ILE . 17.7 mt -84.53 133.27 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.884 168.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.33 113.26 5.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.802 1.641 . . . . 0.0 112.758 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -72.84 -39.46 66.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -56.29 -21.22 22.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.357 2.663 . . . . 0.0 114.344 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.56 -36.13 75.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.797 -1.814 . . . . 0.0 114.69 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.944 1.697 . . . . 0.0 113.003 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 72.09 167.33 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.139 1.776 . . . . 0.0 112.141 -170.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 148.33 90.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.761 2.974 . . . . 0.0 115.597 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.5 mtp -85.93 99.31 11.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.879 -1.138 . . . . 0.0 108.605 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.79 22.99 0.17 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.07 1.748 . . . . 0.0 114.139 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.4 164.96 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.32 3.048 . . . . 0.0 111.213 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -16.56 63.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -159.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.31 -6.8 20.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.491 -1.381 . . . . 0.0 114.248 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -59.47 -5.8 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -164.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.66 -3.76 12.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 122.247 2.294 . . . . 0.0 113.947 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.07 104.43 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.831 1.652 . . . . 0.0 111.871 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -29.81 65.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.38 -9.1 58.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.637 1.975 . . . . 0.0 115.521 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -135.0 78.59 1.74 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.138 -1.602 . . . . 0.0 109.804 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.26 28.11 0.26 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.062 1.791 . . . . 0.0 114.121 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -137.63 167.69 21.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -157.44 -175.96 5.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.568 2.747 . . . . 0.0 111.33 173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 C-N-CA 126.554 2.026 . . . . 0.0 112.124 -176.616 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.52 163.45 19.48 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.769 2.128 . . . . 0.0 115.217 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.5 t70 57.59 119.77 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 132.005 4.122 . . . . 0.0 115.621 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 -169.13 24.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.888 2.661 . . . . 0.0 112.422 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -111.34 -14.91 13.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -78.01 111.98 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 120.082 -1.636 . . . . 0.0 106.783 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.99 111.05 2.0 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.187 1.795 . . . . 0.0 112.218 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -70.54 -42.54 71.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 119.843 -1.786 . . . . 0.0 114.515 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -64.92 -25.0 67.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.185 1.394 . . . . 0.0 113.747 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.44 -34.23 77.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.126 -1.609 . . . . 0.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -90.59 -22.11 21.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -137.5 153.48 74.44 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 121.365 1.893 . . . . 0.0 114.791 -167.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.02 168.3 23.59 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 126.161 4.574 . . . . 0.0 113.972 170.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.58 143.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.731 1.612 . . . . 0.0 110.903 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -176.09 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.055 2.942 . . . . 0.0 111.641 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -55.31 141.04 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.196 0.998 . . . . 0.0 113.415 174.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -71.3 -9.97 58.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.952 2.101 . . . . 0.0 114.944 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -75.03 85.93 2.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.013 2.125 . . . . 0.0 111.45 151.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -139.63 -6.82 1.31 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.669 1.987 . . . . 0.0 115.262 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -134.21 -24.29 1.64 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.525 1.93 . . . . 0.0 111.528 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.11 107.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.091 1.756 . . . . 0.0 108.363 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.7 mtp -56.76 -21.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -122.43 19.69 10.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.213 1.805 . . . . 0.0 113.725 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -124.74 94.64 4.25 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.979 1.712 . . . . 0.0 109.819 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.93 25.34 0.19 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-O 116.739 -2.145 . . . . 0.0 111.877 -167.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -138.94 158.11 44.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.936 2.368 . . . . 0.0 114.146 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -143.34 -177.65 5.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.21 161.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.734 2.588 . . . . 0.0 116.763 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 94.66 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 127.013 2.244 . . . . 0.0 111.812 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 58.56 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.854 2.462 . . . . 0.0 116.424 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.7 -162.47 32.51 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 126.359 1.933 . . . . 0.0 114.169 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.2 p -124.39 -34.35 2.91 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.115 2.166 . . . . 0.0 115.662 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.24 112.71 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.365 1.866 . . . . 0.0 110.17 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.96 107.64 0.22 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.814 2.046 . . . . 0.0 112.159 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.45 -57.55 12.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.445 1.098 . . . . 0.0 112.036 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.62 -26.93 68.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -65.6 -44.89 85.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.555 0.616 . . . . 0.0 109.984 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -72.03 -34.06 68.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.525 -1.984 . . . . 0.0 115.891 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -147.49 162.12 33.27 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.81 147.2 44.0 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.224 1.949 . . . . 0.0 110.852 163.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.3 132.84 17.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.501 1.12 . . . . 0.0 110.855 170.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -133.35 73.12 1.5 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.551 1.167 . . . . 0.0 110.544 -163.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.14 159.16 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.756 1.265 . . . . 0.0 114.194 -165.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -64.09 -24.73 67.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.89 14.59 2.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.375 1.87 . . . . 0.0 115.661 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -51.87 -43.09 63.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.325 -1.484 . . . . 0.0 114.345 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.19 8.9 7.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.62 114.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 119.952 1.251 . . . . 0.0 108.649 173.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.7 mtm -82.01 -18.9 41.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.428 2.291 . . . . 0.0 111.966 173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.97 13.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.795 2.038 . . . . 0.0 114.587 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 t -151.53 -170.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.37 1.868 . . . . 0.0 112.846 -165.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.46 22.53 1.66 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.846 1.689 . . . . 0.0 115.016 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.33 137.2 32.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.802 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.72 -173.01 2.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.932 1.693 . . . . 0.0 112.527 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.336 -1.813 . . . . 0.0 116.376 -172.039 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.66 -15.48 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.09 128.59 12.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.382 2.091 . . . . 0.0 111.84 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.76 -139.37 7.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.287 1.422 . . . . 0.0 113.279 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -142.32 -34.27 0.46 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.8 133.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.74 -1.225 . . . . 0.0 110.069 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.55 129.4 38.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.632 -1.917 . . . . 0.0 109.947 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.74 -6.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 119.094 -2.253 . . . . 0.0 113.681 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -119.48 12.89 12.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.826 2.451 . . . . 0.0 113.495 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -62.72 -29.37 70.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.916 2.486 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -125.07 -0.41 7.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.345 1.858 . . . . 0.0 115.884 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -156.36 167.36 14.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.92 1.688 . . . . 0.0 111.87 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -64.75 170.39 10.08 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.87 2.38 . . . . 0.0 112.625 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.15 49.11 2.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.332 2.653 . . . . 0.0 110.043 165.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.36 47.11 0.36 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.947 3.699 . . . . 0.0 115.524 -169.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.83 -177.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 127.904 2.481 . . . . 0.0 112.09 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -80.15 1.52 27.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -115.39 78.91 1.22 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.238 1.815 . . . . 0.0 110.319 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.88 -0.83 1.14 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -138.04 52.23 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.579 2.352 . . . . 0.0 112.259 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.02 109.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.828 2.051 . . . . 0.0 109.362 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -54.33 -36.57 63.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.653 1.581 . . . . 0.0 113.89 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -86.28 -3.05 58.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 t -100.19 176.42 5.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.811 1.187 . . . . 0.0 112.441 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.47 -4.96 65.79 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 117.289 1.676 . . . . 0.0 117.289 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.06 1.93 . . . . 0.0 111.038 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -171.37 3.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.022 1.729 . . . . 0.0 112.025 167.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.549 2.976 . . . . 0.0 113.488 174.692 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 CA-C-O 121.029 0.238 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.91 -41.38 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 165.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -147.4 111.02 4.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.079 1.351 . . . . 0.0 111.791 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.04 -173.86 36.74 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 126.301 1.905 . . . . 0.0 114.156 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -119.12 -28.78 5.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.26 2.224 . . . . 0.0 113.1 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -73.45 135.39 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.303 1.041 . . . . 0.0 108.273 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.12 133.02 44.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.735 -1.228 . . . . 0.0 111.422 171.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.18 -52.88 52.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.799 0.839 . . . . 0.0 110.191 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -75.64 16.83 0.34 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.758 2.023 . . . . 0.0 113.378 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -48.53 -37.31 17.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.359 2.263 . . . . 0.0 112.698 -170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -99.23 -66.5 0.9 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.867 1.267 . . . . 0.0 111.621 167.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -139.32 153.44 70.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 126.63 1.972 . . . . 0.0 112.483 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.5 154.29 65.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.4 2.067 . . . . 0.0 110.513 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.74 22.53 5.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 119.99 -1.694 . . . . 0.0 113.951 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.0 p80 52.34 2.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 130.289 3.436 . . . . 0.0 118.165 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.95 168.46 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -59.37 -21.43 59.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.589 3.156 . . . . 0.0 115.686 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.64 -4.48 6.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -56.82 -23.6 44.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 167.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.18 11.64 25.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.776 2.43 . . . . 0.0 115.718 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.12 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 123.876 1.798 . . . . 0.0 108.48 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -52.66 -40.13 62.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 129.326 3.05 . . . . 0.0 112.331 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.96 -19.85 61.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.725 2.01 . . . . 0.0 114.478 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 t -131.75 -19.72 2.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -156.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 54.17 1.51 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 117.135 -1.925 . . . . 0.0 113.979 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -132.24 156.27 46.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.487 2.144 . . . . 0.0 114.016 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -143.24 -177.78 5.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.017 2.127 . . . . 0.0 111.493 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.979 1.752 . . . . 0.0 115.472 173.303 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.37 30.66 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.321 0.962 . . . . 0.0 111.752 163.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 49.3 80.75 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.079 2.151 . . . . 0.0 113.662 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.39 -169.13 32.33 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.387 1.47 . . . . 0.0 112.895 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -121.07 -22.16 6.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.932 0.893 . . . . 0.0 113.179 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.0 125.37 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.408 2.683 . . . . 0.0 108.842 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.21 126.23 30.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.862 0.756 . . . . 0.0 112.218 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.16 -55.31 35.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.059 -0.401 . . . . 0.0 110.789 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -64.56 -17.74 64.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -168.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -15.36 -73.0 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.951 3.301 . . . . 0.0 115.56 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -124.95 21.79 8.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.055 0.942 . . . . 0.0 113.274 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.67 158.83 66.08 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.586 1.554 . . . . 0.0 113.754 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.07 -178.27 4.39 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.363 2.042 . . . . 0.0 111.75 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.3 mtp 69.36 57.57 0.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.759 2.424 . . . . 0.0 110.916 -171.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -71.55 70.74 0.67 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.137 2.175 . . . . 0.0 113.358 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.17 -178.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 127.807 2.443 . . . . 0.0 111.384 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -62.31 -5.91 2.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -171.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -73.94 -5.82 43.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 119.203 -2.186 . . . . 0.0 116.838 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -177.12 0.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 163.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 56.74 10.2 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 165.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -66.03 151.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 119.47 -2.019 . . . . 0.0 107.901 165.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.0 ttm -121.63 -46.7 2.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.711 -1.243 . . . . 0.0 113.858 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.08 -7.38 1.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 163.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 t -162.9 -179.98 7.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.781 2.432 . . . . 0.0 111.122 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.51 12.18 33.75 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.508 -0.745 . . . . 0.0 114.88 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -123.5 169.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.525 1.663 . . . . 0.0 113.092 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -154.67 -176.97 6.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.478 2.711 . . . . 0.0 111.296 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 126.866 2.174 . . . . 0.0 111.774 171.083 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 117.574 -1.681 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.49 165.5 13.82 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 126.515 2.007 . . . . 0.0 109.429 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.5 t0 54.02 92.13 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.77 179.57 46.35 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 123.926 0.774 . . . . 0.0 112.682 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 t -94.77 -13.06 26.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.96 135.01 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.348 1.859 . . . . 0.0 110.41 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.37 120.18 12.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.539 1.063 . . . . 0.0 110.927 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.65 7.53 2.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -129.53 10.15 5.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.383 2.273 . . . . 0.0 111.657 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -41.61 -47.45 3.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.641 1.176 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.7 -43.65 0.27 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.251 1.821 . . . . 0.0 112.191 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -47.56 154.36 0.9 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 128.048 2.539 . . . . 0.0 115.289 168.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.51 171.01 12.5 Favored 'Trans proline' 0 N--CA 1.45 -1.069 1 C-N-CA 125.759 4.306 . . . . 0.0 114.792 -175.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.91 21.34 6.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.859 3.263 . . . . 0.0 112.22 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -51.25 -17.04 0.61 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.092 4.157 . . . . 0.0 116.073 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.73 151.24 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 123.264 1.507 . . . . 0.0 114.145 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -61.59 -16.35 47.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.687 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.33 -1.55 24.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.233 1.813 . . . . 0.0 114.141 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -50.9 -35.59 33.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -79.19 -16.26 56.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.968 -1.707 . . . . 0.0 114.262 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.87 105.05 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.708 1.14 . . . . 0.0 108.649 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.4 ptm -73.62 -22.1 60.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.163 0.985 . . . . 0.0 112.707 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.13 -12.27 54.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.9 m -131.33 65.57 1.56 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.655 1.182 . . . . 0.0 109.231 -169.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.58 18.53 5.71 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.303 2.383 . . . . 0.0 112.826 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -134.46 153.01 52.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 123.782 1.753 . . . . 0.0 113.801 -162.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -176.31 5.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 118.79 -2.444 . . . . 0.0 111.912 171.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 125.704 1.621 . . . . 0.0 112.763 -175.053 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.39 9.92 Favored Glycine 0 CA--C 1.522 0.487 0 O-C-N 121.133 -1.216 . . . . 0.0 114.299 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.6 t0 55.53 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.012 3.325 . . . . 0.0 118.646 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.65 -171.3 19.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 126.777 2.132 . . . . 0.0 111.097 -159.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.1 p -134.93 -4.66 2.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -77.4 123.16 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 120.596 1.544 . . . . 0.0 107.232 168.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 112.17 1.28 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.92 -28.82 70.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.05 1.74 . . . . 0.0 113.017 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -89.37 -6.63 56.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.94 119.61 11.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 121.76 2.073 . . . . 0.0 111.6 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t30 51.66 3.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 129.86 3.264 . . . . 0.0 117.308 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -129.67 146.63 62.0 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 130.482 3.513 . . . . 0.0 109.356 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.18 156.17 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.524 2.149 . . . . 0.0 111.931 -169.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.07 56.44 0.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.213 2.605 . . . . 0.0 109.785 171.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -71.87 30.02 0.05 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 130.019 3.328 . . . . 0.0 113.526 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.35 150.32 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 129.438 3.095 . . . . 0.0 113.168 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -57.09 -29.7 63.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HA ' HD13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.7 -3.25 11.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 114.427 174.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -55.71 -20.05 13.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -103.72 -1.9 27.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.731 2.012 . . . . 0.0 113.08 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 18' ' ' ASP . 1.4 mp -99.98 98.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -171.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 mmt -54.22 -31.24 52.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.428 1.891 . . . . 0.0 111.811 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -65.44 -28.76 69.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -128.72 63.65 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.466 2.306 . . . . 0.0 110.09 -170.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.8 25.21 9.69 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 115.446 -2.863 . . . . 0.0 114.444 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.31 166.85 23.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.412 2.606 . . . . 0.0 112.824 -158.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -138.19 173.16 11.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.465 1.506 . . . . 0.0 110.99 156.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.594 -175.575 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.88 -75.74 1.3 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.113 1.34 . . . . 0.0 111.858 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.04 146.79 27.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 123.456 1.598 . . . . 0.0 112.76 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.43 -150.21 21.74 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 120.31 -1.493 . . . . 0.0 112.941 169.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -124.69 -49.92 1.75 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.974 1.31 . . . . 0.0 110.672 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.31 124.13 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 108.099 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.36 130.4 42.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 173.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -77.5 -17.06 58.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.793 -1.817 . . . . 0.0 113.277 -157.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.07 -3.79 18.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 169.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -46.22 -45.74 17.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -112.11 95.48 5.49 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 116.118 -1.896 . . . . 0.0 108.056 165.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 71.13 145.27 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 129.421 3.088 . . . . 0.0 112.938 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -63.27 149.89 90.07 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.146 1.897 . . . . 0.0 112.718 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -62.74 112.72 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.023 1.329 . . . . 0.0 110.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -80.99 -1.0 42.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.973 1.309 . . . . 0.0 114.475 -171.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.13 173.37 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.241 1.417 . . . . 0.0 111.235 162.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -68.4 -32.31 72.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 119.007 -2.308 . . . . 0.0 113.519 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -83.42 103.72 13.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.893 1.224 . . . . 0.0 111.043 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -142.13 -25.32 0.66 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.77 -11.68 60.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.3 mp -72.18 92.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.489 1.116 . . . . 0.0 108.373 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.8 mmm -57.83 -27.23 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.93 -16.24 62.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.354 1.862 . . . . 0.0 113.756 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 t -152.72 96.07 2.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.052 1.341 . . . . 0.0 110.288 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.24 0.39 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.327 1.441 . . . . 0.0 113.064 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -130.95 174.21 10.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.736 1.614 . . . . 0.0 113.936 -167.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.14 179.65 8.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.475 2.31 . . . . 0.0 112.581 170.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.825 3.107 . . . . 0.0 111.829 169.735 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.52 100.1 0.57 Allowed Glycine 0 CA--C 1.522 0.471 0 CA-C-N 120.527 2.163 . . . . 0.0 113.899 174.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.2 160.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.516 2.326 . . . . 0.0 116.293 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.79 -143.48 16.94 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.044 -1.66 . . . . 0.0 109.184 -160.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -158.96 -8.56 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 172.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -71.79 124.34 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.48 110.59 0.58 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.811 1.644 . . . . 0.0 113.041 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.68 -6.64 32.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.234 1.413 . . . . 0.0 113.645 -175.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.56 -7.16 19.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.136 2.174 . . . . 0.0 114.607 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -91.37 133.63 35.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.235 0.925 . . . . 0.0 113.276 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.41 18.46 2.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.156 2.182 . . . . 0.0 115.234 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -141.91 158.04 63.01 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 117.974 -1.013 . . . . 0.0 111.694 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.65 159.87 45.02 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.294 2.663 . . . . 0.0 110.203 163.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -121.74 -85.22 0.66 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.879 1.672 . . . . 0.0 110.63 -164.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.29 -6.47 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 130.941 3.696 . . . . 0.0 117.324 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 156.55 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 119.558 -1.964 . . . . 0.0 112.493 164.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.49 16.17 0.15 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -90.23 -3.27 57.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.794 1.638 . . . . 0.0 115.068 168.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.02 -7.87 4.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -119.01 -3.76 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.945 2.498 . . . . 0.0 114.182 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.05 101.9 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -160.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 71.6 mmm -60.14 -29.51 68.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -164.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.63 -50.76 69.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.671 1.588 . . . . 0.0 114.475 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 p -86.15 5.11 35.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -166.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.18 31.37 2.61 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 119.647 -1.908 . . . . 0.0 115.133 -171.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -127.62 165.4 20.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.501 1.65 . . . . 0.0 114.366 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -146.06 -173.08 4.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.65 1.98 . . . . 0.0 112.097 159.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.549 2.5 . . . . 0.0 110.843 175.405 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 121.384 0.435 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.49 -32.88 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 126.742 2.115 . . . . 0.0 112.875 170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -138.88 117.62 12.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.821 1.648 . . . . 0.0 110.145 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.43 -166.7 33.31 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 127.381 2.419 . . . . 0.0 113.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.9 m -113.42 -17.92 12.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.9 mt -97.34 114.71 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 121.082 1.764 . . . . 0.0 108.829 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 134.06 54.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.116 1.366 . . . . 0.0 110.884 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.97 -26.32 68.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.125 -1.609 . . . . 0.0 115.047 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -82.87 1.26 40.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.093 1.357 . . . . 0.0 114.513 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -52.78 -44.44 66.55 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.919 1.691 . . . . 0.0 114.837 -171.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -121.92 19.53 10.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.831 2.452 . . . . 0.0 111.585 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.44 154.9 80.81 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 127.604 2.362 . . . . 0.0 112.928 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.05 170.22 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.102 2.534 . . . . 0.0 108.686 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 21.7 mmt -71.85 63.45 0.46 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.102 0.961 . . . . 0.0 111.907 170.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -82.28 -26.72 32.87 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.518 1.927 . . . . 0.0 112.059 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.1 pt -57.59 145.12 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 128.552 2.741 . . . . 0.0 111.512 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -25.26 60.6 Favored 'General case' 0 N--CA 1.45 -0.458 0 O-C-N 125.037 1.461 . . . . 0.0 113.534 171.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -63.8 -1.12 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.72 2.008 . . . . 0.0 115.496 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -61.23 -18.13 56.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.539 2.792 . . . . 0.0 118.539 -168.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -108.85 0.64 20.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 171.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.78 85.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.982 1.713 . . . . 0.0 108.774 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 ttt -67.85 -14.28 62.83 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.864 -1.148 . . . . 0.0 114.058 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.27 -9.49 33.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.662 2.785 . . . . 0.0 113.686 168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.6 t -138.9 174.55 10.4 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.262 1.425 . . . . 0.0 109.696 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.55 58.39 1.44 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 114.523 -1.217 . . . . 0.0 115.799 162.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.07 167.07 22.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.535 1.934 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -145.92 174.62 11.09 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.706 1.602 . . . . 0.0 113.713 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 174.069 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.521 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.6 112.3 4.05 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.668 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 57.84 81.15 0.15 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.862 2.065 . . . . 0.0 114.021 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.98 -148.47 5.29 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 116.339 1.295 . . . . 0.0 116.339 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.6 m -122.67 -36.3 2.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.232 1.813 . . . . 0.0 115.724 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -82.98 118.16 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 127.221 2.208 . . . . 0.0 107.567 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.86 122.69 6.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.978 1.371 . . . . 0.0 111.5 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -58.06 -33.0 68.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.108 -2.87 . . . . 0.0 113.822 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -97.71 11.52 36.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.018 2.127 . . . . 0.0 112.398 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -48.57 -41.41 30.52 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.949 2.5 . . . . 0.0 114.138 -172.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -127.74 -2.14 6.01 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.432 1.093 . . . . 0.0 112.518 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 68.0 mtp85 -137.72 150.15 67.02 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.263 1.425 . . . . 0.0 112.415 -168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.2 143.37 28.37 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.446 2.097 . . . . 0.0 112.207 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.3 ptm -66.19 116.27 7.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -130.52 63.93 1.56 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.786 2.834 . . . . 0.0 110.709 174.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.59 157.36 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.054 1.341 . . . . 0.0 111.932 -171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -72.04 -24.78 61.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -65.58 1.83 1.12 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -57.86 -13.27 4.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 118.113 2.634 . . . . 0.0 118.113 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -105.77 -4.87 20.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.941 2.097 . . . . 0.0 113.293 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.29 107.43 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.638 1.175 . . . . 0.0 108.82 -167.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.45 58.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -14.22 61.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.918 2.087 . . . . 0.0 115.71 174.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -141.35 116.3 9.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.743 -1.223 . . . . 0.0 112.254 -165.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.63 17.08 0.07 OUTLIER Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.163 -0.799 . . . . 0.0 114.085 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.01 155.92 32.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.024 1.912 . . . . 0.0 113.713 -167.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -141.31 -175.29 4.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.916 1.686 . . . . 0.0 112.612 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.395 1.95 . . . . 0.0 114.929 178.675 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.514 0 CA-C-O 117.742 -1.588 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.77 164.1 13.61 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 123.456 1.587 . . . . 0.0 113.914 158.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 58.0 105.27 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.765 2.826 . . . . 0.0 117.699 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.74 -172.86 30.4 Favored Glycine 0 CA--C 1.522 0.514 0 O-C-N 120.651 -1.281 . . . . 0.0 115.416 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -75.8 -54.89 6.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.679 1.192 . . . . 0.0 112.406 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.48 105.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.454 2.302 . . . . 0.0 106.662 -165.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.68 104.08 0.4 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.639 1.576 . . . . 0.0 110.899 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -53.06 -31.07 39.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -164.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.18 -9.19 58.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 116.875 -1.536 . . . . 0.0 114.135 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.75 -20.72 61.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -136.12 -10.5 1.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -146.65 154.4 48.11 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 128.164 2.586 . . . . 0.0 110.383 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.81 143.66 80.83 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.083 2.522 . . . . 0.0 113.035 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 64.4 mmm -75.85 64.18 1.78 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.608 2.363 . . . . 0.0 108.068 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -67.47 1.78 2.12 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.59 1.956 . . . . 0.0 114.133 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.5 pp -119.23 167.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.494 2.318 . . . . 0.0 111.601 -167.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -54.77 -19.64 6.78 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.822 2.449 . . . . 0.0 117.549 -166.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -64.92 -8.11 14.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 171.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -53.35 -22.08 6.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -110.23 2.18 19.11 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.757 2.526 . . . . 0.0 116.332 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.15 97.34 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 O-C-N 120.495 -1.378 . . . . 0.0 107.953 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 43.1 ttp -59.52 -29.23 67.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.313 1.845 . . . . 0.0 113.968 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.87 -1.07 12.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.088 2.555 . . . . 0.0 114.759 171.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.8 t -121.12 -176.31 3.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.074 2.55 . . . . 0.0 109.554 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.56 34.0 4.88 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 126.211 1.862 . . . . 0.0 113.562 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -141.17 160.39 40.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 117.646 0.723 . . . . 0.0 110.126 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -155.34 -173.18 4.45 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.038 2.535 . . . . 0.0 112.573 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 N-CA-C 106.937 -2.465 . . . . 0.0 106.937 -177.817 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.79 -140.34 3.11 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 121.884 2.842 . . . . 0.0 113.229 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -66.99 137.31 56.41 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.316 2.247 . . . . 0.0 111.745 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.02 -164.38 31.8 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 126.328 1.918 . . . . 0.0 114.133 -174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 m -134.32 -31.65 1.09 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 mt -75.6 138.37 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 107.417 168.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.11 128.3 33.59 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.495 -2.003 . . . . 0.0 114.586 175.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -61.61 -24.28 66.59 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 116.41 -1.757 . . . . 0.0 114.245 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -67.92 -21.39 65.12 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 121.252 1.842 . . . . 0.0 114.99 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -65.56 -36.12 82.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -169.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -124.96 98.91 5.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.497 1.919 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 66.33 156.79 0.13 Allowed Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 129.551 3.14 . . . . 0.0 114.077 -170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.08 162.76 20.4 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.324 1.349 . . . . 0.0 113.087 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 51.7 mtt -126.75 114.07 17.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.777 163.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -80.9 67.52 6.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.821 -1.174 . . . . 0.0 109.62 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.3 151.66 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.578 1.951 . . . . 0.0 109.256 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -76.06 9.78 2.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -162.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -118.54 1.86 11.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.715 2.406 . . . . 0.0 114.407 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -53.56 -25.65 18.08 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -160.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -83.71 -29.13 27.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 -175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mp -75.41 116.0 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.466 0.706 . . . . 0.0 110.361 -158.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 50.4 mtt -57.92 -50.76 72.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.956 2.102 . . . . 0.0 113.878 -168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -70.25 6.52 1.29 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.259 1.024 . . . . 0.0 113.7 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 173.6 11.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.64 1.976 . . . . 0.0 108.959 -168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.46 33.2 20.33 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 118.135 -1.369 . . . . 0.0 113.001 162.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -83.87 171.9 12.64 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.296 2.048 . . . . 0.0 115.533 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -151.61 -179.06 7.08 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 131.814 4.045 . . . . 0.0 110.545 164.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 C-N-CA 125.053 1.311 . . . . 0.0 111.982 -176.142 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 115.286 0.874 . . . . 0.0 115.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 157.21 -72.99 0.23 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.115 0.958 . . . . 0.0 113.496 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -101.29 130.65 47.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 116.503 2.038 . . . . 0.0 116.503 -161.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.5 -136.05 8.57 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 124.875 1.226 . . . . 0.0 112.15 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -142.08 -18.33 0.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.44 1.496 . . . . 0.0 113.503 -170.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.9 mt -99.63 113.26 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.86 134.1 37.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.166 -0.959 . . . . 0.0 112.757 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.75 -9.85 3.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -93.65 15.43 16.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.263 3.025 . . . . 0.0 115.687 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -47.64 -49.34 27.59 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.729 2.011 . . . . 0.0 113.567 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -80.75 10.89 4.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.086 1.354 . . . . 0.0 113.726 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 98.78 148.93 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 133.244 4.618 . . . . 0.0 111.118 -168.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -65.83 140.42 61.14 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 122.416 1.898 . . . . 0.0 111.612 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 83.3 mtp -66.1 18.38 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.448 2.299 . . . . 0.0 115.604 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 43.42 78.84 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.044 2.138 . . . . 0.0 112.355 -158.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.4 149.68 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.755 1.622 . . . . 0.0 110.478 -166.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.83 -19.53 65.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -173.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.24 11.89 36.42 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -44.09 -48.8 9.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.51 1.924 . . . . 0.0 112.721 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -59.58 -13.64 10.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -89.03 121.86 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 121.191 1.814 . . . . 0.0 107.106 -175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.9 mtp -99.71 -39.68 8.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.001 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -16.45 63.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.5 m -149.49 177.98 9.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.858 2.863 . . . . 0.0 108.969 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.35 29.02 15.31 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-O 121.856 0.698 . . . . 0.0 113.851 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -91.0 168.05 11.94 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -126.79 173.66 9.38 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.432 3.093 . . . . 0.0 109.443 147.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 O-C-N 121.158 -0.964 . . . . 0.0 111.668 -172.564 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.481 0 N-CA-C 117.58 1.792 . . . . 0.0 117.58 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.62 77.01 1.64 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 118.883 1.341 . . . . 0.0 113.569 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.9 t70 57.51 151.32 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.204 3.001 . . . . 0.0 117.57 -173.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.24 -156.64 27.25 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 125.093 1.33 . . . . 0.0 113.029 -171.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -124.18 -38.56 2.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.16 2.184 . . . . 0.0 112.699 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -86.32 140.51 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.378 1.471 . . . . 0.0 108.449 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.17 130.36 41.28 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.263 -2.148 . . . . 0.0 111.871 172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -50.42 -40.22 49.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.831 2.052 . . . . 0.0 112.794 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -82.35 1.88 34.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 130.18 3.392 . . . . 0.0 115.421 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -57.8 -56.63 19.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 119.281 0.946 . . . . 0.0 111.249 168.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -39.98 66.85 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -166.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -140.94 166.42 22.77 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.063 2.545 . . . . 0.0 110.601 171.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -55.41 161.74 6.98 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.503 2.136 . . . . 0.0 113.384 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.2 mmt -138.47 85.54 2.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.983 2.513 . . . . 0.0 108.808 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -74.88 64.47 1.29 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.312 3.045 . . . . 0.0 111.635 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.76 158.93 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.465 2.706 . . . . 0.0 113.987 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.2 m80 -63.31 -25.43 68.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -172.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.48 -15.75 40.65 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -58.99 -18.11 31.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.76 2.024 . . . . 0.0 115.572 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -86.86 -12.74 46.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 120.719 -1.238 . . . . 0.0 113.304 172.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mp -103.97 98.5 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 126.75 2.02 . . . . 0.0 110.358 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -61.22 -34.12 74.6 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.53 -5.83 55.7 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -132.99 105.87 7.33 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 145.26 61.37 0.02 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -133.43 160.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.804 1.642 . . . . 0.0 115.16 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -149.99 178.6 8.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.537 2.335 . . . . 0.0 111.434 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 O-C-N 121.188 -0.945 . . . . 0.0 115.268 178.392 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.23 98.58 1.48 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 126.952 2.215 . . . . 0.0 111.273 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 t70 63.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.603 2.761 . . . . 0.0 117.771 167.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.79 179.88 27.82 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 127.866 2.65 . . . . 0.0 114.466 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.5 m -78.64 -17.39 56.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.89 146.72 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.776 1.23 . . . . 0.0 108.704 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.32 135.8 54.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 119.98 -1.7 . . . . 0.0 111.382 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.48 -29.87 59.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 120.228 -1.545 . . . . 0.0 114.499 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -106.8 17.3 23.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 130.602 3.561 . . . . 0.0 113.229 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -50.59 -41.33 54.39 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.713 -1.137 . . . . 0.0 113.68 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -118.02 5.64 12.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtm180 -147.64 160.79 37.66 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.95 -1.719 . . . . 0.0 114.108 -164.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.84 169.29 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 123.869 3.046 . . . . 0.0 113.607 156.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 65.8 mtm -93.41 -55.21 3.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.235 1.414 . . . . 0.0 111.347 174.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m170 52.26 26.59 4.09 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.514 1.926 . . . . 0.0 115.432 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -127.4 156.34 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.053 2.141 . . . . 0.0 111.905 170.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -58.3 -26.08 62.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.406 2.283 . . . . 0.0 113.941 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -63.79 -7.54 8.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 118.924 -2.36 . . . . 0.0 114.778 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.8 p-90 -60.02 -10.06 3.82 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.75 2.02 . . . . 0.0 114.901 -169.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -109.88 -8.76 14.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.776 1.631 . . . . 0.0 115.015 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 43.3 mt -71.6 94.16 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 127.41 2.284 . . . . 0.0 108.573 172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.7 mtt -57.63 -26.42 61.56 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.417 1.487 . . . . 0.0 113.998 174.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -75.47 0.6 16.57 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.544 2.338 . . . . 0.0 116.631 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 t -140.44 -172.96 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 118.977 -2.327 . . . . 0.0 111.443 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.34 38.58 5.3 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 121.375 -0.828 . . . . 0.0 111.966 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -135.35 156.82 48.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.489 -1.006 . . . . 0.0 111.351 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.07 170.29 19.24 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 123.911 1.815 . . . . 0.0 113.637 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.477 2.465 . . . . 0.0 113.724 167.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.651 0.621 . . . . 0.0 114.651 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.78 10.53 13.98 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.16 -1.2 . . . . 0.0 114.571 176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -149.58 112.04 4.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.289 1.545 . . . . 0.0 113.603 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.84 -157.37 27.2 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 125.763 1.649 . . . . 0.0 110.346 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.1 m -125.97 -9.89 6.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.959 -1.318 . . . . 0.0 113.222 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -85.12 113.89 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 120.846 1.657 . . . . 0.0 108.932 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.45 113.12 1.46 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.694 1.712 . . . . 0.0 114.609 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -61.96 -4.44 1.6 Allowed 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.049 -2.907 . . . . 0.0 116.561 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -120.15 -0.92 10.4 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 129.581 3.153 . . . . 0.0 114.795 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -58.86 -43.3 90.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.746 2.066 . . . . 0.0 113.262 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -66.54 -68.77 0.35 Allowed 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 119.916 -1.74 . . . . 0.0 108.522 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -142.66 140.7 18.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 127.161 2.185 . . . . 0.0 110.362 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -68.72 177.13 5.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.283 1.989 . . . . 0.0 110.883 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 74.1 mtp -71.64 -5.14 31.4 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 113.828 174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 56.45 19.14 3.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.809 2.443 . . . . 0.0 116.079 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.7 -175.45 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 126.529 1.932 . . . . 0.0 110.571 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -59.05 6.15 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.591 3.157 . . . . 0.0 118.655 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -122.87 93.69 4.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 128.119 2.568 . . . . 0.0 112.589 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.412 ' CE2' ' HG3' ' A' ' 20' ' ' GLN . 17.5 p-90 -150.82 -31.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.736 2.015 . . . . 0.0 114.885 167.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 19' ' ' TRP . 22.9 mt-30 -71.05 -18.03 62.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 33.0 mm -67.44 97.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.204 1.802 . . . . 0.0 110.221 178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -64.03 -20.77 66.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.329 1.852 . . . . 0.0 114.008 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.7 -2.36 42.58 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 t -144.62 -173.04 3.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.32 1.448 . . . . 0.0 111.382 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.41 47.23 22.98 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.391 1.472 . . . . 0.0 112.499 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.2 154.08 50.96 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -138.39 177.74 7.65 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 166.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 126.766 2.127 . . . . 0.0 111.84 -179.893 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 CA-C-O 118.074 -1.403 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.36 -31.22 0.05 OUTLIER Glycine 0 C--N 1.334 0.464 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 171.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -133.46 125.73 29.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.22 1.51 . . . . 0.0 113.105 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.27 -164.86 30.68 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.37 1.462 . . . . 0.0 109.645 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -113.74 0.58 14.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.072 1.349 . . . . 0.0 111.866 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.9 mt -115.31 141.05 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.376 1.871 . . . . 0.0 110.842 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.63 126.85 31.78 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.185 1.394 . . . . 0.0 113.359 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.5 -36.05 82.7 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.075 0.95 . . . . 0.0 112.283 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -76.2 7.31 4.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.315 -0.85 . . . . 0.0 113.18 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -63.95 -49.35 72.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 120.599 1.545 . . . . 0.0 113.129 176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -79.34 -22.56 44.33 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.22 157.68 25.06 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.999 1.72 . . . . 0.0 113.539 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.46 157.65 60.95 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.603 1.535 . . . . 0.0 108.378 164.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 6.0 ptm -151.71 114.94 4.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.704 0.802 . . . . 0.0 111.813 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -82.81 71.81 9.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.961 1.305 . . . . 0.0 112.448 -164.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.0 pt -116.46 154.97 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 126.396 1.878 . . . . 0.0 113.198 -170.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -71.63 -22.14 61.73 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -1.43 23.59 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.591 2.356 . . . . 0.0 112.968 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -52.32 -19.34 2.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.605 1.962 . . . . 0.0 116.241 -169.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -109.39 -7.15 15.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.067 1.747 . . . . 0.0 114.429 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -78.25 82.01 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 120.437 -1.414 . . . . 0.0 109.362 -174.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.0 ttp -57.3 -25.34 59.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.84 2.856 . . . . 0.0 113.774 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -92.44 9.65 33.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.185 1.794 . . . . 0.0 112.726 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 t -146.31 -165.42 2.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.747 -1.846 . . . . 0.0 112.721 172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.27 77.17 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.147 2.308 . . . . 0.0 117.736 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -64.64 166.6 8.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.178 1.791 . . . . 0.0 114.899 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.83 -178.87 6.13 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.14 1.376 . . . . 0.0 114.122 160.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 C-N-CA 130.389 3.852 . . . . 0.0 110.147 176.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.503 0 N-CA-C 114.469 0.548 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.26 20.86 3.33 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 125.382 1.468 . . . . 0.0 115.833 177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -143.77 110.41 5.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 119.217 1.509 . . . . 0.0 111.395 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.51 -143.9 15.43 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 126.0 1.762 . . . . 0.0 113.774 -174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.2 m -145.44 -23.33 0.48 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.47 138.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 O-C-N 118.456 -2.653 . . . . 0.0 110.45 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.44 107.95 0.74 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.85 1.66 . . . . 0.0 112.589 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.77 -6.27 3.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -112.98 11.32 19.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 172.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -55.12 -29.63 58.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.014 2.125 . . . . 0.0 113.817 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -134.19 58.9 1.75 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 123.188 1.471 . . . . 0.0 108.613 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -135.53 147.99 63.98 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 127.222 2.209 . . . . 0.0 112.38 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -66.97 167.56 19.48 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.734 2.956 . . . . 0.0 109.421 158.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 62.2 mtm -70.61 64.41 0.29 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.495 1.518 . . . . 0.0 113.169 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -149.0 29.19 0.81 Allowed 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.062 1.345 . . . . 0.0 112.738 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.33 151.57 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 127.948 2.499 . . . . 0.0 109.693 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -84.14 -4.24 58.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.65 -13.45 61.21 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -24.52 4.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 119.979 3.325 . . . . 0.0 119.979 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -131.0 8.01 4.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.065 2.146 . . . . 0.0 113.228 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.0 mp -142.46 88.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 128.164 2.586 . . . . 0.0 108.803 -175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 84.6 mtp -58.94 -32.8 69.92 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.781 -1.199 . . . . 0.0 112.294 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.65 -28.6 69.72 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 t -78.09 40.01 0.32 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.344 1.858 . . . . 0.0 112.172 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.75 75.51 0.1 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.255 1.407 . . . . 0.0 114.543 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -111.95 130.22 55.92 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.16 0.981 . . . . 0.0 110.557 169.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -138.47 166.7 23.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 164.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 129.382 3.372 . . . . 0.0 107.403 174.237 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 CA-C-O 116.386 -2.341 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.42 -94.96 0.46 Allowed Glycine 0 CA--C 1.522 0.504 0 CA-C-N 119.37 1.585 . . . . 0.0 113.208 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -90.18 154.06 20.04 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.475 1.51 . . . . 0.0 113.558 -177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.02 -178.34 28.49 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 127.271 2.367 . . . . 0.0 114.821 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.6 p -110.88 -14.37 13.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.791 1.296 . . . . 0.0 114.377 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 6' ' ' ILE . 17.7 mt -84.53 133.27 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.884 168.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.33 113.26 5.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.802 1.641 . . . . 0.0 112.758 172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -72.84 -39.46 66.54 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -56.29 -21.22 22.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 128.357 2.663 . . . . 0.0 114.344 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -59.56 -36.13 75.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.797 -1.814 . . . . 0.0 114.69 172.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -85.22 54.54 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.944 1.697 . . . . 0.0 113.003 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 72.09 167.33 0.12 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.139 1.776 . . . . 0.0 112.141 -170.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.39 148.33 90.89 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.761 2.974 . . . . 0.0 115.597 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.5 mtp -85.93 99.31 11.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 120.879 -1.138 . . . . 0.0 108.605 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -76.79 22.99 0.17 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.07 1.748 . . . . 0.0 114.139 -178.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.4 164.96 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.32 3.048 . . . . 0.0 111.213 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.94 -16.56 63.98 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -159.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.31 -6.8 20.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.491 -1.381 . . . . 0.0 114.248 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 27.6 p-90 -59.47 -5.8 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -164.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -115.66 -3.76 12.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 122.247 2.294 . . . . 0.0 113.947 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.07 104.43 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.831 1.652 . . . . 0.0 111.871 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -29.81 65.56 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.38 -9.1 58.35 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.637 1.975 . . . . 0.0 115.521 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 t -135.0 78.59 1.74 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.138 -1.602 . . . . 0.0 109.804 -173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -162.26 28.11 0.26 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.062 1.791 . . . . 0.0 114.121 -168.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -137.63 167.69 21.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -157.44 -175.96 5.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.568 2.747 . . . . 0.0 111.33 173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 C-N-CA 126.554 2.026 . . . . 0.0 112.124 -176.616 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.52 163.45 19.48 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.769 2.128 . . . . 0.0 115.217 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.5 t70 57.59 119.77 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.498 1 C-N-CA 132.005 4.122 . . . . 0.0 115.621 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 -169.13 24.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 127.888 2.661 . . . . 0.0 112.422 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.4 m -111.34 -14.91 13.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 mt -78.01 111.98 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 O-C-N 120.082 -1.636 . . . . 0.0 106.783 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.99 111.05 2.0 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.187 1.795 . . . . 0.0 112.218 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -70.54 -42.54 71.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 119.843 -1.786 . . . . 0.0 114.515 -173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -64.92 -25.0 67.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.185 1.394 . . . . 0.0 113.747 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.44 -34.23 77.81 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 120.126 -1.609 . . . . 0.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -90.59 -22.11 21.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -137.5 153.48 74.44 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 121.365 1.893 . . . . 0.0 114.791 -167.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -71.02 168.3 23.59 Favored 'Trans proline' 0 N--CA 1.449 -1.124 1 C-N-CA 126.161 4.574 . . . . 0.0 113.972 170.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -85.58 143.17 28.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.731 1.612 . . . . 0.0 110.903 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -176.09 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 129.055 2.942 . . . . 0.0 111.641 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -55.31 141.04 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.196 0.998 . . . . 0.0 113.415 174.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -71.3 -9.97 58.99 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.952 2.101 . . . . 0.0 114.944 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -75.03 85.93 2.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.013 2.125 . . . . 0.0 111.45 151.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -139.63 -6.82 1.31 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.669 1.987 . . . . 0.0 115.262 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -134.21 -24.29 1.64 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.525 1.93 . . . . 0.0 111.528 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 54.1 mt -55.11 107.82 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.091 1.756 . . . . 0.0 108.363 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.7 mtp -56.76 -21.0 25.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 -172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -122.43 19.69 10.48 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.213 1.805 . . . . 0.0 113.725 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.8 t -124.74 94.64 4.25 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.979 1.712 . . . . 0.0 109.819 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.93 25.34 0.19 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-O 116.739 -2.145 . . . . 0.0 111.877 -167.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -138.94 158.11 44.79 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.936 2.368 . . . . 0.0 114.146 -159.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -143.34 -177.65 5.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.21 161.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 C-N-CA 127.734 2.588 . . . . 0.0 116.763 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.493 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 94.66 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 127.013 2.244 . . . . 0.0 111.812 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.2 t70 58.56 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.854 2.462 . . . . 0.0 116.424 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.7 -162.47 32.51 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 126.359 1.933 . . . . 0.0 114.169 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.2 p -124.39 -34.35 2.91 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.115 2.166 . . . . 0.0 115.662 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -69.24 112.71 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 126.365 1.866 . . . . 0.0 110.17 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.96 107.64 0.22 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.814 2.046 . . . . 0.0 112.159 178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -60.45 -57.55 12.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.445 1.098 . . . . 0.0 112.036 -169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -61.62 -26.93 68.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -65.6 -44.89 85.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.555 0.616 . . . . 0.0 109.984 169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -72.03 -34.06 68.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.525 -1.984 . . . . 0.0 115.891 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -147.49 162.12 33.27 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.81 147.2 44.0 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.224 1.949 . . . . 0.0 110.852 163.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.3 132.84 17.72 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.501 1.12 . . . . 0.0 110.855 170.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -133.35 73.12 1.5 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.551 1.167 . . . . 0.0 110.544 -163.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.14 159.16 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.756 1.265 . . . . 0.0 114.194 -165.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -64.09 -24.73 67.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.89 14.59 2.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.375 1.87 . . . . 0.0 115.661 175.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 13.1 p-90 -51.87 -43.09 63.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.325 -1.484 . . . . 0.0 114.345 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -81.19 8.9 7.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.62 114.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 119.952 1.251 . . . . 0.0 108.649 173.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 52.7 mtm -82.01 -18.9 41.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.428 2.291 . . . . 0.0 111.966 173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.88 -19.97 13.92 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.795 2.038 . . . . 0.0 114.587 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.9 t -151.53 -170.12 3.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.37 1.868 . . . . 0.0 112.846 -165.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.46 22.53 1.66 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.846 1.689 . . . . 0.0 115.016 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.33 137.2 32.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 117.908 -1.044 . . . . 0.0 110.802 -168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.72 -173.01 2.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.932 1.693 . . . . 0.0 112.527 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.336 -1.813 . . . . 0.0 116.376 -172.039 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 112.412 -0.275 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.66 -15.48 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 117.367 1.707 . . . . 0.0 117.367 -176.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.09 128.59 12.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 120.382 2.091 . . . . 0.0 111.84 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.76 -139.37 7.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.287 1.422 . . . . 0.0 113.279 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.7 p -142.32 -34.27 0.46 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -172.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.8 133.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 O-C-N 120.74 -1.225 . . . . 0.0 110.069 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.55 129.4 38.2 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 119.632 -1.917 . . . . 0.0 109.947 172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.74 -6.91 6.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 119.094 -2.253 . . . . 0.0 113.681 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -119.48 12.89 12.51 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.826 2.451 . . . . 0.0 113.495 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -62.72 -29.37 70.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.916 2.486 . . . . 0.0 112.626 172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -125.07 -0.41 7.82 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.345 1.858 . . . . 0.0 115.884 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -156.36 167.36 14.54 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.92 1.688 . . . . 0.0 111.87 -167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -64.75 170.39 10.08 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.87 2.38 . . . . 0.0 112.625 167.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.15 49.11 2.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.332 2.653 . . . . 0.0 110.043 165.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -75.36 47.11 0.36 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 130.947 3.699 . . . . 0.0 115.524 -169.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.83 -177.98 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 127.904 2.481 . . . . 0.0 112.09 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -80.15 1.52 27.78 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -115.39 78.91 1.22 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.238 1.815 . . . . 0.0 110.319 173.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -142.88 -0.83 1.14 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -138.04 52.23 1.86 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.579 2.352 . . . . 0.0 112.259 175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.02 109.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.828 2.051 . . . . 0.0 109.362 175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.9 ttt -54.33 -36.57 63.91 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.653 1.581 . . . . 0.0 113.89 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -86.28 -3.05 58.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 t -100.19 176.42 5.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 119.811 1.187 . . . . 0.0 112.441 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.47 -4.96 65.79 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 117.289 1.676 . . . . 0.0 117.289 173.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.06 1.93 . . . . 0.0 111.038 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -146.72 -171.37 3.74 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.022 1.729 . . . . 0.0 112.025 167.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 C-N-CA 128.549 2.976 . . . . 0.0 113.488 174.692 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 CA-C-O 121.029 0.238 . . . . 0.0 113.012 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.91 -41.38 0.02 OUTLIER Glycine 0 CA--C 1.522 0.506 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 165.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -147.4 111.02 4.96 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.079 1.351 . . . . 0.0 111.791 -168.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.04 -173.86 36.74 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 126.301 1.905 . . . . 0.0 114.156 -175.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -119.12 -28.78 5.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.26 2.224 . . . . 0.0 113.1 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 mt -73.45 135.39 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.303 1.041 . . . . 0.0 108.273 171.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.12 133.02 44.01 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.735 -1.228 . . . . 0.0 111.422 171.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -65.18 -52.88 52.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.799 0.839 . . . . 0.0 110.191 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -75.64 16.83 0.34 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.758 2.023 . . . . 0.0 113.378 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -48.53 -37.31 17.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.359 2.263 . . . . 0.0 112.698 -170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -99.23 -66.5 0.9 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.867 1.267 . . . . 0.0 111.621 167.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -139.32 153.44 70.98 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 126.63 1.972 . . . . 0.0 112.483 -169.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.5 154.29 65.51 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.4 2.067 . . . . 0.0 110.513 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.4 mmt -93.74 22.53 5.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 119.99 -1.694 . . . . 0.0 113.951 176.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.0 p80 52.34 2.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 130.289 3.436 . . . . 0.0 118.165 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -93.95 168.46 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -59.37 -21.43 59.84 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.589 3.156 . . . . 0.0 115.686 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -65.64 -4.48 6.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -56.82 -23.6 44.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 167.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.18 11.64 25.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.776 2.43 . . . . 0.0 115.718 175.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.9 mt -123.12 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 123.876 1.798 . . . . 0.0 108.48 -169.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -52.66 -40.13 62.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 129.326 3.05 . . . . 0.0 112.331 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.96 -19.85 61.53 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.725 2.01 . . . . 0.0 114.478 174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 t -131.75 -19.72 2.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -156.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.33 54.17 1.51 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 117.135 -1.925 . . . . 0.0 113.979 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -132.24 156.27 46.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 120.487 2.144 . . . . 0.0 114.016 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -143.24 -177.78 5.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.017 2.127 . . . . 0.0 111.493 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 C-N-CA 125.979 1.752 . . . . 0.0 115.472 173.303 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.21 173.37 30.66 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 124.321 0.962 . . . . 0.0 111.752 163.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 t0 49.3 80.75 0.06 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.079 2.151 . . . . 0.0 113.662 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.39 -169.13 32.33 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 125.387 1.47 . . . . 0.0 112.895 173.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -121.07 -22.16 6.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.932 0.893 . . . . 0.0 113.179 -176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.4 mt -92.0 125.37 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 128.408 2.683 . . . . 0.0 108.842 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.21 126.23 30.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 118.862 0.756 . . . . 0.0 112.218 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.16 -55.31 35.42 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.059 -0.401 . . . . 0.0 110.789 174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -64.56 -17.74 64.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -168.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -15.36 -73.0 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.951 3.301 . . . . 0.0 115.56 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -124.95 21.79 8.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.055 0.942 . . . . 0.0 113.274 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -64.67 158.83 66.08 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.586 1.554 . . . . 0.0 113.754 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.07 -178.27 4.39 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.363 2.042 . . . . 0.0 111.75 165.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.3 mtp 69.36 57.57 0.35 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.759 2.424 . . . . 0.0 110.916 -171.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -71.55 70.74 0.67 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.137 2.175 . . . . 0.0 113.358 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 pp -124.17 -178.47 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 127.807 2.443 . . . . 0.0 111.384 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -62.31 -5.91 2.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 -171.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -73.94 -5.82 43.56 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 119.203 -2.186 . . . . 0.0 116.838 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -177.12 0.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 163.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 56.74 10.2 0.69 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 165.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.8 mm -66.03 151.0 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 119.47 -2.019 . . . . 0.0 107.901 165.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.0 ttm -121.63 -46.7 2.24 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 120.711 -1.243 . . . . 0.0 113.858 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.08 -7.38 1.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 163.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 t -162.9 -179.98 7.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.781 2.432 . . . . 0.0 111.122 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.51 12.18 33.75 Favored Glycine 0 CA--C 1.522 0.513 0 O-C-N 121.508 -0.745 . . . . 0.0 114.88 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -123.5 169.0 11.85 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 119.525 1.663 . . . . 0.0 113.092 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -154.67 -176.97 6.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.478 2.711 . . . . 0.0 111.296 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 126.866 2.174 . . . . 0.0 111.774 171.083 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 CA-C-O 117.574 -1.681 . . . . 0.0 111.783 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.49 165.5 13.82 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 126.515 2.007 . . . . 0.0 109.429 164.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.5 t0 54.02 92.13 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.77 179.57 46.35 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 123.926 0.774 . . . . 0.0 112.682 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 t -94.77 -13.06 26.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 mt -106.96 135.01 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 126.348 1.859 . . . . 0.0 110.41 -172.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.37 120.18 12.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.539 1.063 . . . . 0.0 110.927 174.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -74.65 7.53 2.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -129.53 10.15 5.62 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.383 2.273 . . . . 0.0 111.657 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -41.61 -47.45 3.87 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.641 1.176 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.7 -43.65 0.27 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.251 1.821 . . . . 0.0 112.191 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -47.56 154.36 0.9 Allowed Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 128.048 2.539 . . . . 0.0 115.289 168.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.51 171.01 12.5 Favored 'Trans proline' 0 N--CA 1.45 -1.069 1 C-N-CA 125.759 4.306 . . . . 0.0 114.792 -175.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.91 21.34 6.91 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.859 3.263 . . . . 0.0 112.22 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -51.25 -17.04 0.61 Allowed 'General case' 0 N--CA 1.449 -0.516 1 C-N-CA 132.092 4.157 . . . . 0.0 116.073 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -71.73 151.24 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-O 123.264 1.507 . . . . 0.0 114.145 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -61.59 -16.35 47.27 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.687 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -75.33 -1.55 24.22 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.233 1.813 . . . . 0.0 114.141 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -50.9 -35.59 33.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -79.19 -16.26 56.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 119.968 -1.707 . . . . 0.0 114.262 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.87 105.05 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 119.708 1.14 . . . . 0.0 108.649 -168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.4 ptm -73.62 -22.1 60.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.163 0.985 . . . . 0.0 112.707 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.13 -12.27 54.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 166.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.9 m -131.33 65.57 1.56 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.655 1.182 . . . . 0.0 109.231 -169.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.58 18.53 5.71 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 127.303 2.383 . . . . 0.0 112.826 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -134.46 153.01 52.15 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 123.782 1.753 . . . . 0.0 113.801 -162.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.62 -176.31 5.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 118.79 -2.444 . . . . 0.0 111.912 171.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 C-N-CA 125.704 1.621 . . . . 0.0 112.763 -175.053 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.39 130.39 9.92 Favored Glycine 0 CA--C 1.522 0.487 0 O-C-N 121.133 -1.216 . . . . 0.0 114.299 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.6 t0 55.53 155.67 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.012 3.325 . . . . 0.0 118.646 174.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.65 -171.3 19.09 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 126.777 2.132 . . . . 0.0 111.097 -159.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 95.1 p -134.93 -4.66 2.45 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -77.4 123.16 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 120.596 1.544 . . . . 0.0 107.232 168.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 112.17 1.28 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.92 -28.82 70.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.05 1.74 . . . . 0.0 113.017 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -89.37 -6.63 56.47 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.94 119.61 11.03 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 121.76 2.073 . . . . 0.0 111.6 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.0 t30 51.66 3.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 129.86 3.264 . . . . 0.0 117.308 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -129.67 146.63 62.0 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 130.482 3.513 . . . . 0.0 109.356 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.18 156.17 46.81 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.524 2.149 . . . . 0.0 111.931 -169.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.07 56.44 0.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.213 2.605 . . . . 0.0 109.785 171.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.6 p-80 -71.87 30.02 0.05 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 130.019 3.328 . . . . 0.0 113.526 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.35 150.32 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 129.438 3.095 . . . . 0.0 113.168 -172.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -57.09 -29.7 63.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HA ' HD13 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.7 -3.25 11.44 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 114.427 174.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -55.71 -20.05 13.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -103.72 -1.9 27.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.731 2.012 . . . . 0.0 113.08 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 18' ' ' ASP . 1.4 mp -99.98 98.02 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -171.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.2 mmt -54.22 -31.24 52.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.428 1.891 . . . . 0.0 111.811 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -65.44 -28.76 69.46 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -128.72 63.65 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.466 2.306 . . . . 0.0 110.09 -170.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.8 25.21 9.69 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-O 115.446 -2.863 . . . . 0.0 114.444 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.31 166.85 23.16 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 121.412 2.606 . . . . 0.0 112.824 -158.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -138.19 173.16 11.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.465 1.506 . . . . 0.0 110.99 156.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.594 -175.575 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.498 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.88 -75.74 1.3 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 125.113 1.34 . . . . 0.0 111.858 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -85.04 146.79 27.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 123.456 1.598 . . . . 0.0 112.76 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.43 -150.21 21.74 Favored Glycine 0 C--N 1.335 0.495 0 O-C-N 120.31 -1.493 . . . . 0.0 112.941 169.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.9 m -124.69 -49.92 1.75 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.974 1.31 . . . . 0.0 110.672 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.31 124.13 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 125.822 1.649 . . . . 0.0 108.099 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.36 130.4 42.78 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 173.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -77.5 -17.06 58.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.793 -1.817 . . . . 0.0 113.277 -157.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -70.07 -3.79 18.13 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 169.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -46.22 -45.74 17.18 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -112.11 95.48 5.49 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 116.118 -1.896 . . . . 0.0 108.056 165.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 71.13 145.27 0.11 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 129.421 3.088 . . . . 0.0 112.938 174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -63.27 149.89 90.07 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.146 1.897 . . . . 0.0 112.718 175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -62.74 112.72 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.023 1.329 . . . . 0.0 110.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -80.99 -1.0 42.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.973 1.309 . . . . 0.0 114.475 -171.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.13 173.37 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.241 1.417 . . . . 0.0 111.235 162.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -68.4 -32.31 72.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 119.007 -2.308 . . . . 0.0 113.519 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -83.42 103.72 13.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 119.893 1.224 . . . . 0.0 111.043 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -142.13 -25.32 0.66 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.77 -11.68 60.71 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.3 mp -72.18 92.38 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.489 1.116 . . . . 0.0 108.373 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 96.8 mmm -57.83 -27.23 63.0 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.93 -16.24 62.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.354 1.862 . . . . 0.0 113.756 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 t -152.72 96.07 2.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.052 1.341 . . . . 0.0 110.288 -175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.39 35.24 0.39 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 125.327 1.441 . . . . 0.0 113.064 -175.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -130.95 174.21 10.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.736 1.614 . . . . 0.0 113.936 -167.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -152.14 179.65 8.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.475 2.31 . . . . 0.0 112.581 170.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.825 3.107 . . . . 0.0 111.829 169.735 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.52 100.1 0.57 Allowed Glycine 0 CA--C 1.522 0.471 0 CA-C-N 120.527 2.163 . . . . 0.0 113.899 174.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 57.2 160.98 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.516 2.326 . . . . 0.0 116.293 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.79 -143.48 16.94 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.044 -1.66 . . . . 0.0 109.184 -160.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -158.96 -8.56 0.07 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 172.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.5 mt -71.79 124.34 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.48 110.59 0.58 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.811 1.644 . . . . 0.0 113.041 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.68 -6.64 32.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.234 1.413 . . . . 0.0 113.645 -175.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.56 -7.16 19.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 127.136 2.174 . . . . 0.0 114.607 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -91.37 133.63 35.29 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.235 0.925 . . . . 0.0 113.276 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t30 55.41 18.46 2.62 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.156 2.182 . . . . 0.0 115.234 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -141.91 158.04 63.01 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 117.974 -1.013 . . . . 0.0 111.694 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -73.65 159.87 45.02 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 123.294 2.663 . . . . 0.0 110.203 163.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -121.74 -85.22 0.66 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.879 1.672 . . . . 0.0 110.63 -164.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 62.29 -6.47 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 130.941 3.696 . . . . 0.0 117.324 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.04 156.55 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 119.558 -1.964 . . . . 0.0 112.493 164.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.49 16.17 0.15 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -90.23 -3.27 57.92 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.794 1.638 . . . . 0.0 115.068 168.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 31.8 p-90 -62.02 -7.87 4.51 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -119.01 -3.76 10.65 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.945 2.498 . . . . 0.0 114.182 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.9 mt -123.05 101.9 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -160.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 71.6 mmm -60.14 -29.51 68.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -164.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.63 -50.76 69.94 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.671 1.588 . . . . 0.0 114.475 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 p -86.15 5.11 35.46 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -166.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.18 31.37 2.61 Favored Glycine 0 CA--C 1.522 0.531 0 O-C-N 119.647 -1.908 . . . . 0.0 115.133 -171.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -127.62 165.4 20.03 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 119.501 1.65 . . . . 0.0 114.366 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -146.06 -173.08 4.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.65 1.98 . . . . 0.0 112.097 159.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.549 2.5 . . . . 0.0 110.843 175.405 . . . . . . . . 0 0 . 1 stop_ save_